Amino Acid Producing Microorganism And A Method For Producing An Amino Acid

Abstract

A microorganism is provided which has an ability to produce an L-amino acid such as L-lysine, L-tryptophan, L-phenylalanine, L-valine, L-leucine, L-isoleucine and L-serine, and has been modified to increase the activity of pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase. This microorganism is cultured in a medium containing ethanol or an aliphatic acid as the carbon source to produce and accumulate the L-amino acid in the medium or cells, and the L-amino acid is collected from the medium or the cells.

Description

[0001] This application is a divisional application under 35 U.S.C. .sctn.120 of U.S. patent application Ser. No. 12/202,476, filed on Sep. 2, 2008, which claims priority under 35 U.S.C. .sctn.119 to Japanese Patent Application No. 2007-228733, filed Sep. 4, 2007, both of which are incorporated by reference in their entireties. The Sequence Listing in electronic format filed herewith is also hereby incorporated by reference in its entirety (File Name: US-372D_Seq_List; File Size: 210 KB; Date Created: Dec. 10, 2009).

TECHNICAL FIELD

[0002] The present invention relates to a microorganism which produces an L-amino acid and a method for producing an L-amino acid. L-lysine and L-tryptophan are widely used as feed additives, etc. L-phenylalanine is used as a raw material in the production of sweeteners. L-valine, L-leucine, and L-isoleucine are used for amino acid infusions or supplements. L-serine is useful as a food additive and a raw material in the production of cosmetics, etc.

BACKGROUND ART

[0003] Methods for production of a target substance, such as an L-amino acid, by fermentation of a microorganism have been reported. The microorganisms used for this purpose include wild-type microorganisms (wild-type strain), auxotrophic strains derived from wild-type strains, metabolic regulation mutant strains derived from wild-type strains which are resistant to various drugs, strains which act as both auxotrophic and metabolic regulation mutants, and so forth.

[0004] In recent years, recombinant DNA techniques have been used in the production of target substances by fermentation. For example, it is well-known that L-amino acid productivity of a microorganism can be improved by enhancing expression of a gene encoding an L-amino acid biosynthetic enzyme or by enhancing uptake of a carbon source to the L-amino acid biosynthesis system.

[0005] For example, known methods include, for L-lysine, enhancing expression of genes encoding enzymes such as dihydrodipicolinate synthase, aspartokinase, dihydrodipicolinate reductase, diaminopimelate decarboxylase, and diaminopimelate dehydrogenase (U.S. Pat. No. 6,040,160), reducing the activities of homoserine dehydrogenase and lysine decarboxylase (U.S. Pat. No. 5,827,698), reducing the activity of the malic enzyme (WO2005/010175), and so forth.

[0006] For L-tryptophan, desensitization to the feedback inhibition of phosphoglycerate dehydrogenase and anthranilate synthase (U.S. Pat. No. 6,180,373), deletion of tryptophanase (U.S. Pat. No. 4,371,614), and so forth are known.

[0007] For L-phenylalanine, desensitization to the feedback inhibition of chorismate mutase-prephenate dehydratase (U.S. Pat. No. 5,354,672), deletion of chorismate mutase-prephenate dehydrogenase and tyrosine repressor (WO03/044191), and so forth are known.

[0008] For L-valine, a mutant strain requiring lipoic acid for its growth and/or which is deficient in H.sup.+-ATPase (U.S. Pat. No. 5,888,783), and so forth are known. For L-leucine, desensitization to the feedback inhibition of isopropyl malate synthase (U.S. Pat. No. 6,403,342) and so forth are known, and for L-isoleucine, increasing the expression of genes encoding threonine deaminase and acetohydroxy acid synthase (U.S. Pat. No. 5,998,178), and so forth are known.

[0009] For L-serine, a strain containing 3-phosphoglycerate dehydrogenase which is desensitized to feedback inhibition by serine (U.S. Pat. No. 5,618,716), a bacterium having L-serine-producing ability and at least phosphoserine phosphatase activity, phosphoserine transaminase activity, or both, is enhanced, a bacterium deficient in L-serine decomposition ability (U.S. Pat. No. 6,037,154), a bacterium resistant to azaserine or .beta.-(2-thienyl)-DL-alanine and having L-serine-producing ability (U.S. Pat. No. 6,258,573), and so forth are known.

SUMMARY OF THE INVENTION

[0010] The present invention provides a bacterial strain which can efficiently produce an L-amino acid. A method is also provided for efficiently producing an L-amino acid using such a strain.

[0011] Conventional L-amino acid production is mainly based on maintaining the supply of acetyl-CoA to the TCA cycle by pyruvate dehydrogenase using sugar as the carbon source. However, since the reaction catalyzed by pyruvate dehydrogenase is accompanied by decathoxylation, one molecule of CO.sub.2 is inevitably released. Therefore, in order to further increase the productivity, it is necessary to decrease this decathoxylation. As a result, ethanol and aliphatic acids can be used as the carbon source which provides acetyl-CoA. Also, the enzymatic activity of pyruvate synthase can be increased. This enzyme catalyzes carbon dioxide fixation, or pyruvate:NADP.sup.+ oxidoreductase. Furthermore, L-amino acid production can be improved by increasing the enzymatic activity of ferredoxin-NADP.sup.+ reductase, which reduces ferredoxin or flavodoxin from the oxidized proteins, and is required for the enzymatic activity of pyruvate synthase. Also, the ability to produce ferredoxin or flavodoxin can be increased.

[0012] It is an aspect of the present invention to provide a microorganism which has an ability to produce an L-amino acid selected from the group consisting of L-lysine, L-tryptophan, L-phenylalanine, L-valine, L-leucine, L-isoleucine and L-serine, and has been modified to increase the activity of pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase.

[0013] It is a further aspect of the present invention to provide the aforementioned microorganism, which is modified to increase the activity of pyruvate synthase.

[0014] It is a further aspect of the present invention to provide the aforementioned microorganism, which is modified to increase the activity of pyruvate:NADP.sup.+ oxidoreductase.

[0015] It is a further aspect of the present invention to provide the aforementioned microorganism, wherein the activity of pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase is increased by a method selected from the group consisting of [0016] A) increasing expression of the gene encoding pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase, [0017] b) increasing translation of the gene, and [0018] c) combinations thereof.

[0019] It is a further aspect of the present invention to provide the aforementioned microorganism, wherein the activity of pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase is increased by increasing the copy number of the gene encoding pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase, or by modifying an expression control sequence of the gene.

[0020] It is a further aspect of the present invention to provide the aforementioned microorganism, wherein pyruvate synthase is selected from the group consisting of:

[0021] (A) a polypeptide comprising the amino acid sequence shown in SEQ ID NO: 2,

[0022] (B) a polypeptide comprising the amino acid sequence shown in SEQ ID NO: 2, but which includes one or more substitutions, deletions, insertions, or additions of one or several amino acid residues, and having pyruvate synthase activity,

[0023] (C) a polypeptide comprising the amino acid sequence shown in SEQ ID NO: 4,

[0024] (D) a polypeptide comprising the amino acid sequence shown in SEQ ID NO: 4, but which includes one or more substitutions, deletions, insertions, or additions of one or several amino acid residues and having pyruvate synthase activity.

[0025] It is a further aspect of the present invention to provide the aforementioned microorganism, wherein the gene encoding pyruvate synthase is selected from the group consisting of:

[0026] (a) a DNA comprising the nucleotide sequence shown in SEQ ID NO: 1,

[0027] (b) a DNA which is able to hybridize with a sequence complementary to the nucleotide sequence shown in SEQ ID NO: 1, or a probe which is prepared from the nucleotide sequence, under stringent conditions, and encoding a polypeptide having pyruvate synthase activity,

[0028] (c) a DNA comprising the nucleotide sequence shown in SEQ ID NO: 3,

[0029] (d) a DNA which is able to hybridize with a sequence complementary to the nucleotide sequence shown in SEQ ID NO: 3, or a probe which can be prepared from the nucleotide sequence, under stringent conditions, and encoding a polypeptide having pyruvate synthase activity.

[0030] (8) The aforementioned microorganism, wherein NADP.sup.+ oxidoreductase is selected from the group consisting of:

[0031] (A) a polypeptide comprising the amino acid sequence shown in SEQ ID NO: 6,

[0032] (B) a polypeptide comprising the amino acid sequence shown in SEQ ID NO: 6, but which includes one or more substitutions, deletions, insertions or addition of one or several amino acid residues and having pyruvate:NADP.sup.+ oxidoreductase activity.

[0033] It is a further aspect of the present invention to provide the aforementioned microorganism, wherein the gene encoding pyruvate:NADP.sup.+ oxidoreductase is selected from the group consisting of:

[0034] (a) a DNA comprising the nucleotide sequence shown in SEQ ID NO: 5,

[0035] (b) a DNA which is able to hybridize with a sequence complementary to the nucleotide sequence shown in SEQ ID NO: 5, or a probe which can be prepared from the nucleotide sequence, under stringent conditions, and encoding a polypeptide having pyruvate:NADP.sup.+ oxidoreductase activity.

[0036] It is a further aspect of the present invention to provide the aforementioned microorganism, which has been modified to increase the activity of ferredoxin-NADP.sup.+ reductase.

[0037] It is a further aspect of the present invention to provide the aforementioned microorganism, which has been modified to improve the ability of said microorganism to produce ferredoxin or flavodoxin.

[0038] It is a further aspect of the present invention to provide the aforementioned microorganism, which has been modified to decrease pyruvate dehydrogenase activity.

[0039] It is a further aspect of the present invention to provide the aforementioned microorganism, which has been modified so that it can aerobically assimilate ethanol.

[0040] It is a further aspect of the present invention to provide the aforementioned microorganism, wherein said microorganism is a bacterium belonging to a genus selected from the group consisting of Escherichia, Enterobacter, Pantoea, Klebsiella and Serratia.

[0041] It is a further aspect of the present invention to provide the aforementioned microorganism, which is a coryneform bacterium.

[0042] It is a further aspect of the present invention to provide a method for producing an L-amino acid comprising culturing the aforementioned microorganism in a medium to produce an L-amino acid selected from the group consisting of L-lysine, L-tryptophan, L-phenylalanine, L-valine, L-leucine, L-isoleucine, and L-serine, and collecting the L-amino acid from the medium or the microorganism.

[0043] It is a further aspect of the present invention to provide the aforementioned method, wherein the medium contains ethanol or an aliphatic acid as the carbon source.

BRIEF DESCRIPTION OF THE DRAWINGS

[0044] FIG. 1 is a photograph showing the result of Western blotting showing expression of the pyruvate:NADP.sup.+ oxidoreductase (PNO) gene derived from Euglena gracilis.

[0045] Lane 1: Markers

[0046] Lane 2: Crude enzyme extract obtained from WC196.DELTA.cadA.DELTA.ldc/pCABD2/pMW-Pthr

[0047] Lane 3: Crude enzyme extract obtained from WC196.DELTA.cadA.DELTA.ldc/pCABD2/pMW-Pthr-PNO.

DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0048] Hereinafter, the present invention will be explained in detail.

[0049] <1> Microorganism

[0050] The microorganism has the ability to produced an L-amino acid, such as L-lysine, L-tryptophan, L-phenylalanine, L-valine, L-leucine, L-isoleucine, and L-serine, and has been modified to increase an activity of pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase.

[0051] The "L-amino acid" means L-lysine, L-tryptophan, L-phenylalaine, L-valine, L-leucine, L-isoleucine, and L-serine, unless specifically mentioned otherwise.

[0052] The phrase "ability to produce an L-amino acid (L-amino acid-producing ability)" refers to the ability to produce an L-amino acid and cause accumulation of the L-amino acid in the cells of the microorganism or into the medium to such a degree that the L-amino acid can be collected from the cells or medium when the microorganism is cultured in the medium. One or more amino acids may be produced by the microorganism. The microorganism may inherently have the ability to produce the L-amino acid, or the ability may be imparted by modifying the microorganism using mutagenesis or recombinant DNA techniques, or by introducing the gene described herein to the microorganism.

[0053] The expression "activity of pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase is increased" or "to increase the activity of pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase" means that the activity of pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase increases in a microorganism which inherently has pyruvate synthase and/or pyruvate:NADP.sup.+ oxidoreductase, or that the activity of pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase is imparted to a microorganism to which pyruvate synthase and pyruvate:NADP.sup.+ oxidoreductase are not native.

[0054] <1-1> Imparting the Ability to Produce an L-Amino Acid

[0055] The microorganism can be obtained by modifying a parent strain which is able to produce an L-amino acid so that the activity of pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase, or both, is increased. The microorganism can also be obtained by modifying a parent strain to have increased activity of pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase, and then imparting or enhancing the ability to produce L-amino acids.

[0056] Methods for imparting the L-amino acid-producing ability to a microorganism, and microorganisms imparted with L-amino acid-producing ability, will be exemplified below, but the methods are not limited to these.

[0057] Microorganisms belonging to .gamma.-Proteobacteria such as bacteria belonging to the genera Escherichia, Enterobacter, Pantoea, Klebsiella, Serratia, Erwinia, Salmonella, Morganella, etc.; coryneform bacteria such as bacteria belonging to the genera Brevibacterium, Corynebacterium, and Microbacterium; and microorganisms belonging to the genera Alicyclobacillus, Bacillus, and Saccharomyces can be used. .gamma.-proteobacteria include those classified according to the NCBI (National Center for Biotechnology Information) taxonomy database and can be used.

[0058] Examples of Escherichia bacteria include Escherichia coli and so forth. When Escherichia coli strains are bred by using genetic engineering techniques, the E. coli K12 strain and derivatives thereof, the Escherichia coli MG1655 strain (ATCC 47076), and the W3110 strain (ATCC 27325) can be used. The Escherichia coli K12 strain was isolated at Stanford University in 1922. This strain is a lysogenic bacterium of .lamda. phage and has the F-factor. This strain is a highly versatile strain from which genetic recombinants can be constructed by conjugation or the like. Furthermore, the genome sequence of the Escherichia coli K12 strain has been determined, and the genetic information can be used freely. The Escherichia coli K12 strain and derivatives thereof are available from the American Type Culture Collection (ATCC, Address: P.O. Box 1549, Manassas, Va. 20108, United States of America).

[0059] In particular, Pantoea bacteria, Erwinia bacteria, and Enterobacter bacteria are classified as .gamma.-proteobacteria, and they are taxonomically very close to one another (J. Gen. Appl. Microbiol., 1997, 43, 355-361; Int. J. Syst. Bacteriol., 1997, 43, 1061-1067). In recent years, some bacteria belonging to the genus Enterobacter were reclassified as Pantoea agglomerans, Pantoea dispersa, or the like, on the basis of DNA-DNA hybridization experiments etc. (International Journal of Systematic Bacteriology, July 1989, 39:337-345). Furthermore, some bacteria belonging to the genus Erwinia were reclassified as Pantoea ananas or Pantoea stewartii (refer to Int. J. Syst. Bacteriol., 1993, 43:162-173).

[0060] Examples of the Enterobacter bacteria include, but are not limited to, Enterobacter agglomerans, Enterobacter aerogenes, and so forth. Specifically, the strains exemplified in European Patent Publication No. 952221 can be used. A typical strain of the genus Enterobacter is the Enterobacter agglomeranses ATCC 12287 strain.

[0061] Typical strains of the Pantoea bacteria include, but are not limited to, Pantoea ananatis, Pantoea stewartii, Pantoea agglomerans, and Pantoea citrea. Specific examples include the following strains:

[0062] Pantoea ananatis AJ13355 (PERM BP-6614, European Patent Publication No. 0952221)

[0063] Pantoea ananatis AJ13356 (FERM BP-6615, European Patent Publication No. 0952221)

[0064] Although these strains are described as Enterobacter agglomerans in European Patent Publication No. 0952221, they are currently classified as Pantoea ananatis on the basis of nucleotide sequence analysis of the 16S rRNA etc., as described above.

[0065] Examples of the Erwinia bacteria include, but are not limited to, Erwinia amylovora and Erwinia carotovora, and examples of the Klebsiella bacteria include Klebsiella planticola. Specific examples include the following strains:

[0066] Erwinia amylovora ATCC 15580

[0067] Erwinia carotovora ATCC 15713

[0068] Klebsiella planticola AJ13399 (FERM BP-6600, European Patent Publication No. 955368)

[0069] Klebsiella planticola AJ13410 (FERM BP-6617, European Patent Publication No. 955368).

[0070] The coryneform bacteria are a group of microorganisms defined in Bergey's Manual of Determinative Bacteriology, 8th Ed., p. 599, 1974, and include aerobic, Gram-positive, and nonacid-fast bacilli which are not able to sporulate, and which were originally classified into the genus Brevibacterium, but are now recognized as being in the genus Corynebacterium (Liebl, W., Ehrmann, M., Ludwig, W., and Schleifer, K. H., 1991, Int. J. Syst. Bacteriol. 41:255-260). These bacteria also include bacteria belonging to the genus Brevibacterium or Microbacterium, which are closely related to the genus Corynebacterium.

[0071] Specific examples of coryneform bacteria which are used to produce amino acids of the L-glutamic acid family include the following:

[0072] Corynebacterium acetoacidophilum

[0073] Corynebacterium acetoglutamicum

[0074] Corynebacterium alkanolyticum

[0075] Corynebacterium callunae

[0076] Corynebacterium glutamicum

[0077] Corynebacterium lilium (Corynebacterium glutamicum)

[0078] Corynebacterium melassecola

[0079] Corynebacterium thermoaminogenes (Corynebacterium efficiens)

[0080] Corynebacterium herculis

[0081] Brevibacterium divaricatum (Corynebacterium glutamicum)

[0082] Brevibacterium flavum (Corynebacterium glutamicum)

[0083] Brevibacterium immariophilum

[0084] Brevibacterium lactofermentum (Corynebacterium glutamicum)

[0085] Brevibacterium roseum

[0086] Brevibacterium saccharolyticum

[0087] Brevibacterium thiogenitalis

[0088] Brevibacterium ammoniagenes (Corynebacterium ammoniagenes)

[0089] Brevibacterium album

[0090] Brevibacterium cerinum

[0091] Microbacterium ammoniaphilum

[0092] Specifically, the following strains can be mentioned:

[0093] Corynebacterium thermoaminogenes AJ12340 (FIRM BP-1539)

[0094] Corynebacterium glutamicum ATCC 13032

[0095] Brevibacterium flavum (Corynebacterium glutamicum) ATCC 13826, ATCC 14067

[0096] Brevibacterium lactofermentum (Corynebacterium glutamicum) ATCC 13665, ATCC 13869

[0097] Brevibacterium ammoniagenes (Corynebacterium ammoniagenes) ATCC 6871

[0098] The bacterium may be able to assimilate ethanol. The bacterium may inherently be able to assimilate ethanol, or the ability to assimilate ethanol may be imparted or increased recombinantly. Escherichia coli is known to have AdhE, which has activities of acetaldehyde dehydrogenase and alcohol dehydrogenase, which are enzymes which can generate ethanol under anaerobic conditions, and catalyze the reactions described below.

Acetyl-CoA+NADH+H.sup.+=acetaldehyde+NAD.sup.++CoA

Acetaldehyde+NADH+H.sup.++=ethanol+NAD.sup.+

[0099] Although Escherichia coli cannot assimilate ethanol under aerobic conditions, the mutation of AdhE results in Escherichia coli to be able to aerobically assimilate ethanol (Clark D. P., and Cronan, J. E. Jr., 1980, J. Bacteriol., 144:179-184; Membrillo-Hernandez, J. et al., 2000, J. Biol. Chem., 275:33869-33875). The specific mutation is that the glutamic acid at position 569 in Escherichia coli AdhE is replaced with an amino acid other than glutamic acid and aspartic acid, such as lysine (Glu568Lys or E568K).

[0100] The aforementioned AdhE mutant may further include the following additional mutations:

[0101] A) Replacement of the glutamic acid at position 560 with another amino acid, such as lysine,

[0102] B) Replacement of the phenylalanine at position 566 with another amino acid,

[0103] C) Replacement of the glutamic acid at position 22, methionine at position 236, tyrosine at position 461, isoleucine at position 554, and alanine at position 786, with glycine, valine, cysteine, serine, and valine, respectively, or

[0104] D) a combination of the aforementioned mutations.

[0105] It is known that Corynebacterium glutamicum has two or more kinds of alcohol dehydrogenases, and can aerobically assimilate ethanol (Pelechova J, Smekal F, Koura V, Plachy J and Krumphanzl V, 1980, Folia Microbiol (Praha) 25:341-346).

[0106] The bacterium may be able to assimilate fat, oil, or an aliphatic acid. The bacterium may inherently be able to assimilate fat, oil, or aliphatic acids, or the ability can be imparted or increased recombinantly. Escherichia coli is known to be able to assimilate long chain aliphatic acids having a length of 12 or longer (Clark D. P. and Cronan J. E., 1996, In Escherichia coli and Salmonella: Cellular and Molecular Biology/Second Edition (Neidhardt, F. C. Ed.) pp. 343-357). Furthermore, Escherichia coli strains which were mutated to assimilate short- to medium-chain aliphatic acids are known (Nunn, W. D. et al., 1979, J. Biol. Chem., 254:9130-9134; Salanitro, J. P. and Wegener, W. S., 1971, J. Bacteriol., 108:885-892).

[0107] A bacterium which is able to produce an L-amino acid means that the bacterium can produce and cause accumulation of an L-amino acid in the medium in such an amount that the L-amino acid can be collected from the medium when the bacterium is cultured in the medium. The target L-amino acid can accumulate in the medium in an amount not less than 0.5 g/L, more preferably not less than 1.0 g/L. The "L-amino acid" encompasses L-lysine, L-tryptophan, L-phenylalanine, L-valine, L-leucine, L-isoleucine, and L-serine. L-Lysine and L-tryptophan are especially preferred.

[0108] Hereinafter, methods for imparting an L-amino acid-producing ability to such bacteria as mentioned above, or methods for enhancing an L-amino acid-producing ability of such bacteria as described above, are described.

[0109] To impart the ability to produce an L-amino acid, methods conventionally employed in the breeding of coryneform bacteria or bacteria of the genus Escherichia (see "Amino Acid Fermentation", Gakkai Shuppan Center (Ltd.), 1st Edition, published May 30, 1986, pp. 77-100) can be used. Such methods include by acquiring the properties of an auxotrophic mutant, an analogue-resistant strain, or a metabolic regulation mutant, or by constructing a recombinant strain so that it overexpresses an L-amino acid biosynthesis enzyme. Here, in the breeding of an L-amino acid-producing bacteria, one or more of the above described properties may be imparted. The expression of L-amino acid biosynthesis enzyme(s) can be enhanced alone or in combinations of two or more. Furthermore, the methods of imparting properties such as an auxotrophic mutation, analogue resistance, or metabolic regulation mutation may be combined with the methods of enhancing the biosynthesis enzymes.

[0110] An auxotrophic mutant strain, L-amino acid analogue-resistant strain, or metabolic regulation mutant strain with the ability to produce an L-amino acid can be obtained by subjecting a parent strain or wild-type strain to conventional mutatagenesis, such as exposure to X-rays or UV irradiation, or treatment with a mutagen such as N-methyl-N-nitro-N-nitrosoguanidine, etc., then selecting those which exhibit autotrophy, analogue resistance, or a metabolic regulation mutation and which also have the ability to produce an L-amino acid.

[0111] Moreover, L-amino acid-producing ability can also be imparted or enhanced by enhancing an enzymatic activity by gene recombination. Examples of the method for enhancing enzymatic activity include, for example, modifying the bacterium to increase expression of a gene encoding an enzyme involved in the biosynthesis of an L-amino acid. Gene expression can also be increased by introducing an amplification plasmid prepared by introducing a DNA fragment containing the gene into an appropriate plasmid, for example, a plasmid vector containing at least a gene responsible for replication and proliferation of the plasmid in the microorganism, increasing the copy number of the gene on the chromosome by conjugation, transfer or the like, or introducing a mutation into the promoter region of the gene (refer to International Patent Publication WO95/34672).

[0112] When a target gene is introduced into the aforementioned amplification plasmid or chromosome, any promoter may be used to express the gene so long as the chosen promoter functions in the L-amino acid-producing bacterium. The promoter may be inherent to the gene, or may be a modified form. Expression of the gene can also be controlled by suitably choosing a promoter that potently functions in the L-amino acid-producing bacterium, or by approximating the -35 and -10 regions of the promoter close to the consensus sequence. The methods for enhancing expression of genes encoding the target enzymes are described in WO00/18935, European Patent Publication No. 1010755, and so forth.

[0113] Examples of methods for imparting L-amino acid-producing ability to a bacterium and bacteria imparted with an L-amino acid-producing ability will be described below.

[0114] L-Lysine-Producing Bacteria

[0115] Examples of L-lysine-producing Escherichia bacteria include mutants which are resistant to L-lysine analogues. L-lysine analogues inhibit growth of the bacteria, but this inhibition is fully or partially desensitized when L-lysine is present in the medium. Examples of the L-lysine analogues include, but are not limited to, oxalysine, lysine hydroxamate, S-(2-aminoethyl)-L-cysteine (AEC), .gamma.-methyllysine, .alpha.-chlorocaprolactam, and so forth. Mutants which are resistant to these lysine analogues can be obtained by subjecting the bacteria to a conventional artificial mutagenesis treatment. Specific examples of bacterial strains useful for producing L-lysine include Escherichia coli AJ11442 (PERM BP-1543, NRRLB-12185; see U.S. Pat. No. 4,346,170) and Escherichia coli VL611. In these microorganisms, feedback inhibition of aspartokinase by L-lysine is desensitized.

[0116] The WC196 strain is an L-lysine-producing Escherichia coli bacterium. This bacterial strain was bred by conferring AEC resistance to the W3110 strain, which was derived from Escherichia coli K-12. The resulting strain was designated Escherichia coli AJ13069 and was deposited at the National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology (currently National Institute of Advanced Industrial Science and Technology, International Patent Organism Depositary, Tsukuba Central 6, 1-1, Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, 305-8566, Japan) on Dec. 6, 1994 and received an accession number of PERM P-14690. Then, it was converted to an international deposit under the provisions of the Budapest Treaty on Sep. 29, 1995, and received an accession number of PERM BP-5252 (U.S. Pat. No. 5,827,698).

[0117] Examples of L-lysine-producing bacteria and parent strains which can be used to derive L-lysine-producing bacteria also include strains in which expression is increased of one or more genes encoding an L-lysine biosynthetic enzyme. Examples of such enzymes include, but are not limited to, dihydrodipicolinate synthase (dapA), aspartokinase (lysC), dihydrodipicolinate reductase (dapB), diaminopimelate decarboxylase (lysA), diaminopimelate dehydrogenase (ddh) (U.S. Pat. No. 6,040,160), phosphoenolpyrvate carboxylase (ppc), aspartate semialdehyde dehydrogenase (asd), diaminopimelate epimerase (dapF), tetrahydrodipicolinate succinylase (dapD), succinyl diaminopimelate deacylase (dapE), and aspartase (aspA) (EP 1253195 A). The abbreviations in parentheses are the gene names which correspond to the enzymes, and this convention is used throughout this specification. Dihydrodipicolinate reductase, diaminopimelate decathoxylase, diaminopimelate dehydrogenase, phosphoenolpyrvate carboxylase, aspartate aminotransferase, diaminopimelate epimerase, aspartate semialdehyde dehydrogenase, tetrahydrodipicolinate succinylase, and succinyl diaminopimelate deacylase are especially preferred. In addition, the chosen parent strains may overexpress the cyo gene, which is involved in energy efficiency (EP 1170376 A), the gene encoding nicotinamide nucleotide transhythogenase (pntAB) (U.S. Pat. No. 5,830,716), the ybjE gene (WO2005/073390), or combinations thereof.

[0118] Examples of L-lysine-producing bacteria and parent strains which can be used to derive L-lysine-producing bacteria also include strains with decreased or no activity of an enzyme that catalyzes a reaction which produces a compound other than L-lysine via a biosynthetic pathway which branches off from the biosynthetic pathway of L-lysine. Examples of these enzymes include homoserine dehydrogenase, lysine decathoxylase (U.S. Pat. No. 5,827,698), and the malic enzyme (WO2005/010175).

[0119] Preferred examples of L-lysine-producing bacteria include Escherichia coli WC196.DELTA.mez/pCABD2 (WO2005/010175), WC196.DELTA.cadA.DELTA.ldc/pCABD2 (WO2006/078039), and so forth. The WC196.DELTA.mez/pCABD2 strain is obtained by introducing the plasmid pCABD2, which is disclosed in U.S. Pat. No. 6,040,160, into the WC196 strain with disrupted sfcA and b2463 genes, which encode the malic enzyme. The nucleotide sequences of the sfcA and b2463 genes and the amino acid sequences encoded by these genes are shown in SEQ ID NOS: 52 to 55.

[0120] The WC196.DELTA.cadA.DELTA.ldc/pCABD2 strain is obtained by introducing the plasmid pCABD2, which is disclosed in U.S. Pat. No. 6,040,160, into a WC196 strain with disrupted cadA and ldcC genes, which encode lysine decarboxylase. The pCABD2 plasmid contains a mutant Escherichia coli dapA gene encoding a dihydrodipicolinate synthase (DDPS) which is desensitized to feedback inhibition by L-lysine, a mutant Escherichia coli lysC gene which encodes aspartokinase III which is desensitized to feedback inhibition by L-lysine, the Escherichia coli dapB gene encoding dihythodipicolinate reductase, and the Brevibacterium lactofermentum ddh gene encoding diaminopimelate dehydrogenase.

[0121] L-Tryptophan-Producing Bacteria

[0122] Examples of L-tryptophan-producing bacteria and parent strains which can be used to derive L-tryptophan-producing bacteria include, but are not limited to, strains belonging to the genus Escherichia, such as E. coli JP4735/pMU3028 (DSM10122) and JP6015/pMU91 (DSM10123), which is deficient in tryptophanyl-tRNA synthetase encoded by a mutant bpS gene (U.S. Pat. No. 5,756,345); E. coli SV164 (pGH5) having a serA allele encoding phosphoglycerate dehydrogenase not subject to feedback inhibition by serine and a trpE allele encoding anthranilate synthase not subject to feedback inhibition by tryptophan (U.S. Pat. No. 6,180,373); E. coli AGX17 (pGX44) (NRRLB-12263) and AGX6(pGX50)aroP (NRRL B-12264) deficient in the enzyme tryptophanase (U.S. Pat. No. 4,371,614); E. coli AGX17/pGX50,pACKG4-pps with enhanced phosphoenolpyruvate-producing ability (WO97/08333, U.S. Pat. No. 6,319,696), and so forth. L-typtophan-producing Escherichia bacteria with enhanced activity of the protein encoded by the yedA or yddG genes may also be used (U.S. Published Patent Applications 2003/0148473 A1 and 2003/0157667 A1).

[0123] Examples of L-tryptophan-producing bacteria and parent strains which can be used to derive L-tryptophan-producing bacteria also include strains with enhanced activity of one or more enzymes such as anthranilate synthase (trpE), phosphoglycerate dehydrogenase (serA), 3-deoxy-D-arabinoheptulosonate-7-phosphate synthase (aroG), 3-dehythoquinate synthase (aroB), shikidmate dehydrogenase (aroE), shikimate kinase (aroL), 5-enolpyruvylshikidmate-3-phosphate synthase (aroA), chorismate synthase (aroC), prephenate dehydratase, chorismate mutase, and tryptophan synthase (trpAB). Prephenate dehydratase and chorismate mutase are encoded by the pheA gene as a bifunctional enzyme (CM-PD). Phosphoglycerate dehydrogenase, 3-deoxy-D-arabinoheptulosonate-7-phosphate synthase, 3-dehydroquinate synthase, shikimate dehydratase, shikimate kinase, 5-enolpyruvylshikimate-3-phosphate synthase, chorismate synthase, prephenate dehydratase, chorismate mutase-prephenate dehydratase are especially preferred. The anthranilate synthase and phosphoglycerate dehydrogenase are both subject to feedback inhibition by L-tryptophan and L-serine, and therefore a mutation desensitizing the feedback inhibition may be introduced into these enzymes. Specific examples of strains having such a mutation include E. coli SV164 which harbors desensitized anthranilate synthase, and a transformant strain obtained by introducing pGH5 (WO 94/08031) into E. coli SV164, which contains a mutant serA gene encoding feedback inhibition-desensitized phosphoglycerate dehydrogenase.

[0124] Examples of L-tryptophan-producing bacteria and parent strains which can be used to derive L-tryptophan-producing bacteria also include strains transformed with the tryptophan operon which contains a gene encoding desensitized anthranilate synthase (JP 57-71397 A, JP 62-244382 A, U.S. Pat. No. 4,371,614). Moreover, L-tryptophan-producing ability may be imparted by enhancing the expression of the gene which encodes tryptophan synthase, which is part of the tryptophan operon (trpBA). The tryptophan synthase consists of .alpha. and .beta. subunits which are encoded by trpA and trpB, respectively. In addition, L-tryptophan-producing ability may be improved by enhancing expression of the isocitrate lyase-malate synthase operon (WO2005/103275).

[0125] L-Phenylalanine-Producing Bacteria

[0126] Examples of L-phenylalanine-producing bacteria and parent strains which can be used to derive L-phenylalanine-producing bacteria include, but are not limited to, strains belonging to the genus Escherichia, such as E. coli AJ12739 (tyrA::Tn10, tyrR) (VKPM B-8197) (WO03/044191), E. coli HW 1089 (ATCC 55371) harboring the pheA34 gene encoding chorismate mutase-prephenate dehydratase desensitized to the feedback inhibition (U.S. Pat. No. 5,354,672), E. coli MWEC101-b (KR8903681), E. coli NRRL B-12141, NRRL B-12145, NRRL B-12146, and NRRL B-12147 (U.S. Pat. No. 4,407,952). Also, as a parent strain, E. coli K-12 [W3110 (tyrA)/pPHAB (FERM BP-3566) having a gene encoding chorismate mutase-prephenate dehydratase desensitized to feedback inhibition, E. coli K-12 [W3110 (tyrA)/pPHAD] (FERM BP-12659), E. coli K-12 [W3110 (tyrA)/pPHATerm] (FERM BP-12662) and E. coli K-12 [W3110 (tyrA)/pBR-aroG4, pACMAB], also called AJ12604 (FERM BP-3579) may be used (EP 488-424 B1). Furthermore, L-phenylalanine-producing Escherichia bacteria with enhanced activity of the protein encoded by the yedA or yddG genes may also be used (U.S. Published Patent Applications 2003/0148473 A1 and 2003/0157667 A1, WO03/044192).

[0127] L-Valine-Producing Bacteria

[0128] Examples of L-valine-producing bacteria and parent strains which can be used to derive L-valine-producing bacteria include, but are not limited to, strains which have been modified to overexpress the ilvGMEDA operon (U.S. Pat. No. 5,998,178). The region in the ilvGMEDA operon which is required for attenuation can be removed so that expression of the operon is not attenuated by the L-valine that is produced. Furthermore, the ilvA gene in the operon can be disrupted so that threonine deaminase activity is decreased.

[0129] Examples of L-valine-producing bacteria and parent strains which can be used to derive L-valine-producing bacteria also include strains with amino-acyl t-RNA synthetase mutants (U.S. Pat. No. 5,658,766). For example, E. coli VL1970, which has a mutation in the ileS gene, which encodes isoleucine tRNA synthetase, can be used. E. coli VL1970 was deposited at the Russian National Collection of Industrial Microorganisms (VKPM) (1 Dorozhny proezd., 1 Moscow 117545, Russia) on Jun. 24, 1988 under accession number VKPM B-4411.

[0130] Furthermore, mutants requiring lipoic acid for growth and/or lacking H.sup.+-ATPase can also be used as parent strains (WO96/06926, U.S. Pat. No. 5,888,783).

[0131] L-Leucine-Producing Bacteria

[0132] Examples of L-leucine-producing bacteria and parent strains which can be used to derive L-leucine-producing bacteria include, but are not limited to, strains belonging to the genus Escherichia, such as E. coli strains resistant to leucine (for example, the strain 57 (VKPM B-7386, U.S. Pat. No. 6,124,121)) or leucine analogues including .beta.-2-thienylalanine, 3-hydroxyleucine, 4-azaleucine and 5,5,5-trifluoroleucine (JP 62-34397 B and JP 8-70879 A); E. coli strains obtained by the genetic engineering method described in WO96/06926; and E. coli H-9068 (JP 8-70879 A).

[0133] The bacterium may be improved by enhancing the expression of one or more genes which encode proteins involved in L-leucine biosynthesis. Examples of such genes include genes of the leuABCD operon, such as a mutant leuA gene encoding isopropylmalate synthase which is not subject to feedback inhibition by L-leucine (U.S. Pat. No. 6,403,342). In addition, the bacterium may be improved by enhancing the expression of one or more genes encoding proteins which promote secretion of L-amino acids from the bacterial cell. Examples of such genes include b2682 and b2683 (ygaZH genes) (EP 1239041 A2).

[0134] L-Isoleucine-Producing Bacteria

[0135] Examples of L-isoleucine-producing bacteria and parent strains which can be used to derive L-isoleucine-producing bacteria include, but are not limited to, mutants having resistance to 6-dimethylaminopurine (JP 5-304969 A), mutants having resistance to an isoleucine analogue such as thiaisoleucine and isoleucine hydroxamate, and mutants additionally having resistance to DL-ethionine and/or arginine hydroxamate (JP 5-130882 A). In addition, recombinant strains transformed with genes encoding proteins involved in L-isoleucine biosynthesis, such as threonine deaminase and acetohydroxy acid synthase, can also be used as parent strains (JP 2-458 A, FR 0356739, and U.S. Pat. No. 5,998,178).

[0136] L-Serine-Producing Bacteria

[0137] Examples of L-serine-producing bacteria and parent strains which can be used to derive L-serine-producing bacteria include Escherichia coli which are desensitized to feedback inhibition of 3-phosphoglycerate dehydrogenase by serine (Japanese Patent No. 2584409, U.S. Pat. No. 5,618,716). Moreover, coryneform bacteria which are able to produce L-serine and have increased activity of at least one of phosphoserine phosphatase and phosphoserine transaminase, coryneform bacteria which cannot decompose L-serine (JP 11-253187 A, U.S. Pat. No. 6,037,154), and coryneform bacteria which is resistant to azaserine or (3-(2-thienyl)-DL-alanine and is able to produce L-serine (JP 11-266881 A, U.S. Pat. No. 6,258,573) can also be used.

[0138] When the aforementioned L-amino acid-producing bacteria are bred by gene recombination, the chosen genes are not limited to genes having the genetic information described above or genes having known sequences, but genes having conservative mutations such as homologues or artificially modified genes can also be used, so long as the functions of the encoded proteins are not degraded. That is, the chosen genes may encode a known amino acid sequence including substitution, deletion, insertion, addition or the like of one or several amino acid residues at one or several positions. As for the "conservative mutation", the descriptions concerning pyruvate synthase etc. described below are also applied to the aforementioned genes.

[0139] <1-2> Enhancement of Pyruvate Synthase or Pyruvate:NADP.sup.+ Oxidoreductase Activity

[0140] The microorganism having an L-amino acid-producing ability is modified so that an activity of pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase is increased. The activity of the pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase activity is increased so that it is higher as compared to that of the parent strain, for example, a wild-type strain or a non-modified strain. In addition, this is true when the pyruvate synthase activity is not native to the microorganism, for example, the pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase activity of the microorganism, which has been modified to have that enzymatic activity, is increased as compared with a non-modified strain.

[0141] The bacterium may be modified first to increase the enzymatic activity of pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase, and then imparted with an L-amino acid-producing ability. In addition, the activity of pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase can be increased by increasing the expression of a gene as described above. That is, enzyme activity may be increased by increasing expression of the endogenous pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase genes by modifying the expression control regions such as the promoter or the like, or by enhancing expression of an exogenous pyruvate synthase gene or pyruvate:NADP.sup.+ oxidoreductase gene by introducing a plasmid containing the pyruvate synthase or pyruvate:NADP.sup.+ oxidoreductase gene into the bacterium, introducing these genes into the chromosome of the bacterium, or the like.

[0142] Pyruvate synthase catalyzes the following reaction, which generates pyruvic acid from acetyl-CoA and CO.sub.2 in the presence of an electron donor such as ferredoxin and flavodoxin (EC 1.2.7.1). Pyruvate synthase may be abbreviated as "PS", and may be also be called pyruvate oxidoreductase, pyruvate ferredoxin oxidoreductase, pyruvate flavodoxin oxidoreductase, or pyruvate oxidoreductase. As the electron donor, ferredoxin or flavodoxin can be used.

Reduced ferredoxin+acetyl-CoA+CO.sub.2=oxidized ferredoxin+pyruvic acid+CoA

[0143] Enhancement of the pyruvate synthase activity can be confirmed by preparing crude enzyme solutions and measuring the pyruvate synthase activity in both the microorganism before making the modification to enhance activity, and after making the modification. The activity of pyruvate synthase can be measured by, for example, the method of Yoon et al. (Yoon, K. S. Ishii, M., Kodama, T., and Igarashi, Y. 1997. Arch. Microbiol. 167:275-279, 1997). For example, pyruvic acid is added to a reaction mixture containing oxidized methylviologen which acts as an electron acceptor, CoA, and crude enzyme solution, and spectroscopically measuring the amount of reduced methylviologen, which increases due to the decarboxylation of pyruvic acid. One unit (U) of the enzymatic activity is defined as the activity of reducing 1 .mu.mol of methylviologen per 1 minute. When the parent strain has pyruvate synthase activity, the activity desirably increases, for example, preferably 1.5 times or more, more preferably 2 times or more, still more preferably 3 times or more, compared with that of the parent strain. When the parent strain does not have pyruvate synthase activity, although it is sufficient that pyruvate synthase is produced by the introduction of the pyruvate synthase gene, the activity is preferably enhanced to such an extent that the enzymatic activity can be measured, and the activity is preferably 0.001 U/mg (cell protein) or higher, more preferably 0.005 U/mg or higher, still more preferably 0.01 U/mg or higher. Pyruvate synthase is sensitive to oxygen, and activity expression and measurement are often generally difficult (Buckel, W. and Golding, B. T., 2006, Ann. Rev. of Microbiol., 60:27-49). Therefore, as described in the examples, the enzymatic activity is measured preferably under reduced oxygen concentration in the reaction vessel.

[0144] The gene encoding pyruvate synthase may be derived from, or native to, bacteria with the reductive TCA cycle, and includes pyruvate synthase genes from Chlorobium tepidum and Hydrogenobacter thermophilus.

[0145] Specific examples include the pyruvate synthase gene having the nucleotide sequence located at nucleotide numbers from 1534432 to 1537989 of the genome sequence of Chlorobium tepidum (Genbank Accession No. NC.sub.--002932) and shown in SEQ ID NO: 1. The amino acid sequence encoded by this gene is shown in SEQ ID NO: 2 (Genbank Accession No. AAC76906). Furthermore, the pyruvate synthase from Hydrogenobacter thermophilus forms a complex of four subunits, the .delta.-subunit (Genbank Accession No. BAA95604), .alpha.-subunit (Genbank Accession No. BAA95605), .beta.-subunit (Genbank Accession No. BAA95606), and .gamma.-subunit (Genbank Accession No. BAA95607) (Ikeda, T. Ochiai, T., Morita, S., Nishiyama, A., Yamada, E., Arai, H., Ishii, M. and Igarashi, Y. 2006, Biochem. Biophys. Res. Commun., 340:76-82). The pyruvate synthase gene may also include the four genes HP1108, HP1109, HP 1110, and HP1111, located at nucleotide numbers from 1170138 to 1173296 in the genome sequence of Helicobacter pylori (GenBank Accession No. NC 000915), and the pyruvate synthase gene encoded by the four genes SSO1208, SSO7412, SSO1207, and SSO1206, identified by nucleotide numbers from 1047593 to 1044711 in the genome sequence of Sulfolobus solfataricus (GenBank Accession No. NC 002754). Furthermore, the pyruvate synthase gene may be cloned from Chlorobium, Desulfobacter, Aquifex, Hydrogenobacter, Thermoproteus, Pyrobaculum bacteria, or the like on the basis of homology to the genes exemplified above.

[0146] The Escherichia coli ydbK gene (b1378), which is shown in SEQ ID NO: 3, is located at nucleotide numbers from 1435284 to 1438808 in the genome sequence of the K-12 strain (GenBank Accession No. U00096). This gene is predicted to encode pyruvate flavodoxin oxidoreductase, that is, pyruvate synthase, on the basis of homology of the sequences. The amino acid sequence encoded by this gene is shown in SEQ ID NO: 4 (GenBank Accession No. AAC76906). As demonstrated in the example section, it was verified that this gene product has pyruvate synthase activity, and enhancing expression of this gene improves the ability to produce an L-amino acid.

[0147] Pyruvate:NADP.sup.+ oxidoreductase catalyzes the following reaction, which generates pyruvic acid from acetyl CoA and CO.sub.2, in the presence of an electron donor such as NADPH or NADH (EC 1.2.1.15). Pyruvate:NADP.sup.+ oxidoreductase may be abbreviated as "PNO", and may also be called pyruvate dehydrogenase. However, pyruvate dehydrogenase activity is the activity of catalyzing the oxidative decathoxylation of pyruvic acid to generate acetyl-CoA, as described later, and pyruvate dehydrogenase (PDH) which catalyses this reaction is different from pyruvate:NADP.sup.+ oxidoreductase. Pyruvate:NADP.sup.+ oxidoreductase can use NADPH or NADH as the electron donor.

NADPH+acetyl-CoA+CO.sub.2=NADP.sup.++pyruvic acid+CoA

[0148] Enhancement of the pyruvate:NADP.sup.+ oxidoreductase activity can be confirmed by preparing crude enzyme solutions and measuring the pyruvate:NADP.sup.+ oxidoreductase activity in both the microorganism before making the modification to enhance activity, and after making the modification. The activity of pyruvate:NADP.sup.+ oxidoreductase can be measured by, for example, the method of Inui et al. (Inui, H., Ono, K., Miyatake, K, Nakano, Y., and Kitaoka, S., 1987, J. Biol. Chem., 262:9130-9135). For example, pyruvic acid is added to a reaction mixture containing oxidized methylviologen which acts as an electron acceptor, CoA, and crude enzyme solution, and spectroscopically measuring the amount of reduced methylviologen, which increases due to the decathoxylation of pyruvic acid. One unit (U) of the enzymatic activity is defined as the activity of reducing 1 .mu.mol of methylviologen per 1 minute. When the parent strain has pyruvate:NADP.sup.+ oxidoreductase activity, the activity increases, for example, preferably 1.5 times or more, more preferably 2 times or more, still more preferably 3 times or more, as compared to that of the parent strain. When the parent strain does not have pyruvate:NADP.sup.+ oxidoreductase activity, although it is sufficient that pyruvate:NADP.sup.+ oxidoreductase is produced by the introduction of the pyruvate:NADP.sup.+ oxidoreductase gene, the activity is preferably enhanced to such an extent that the enzymatic activity can be measured, and the activity is preferably 0.001 U/mg (cell protein) or higher, more preferably 0.005 U/mg or higher, still more preferably 0.01 U/mg or higher. Pyruvate:NADP.sup.+ oxidoreductase is sensitive to oxygen, and activity expression and measurement are often generally difficult (Inui, H., Ono, K., Miyatake, K, Nakano, Y., and Kitaoka, S., 1987, J. Biol. Chem., 262: 9130-9135; Rotte, C., Stejskal, F., Zhu, G., Keithly, J. S., and Martin, W., 2001, Mol. Biol. Evol, 18:710-720). When the activity cannot be measured due to inactivation or the like, it is still possible to confirm expression of the protein by Western blotting or the like, as described in the examples section.

[0149] The gene encoding pyruvate:NADP.sup.+ oxidoreductase may be derived from, or native to, Euglena gracilis, which is a photosynthetic eukaryotic microorganism and is also classified into protozoans (Nakazawa, M., Inui, H. Yamaji R., Yamamoto, T., Takenaka, S., Ueda, M., Nakano, Y., Miyatake, K, 2000, FEBS Lett, 479:155-156), and the protist Cryptosporidium parvum (Rotte, C., Stejskal, F., Zhu, G., Keithly, J. S., and Martin, W., 2001, Mol. Biol. Evol., 18:710-720). Furthermore, it is known that a homologous gene also exists in Tharassiosira pseudonana which belongs to Bacillariophyta (Ctrnacta, V., Ault, J. G., Stejskal, F., and Keithly, J. S., 2006, J. Eukaryot. Microbiol., 53:225-231).

[0150] Specifically, the pyruvate:NADP.sup.+ oxidoreductase gene from Euglena gracilis has the nucleotide sequence shown in SEQ ID NO: 5 (GenBank Accession No. AB021127). The amino acid sequence encoded by this gene is shown in SEQ ID NO: 6 (GenBank Accession No. BAB 12024).

[0151] The microorganism may be modified so that the pyruvate synthase activity is increased by increasing the activity of recycling the oxidized electron donor to a reduced electron donor, which is required for pyruvate synthase activity, as compared to a parent strain, for example, a wild-type strain or a non-modified strain. An example of the activity for recycling the oxidized electron donor to a reduced electron donor is ferredoxin NADP.sup.+ reductase activity. Furthermore, the microorganism may be modified so that the activity of pyruvate synthase is increased, in addition to enhancing the electron donor recycling activity. The gene encoding the electron donor recycling activity may be native to the parent strain, or may be introduced into the parent strain to impart the activity, and the ability to produce an L-amino acid is improved.

[0152] The ferredoxin NADP.sup.+ reductase is an enzyme that reversibly catalyzes the following reaction (EC 1.18.1.2):

Reduced ferredoxin+NADP.sup.+=Oxidized ferredoxin+NADPH+H.sup.+

[0153] This reaction is reversible, and can generate the reduced ferredoxin in the presence NADPH and the oxidized ferredoxin. Ferredoxin can be replaced with flavodoxin, and the enzyme is a functional equivalent to flavodoxin NADP.sup.+ reductase. Ferredoxin NADP.sup.+ reductase has been confirmed to be present in a wide variety of organisms ranging from microorganisms to higher organisms (refer to Carrillo, N. and Ceccarelli, E. A., 2004, Eur. J. Biochem., 270:1900-1915; Ceccarelli, E. A. Arakaki, A. K, Cortez, N., and Carrillo, N. 2004, Biochim Biophys. Acta, 1698:155-165), and it is also known as ferredoxin NADP.sup.+ oxidoreductase or NADPH-ferredoxin oxidoreductase.

[0154] Enhancement of the ferredoxin NADP.sup.+ reductase activity can be confirmed by preparing crude enzyme solutions and measuring the ferredoxin NADP.sup.+ reductase activity in both the microorganism before making the modification to enhance activity, and after making the modification. The activity of ferredoxin NADP.sup.+ reductase can be measured by, for example, the method of Blaschkowski et at (Blaschkowski, H. P., Neuer, G., Ludwig-Festl, M., and Knappe, J. 1989, Eur. J. Biochem., 123:563-569). For example, the activity can be measured by using ferredoxin as a substrate to spectroscopically measure the decrease of the amount of NADPH. One unit (U) of the enzymatic activity is defined as the activity of oxidizing 1 .mu.mol of NADPH per 1 minute. When the parent strain has ferredoxin NADP.sup.+ reductase activity, and the activity of the parent strain is sufficiently high, it is not necessary to enhance the activity. However, the enzymatic activity is desirably increased preferably 1.5 times or more, more preferably 2 times or more, still more preferably 3 times or more, compared with that of the parent strain.

[0155] Genes encoding ferredoxin NADP.sup.+ reductase are found in many biological species, and any that have activity in the chosen L-amino acid producing strain can be used. In Escherichia coli, the fpr gene has been identified as the gene encoding flavodoxin NADP reductase (Bianchi, V. Reichard, P., Eliasson, R., Pontis, E., Krook, M., Jomvall, H., and Haggard-Ljungquist, E. 1993, 175:1590-1595). Moreover, it is known that, in Pseudomonas putida, the NADPH-putidaredoxin reductase gene and the putidaredoxin gene are present as an operon (Koga, H., Yamaguchi, E., Matsunaga, K, Aramaki, H., and Horiuchi, T. 19089, J. Biochem. (Tokyo), 106:831-836).

[0156] The flavodoxin NADP.sup.+ reductase gene from Escherichia coli (fpr gene) is located at nucleotide numbers from 4111749 to 4112495 (complementary strand) in the genome sequence of the Escherichia coli K-12 strain (Genbank Accession No. U00096) and is shown in SEQ ID NO: 7. The amino acid sequence of Fpr is shown in SEQ ID NO: 8 (Genbank Accession No. AAC76906). Moreover, the ferredoxin NADP.sup.+ reductase gene (Genbank Accession No. BAB99777) is found at the nucleotide numbers from 2526234 to 2527211 of the genome sequence of Corynebacterium glutamicum (Genbank Accession No. BA00036).

[0157] The pyruvate synthase activity requires the presence of ferredoxin or flavodoxin, which acts as an electron donor. Therefore, the microorganism may be modified so that the activity of pyruvate synthase is increased by improving the production of ferredoxin or flavodoxin.

[0158] Moreover, the microorganism may also be modified to improve the production of ferredoxin or flavodoxin, in addition to being modified to enhance pyruvate synthase activity alone, or enhance both the activities of flavodoxin NADP.sup.+ reductase and pyruvate synthase.

[0159] "Ferredoxin" refers to a protein containing nonheme iron atoms (Fe) and sulfur atoms bound with an iron-sulfur cluster called 4Fe-4S, 3Fe-4S or 2Fe-2S, and which functions as a one-electron carrier. "Flavodoxin" refers to a protein containing FMN (flavin-mononucleotide) as a prosthetic group and which functions as a one- or two-electron carrier. Ferredoxin and flavodoxin are described in McLean et al. (McLean K. J., Sabri, M., Marshall, K. R, Lawson, R. J., Lewis, D. G., Clift, D., Balding, P. R., Dunford, A. J., Warman, A. J., McVey, J. P., Quinn, A. M., Sutcliffe, M. J., Scrutton, N. S., and Munro, A. W. 2005, Biochem. Soc. Trans., 33:796-801).

[0160] Ferredoxin or flavodoxin may be native to the parent strains which are used to derive the modified microorganism described herein, or a gene encoding ferredoxin or flavodoxin may be introduced into the parent strains to impart the activity to produce ferredoxin or flavodoxin, and to improve L-glutamic producing ability.

[0161] An improvement in the ability to produce ferredoxin or flavodoxin as compared with the parent strain, such as a wild-type or non-modified strain, can be confirmed by, for example, comparing the amount of mRNA for ferredoxin or flavodoxin with that in a wild-type strain or non-modified strain. The expression amount can be confirmed by, for example, Northern hybridization and RT-PCR (Sambrook, J., Fritsch, E. F., and Maniatis, T. 1989, Molecular Cloning A Laboratory Manual/Second Edition, Cold Spring Harbor Laboratory Press, New York). The degree of the increase of the expression is not particularly limited so long as it is increased compared with that of a wild-type strain or non-modified strain. However, it is increased, for example, 1.5 times or more, preferably 2 times or more, more preferably 3 times or more, compared with that of a wild-type strain or non-modified strain.

[0162] Whether the ability to produce ferredoxin or flavodoxin is improved as compared with a parent strain, for example, a wild-type strain or a non-modified strain, can be detected by SDS-PAGE, two-dimensional electrophoresis, or Western blotting using antibodies (Sambrook J., Fritsch, E. F., and Maniatis, T. 1989, Molecular Cloning A Laboratory Manual/Second Edition, Cold Spring Harbor Laboratory Press, New York). The degree of improvement is not particularly limited so long as it is increased as compared with that of a wild-type strain or non-modified strain. However, it is increased, for example, 1.5 times or more, preferably 2 times or more, more preferably 3 times or more, compared with that of a wild-type strain or non-modified strain.

[0163] The activities of ferredoxin and flavodoxin can be measured by adding them to a suitable oxidation-reduction reaction system. For example, reducing ferredoxin with ferredoxin NADP.sup.+ reductase and quantifying the reduction of cytochrome C by the reduced ferredoxin is disclosed by Boyer et al. (Boyer, M. E. et al., 2006, Biotechnol. Bioeng., 94:128-138). Furthermore, the activity of flavodoxin can be measured by the same method, but using flavodoxin NADP.sup.+ reductase.

[0164] Genes encoding ferredoxin or flavodoxin are known from many species, and any of these can be used so long as the ferredoxin or flavodoxin encoded by the genes can be utilized by pyruvate synthase and an electron donor recycling system. For example, in Escherichia coli, the fdx gene encodes ferredoxin which has a 2Fe-2S cluster (Ta, D. T. and Vickery, L. E., 1992, J. Biol. Chem., 267:11120-11125), and the yfhL gene encodes ferredoxin which has a 4Fe-4S cluster. Furthermore, the fldA gene (Osborne C. et al., 1991, J. Bacteriol., 173:1729-1737) and the fldB gene (Gaudu, P. and Weiss, B., 2000, J. Bacteriol., 182:1788-1793) are known to encode flavodoxin. In the genome sequence of Corynebacterium glutamicum (Genbank Accession No. BA00036), multiple ferredoxin genes were found at nucleotide numbers from 562643 to 562963 (fdx--Genbank Accession No. BAB97942), and nucleotide numbers from 1148953 to 1149270 (fer--Genbank Accession No. BAB98495). Furthermore, in Chlorobium tepidum, many ferredoxin genes have been identified, for example, ferredoxin I and ferredoxin II are of the 4Fe-4S type, which acts as the electron acceptor for pyruvate synthase (Yoon, K. S., Bobst, C., Hemann, C F., Hille, R, and Tabita, F. R 2001, J. Biol. Chem., 276:44027-44036). Ferredoxin or flavodoxin native to or derived from bacteria having the reductive TCA cycle, such as the ferredoxin gene of Hydrogenobacter thermophilus, can also be used.

[0165] The ferredoxin gene of Escherichia coli includes the fdx gene at nucleotide numbers from 2654770 to 2655105 (complementary strand) in the genome sequence of the Escherichia coli K-12 strain (Genbank Accession No. U00096) and shown in SEQ ID NO: 9, and the yfhL gene at nucleotide numbers from 2697685 to 2697945 also from K-12, and shown in SEQ ID NO: 11. The amino acid sequences of Fdx and YfhL are shown in SEQ ID NOS: 10 and 12 (Genbank Accession Nos. AAC75578 and AAC75615, respectively). The flavodoxin gene of Escherichia coli includes the fldA gene at nucleotide numbers from 710688 to 710158 (complementary strand) in the genome sequence of the Escherichia coli K-12 strain (Genbank Accession No. U00096) and shown in SEQ ID NO: 13, and the fldB gene at nucleotide numbers from 3037877 to 3038398 also from K-12, and shown in SEQ ID NO: 15. The amino acid sequences encoded by the fldA gene and the fldB gene are shown in SEQ ID NOS: 14 and 16 (Genbank Accession Nos. AAC73778 and AAC75933, respectively).

[0166] The ferredoxin gene of Chlorobium tepidum includes the ferredoxin I gene at nucleotide numbers from 1184078 to 1184266 in the genome sequence of Chlorobium tepidum (Genbank Accession No. NC.sub.--002932) and shown in SEQ ID NO: 17, and the ferredoxin II gene at nucleotide numbers from 1184476 to 1184664 also from Chlorobium tepidum and shown in SEQ ID NO: 19. The amino acid sequences of ferredoxin I and ferredoxin II are shown in SEQ ID NOS: 18 and 20 (Genbank Accession Nos. AAM72491 and AAM72490, respectively). Examples further include the ferredoxin gene of Hydrogenobacter thermophilus (Genbank Accession No. BAE02673) and the ferredoxin gene of Sulfolobus solfataricus, which is present at nucleotide numbers from 2345414 to 2345728 in the genome of Sulfolobus solfataricus. Furthermore, the gene may be those cloned from Chlorobium, Desulfobacter, Aquifex, Hydrogenobacter, Thermoproteus, Pyrobaculum bacteria, or the like on the basis of homology to the genes exemplified above, or those cloned from .gamma.-proteobacteria such as those of the genus Enterobacter, Klebsiella, Serratia, Erwinia, and Yersinia, coryneform bacteria such as Corynebacterium glutamicum and Brevibacterium lactofermentum, Pseudomonas bacteria such as Pseudomonas aeruginosa, Mycobacterium bacteria such as Mycobacterium tuberculosis, and so forth.

[0167] Any of the genes described herein may have conservative mutations, and may be homologues or artificially modified genes so long as the functions of the encoded proteins are not degraded. That is, the genes described herein may encode a conservative variant of the proteins having amino acid sequences of the known proteins or wild-type proteins, and may include one or more substitutions, deletions, insertions, or additions of one or several amino acid residues at one or several positions. Although the number of the "one or several" amino acid residues may differ depending on their position in the three-dimensional structure or the types of amino acid residues of the proteins, it is preferably 1 to 20, more preferably 1 to 10, particularly preferably 1 to 5.

[0168] These substitutions are preferably conservative substitutions that are neutral mutations so to preserve the function of the protein. A conservative mutation is a mutation wherein substitution takes place mutually among Phe, Trp and Tyr, if the substitution site is an aromatic amino acid; among Leu, Ile and Val, if the substitution site is a hydrophobic amino acid; between Gln and Asn, if it is a polar amino acid; among Lys, Arg and His, if it is a basic amino acid; between Asp and Glu, if it is an acidic amino acid; and between Ser and Thr, if it is an amino acid having a hydroxyl group.

[0169] Specific examples of conservative substitutions include: substitution of Ser or Thr for Ala; substitution of Gln, His or Lys for Arg; substitution of Glu, Gln, Lys, His or Asp for Asn; substitution of Asn, Glu or Gln for Asp; substitution of Ser or Ala for Cys; substitution of Asn, Glu, Lys, His, Asp or Arg for Gln; substitution of Gly, Asn, Gln, Lys or Asp for Glu; substitution of Pro for Gly; substitution of Asn, Lys, Gln, Arg or Tyr for His; substitution of Leu, Met, Val or Phe for Ile; substitution of Be, Met, Val or Phe for Leu; substitution of Asn, Glu, Gln, His or Arg for Lys; substitution of Be, Leu, Val or Phe for Met; substitution of Tip, Tyr, Met, Be or Leu for Phe; substitution of Thr or Ala for Ser; substitution of Ser or Ala for Thr; substitution of Phe or Tyr for Trp; substitution of His, Phe or Tip for Tyr; and substitution of Met, Be or Leu for Val. The above-mentioned amino acid substitution, deletion, insertion, addition, inversion etc. may be the result of a naturally-occurring mutation or variation due to an individual difference, or a difference of species of a bacterium.

[0170] Furthermore, a gene may be used which has codon substitutions that can be easily used in the chosen host into which the gene is introduced. Similarly, so long as the gene maintains its function, it may be extended or shortened at either the N-terminus and/or C-terminus by, for example, 50 or less, preferably 20 or less, more preferably 10 or less, particularly preferably 5 or less, of the number of amino acid residues.

[0171] A gene encoding a conservative variant can be obtained by, for example, modifying the nucleotide sequence by site-specific mutagenesis so that the encoded protein includes substitutions, deletions, insertions, or additions of amino acid residues at specific sites. Furthermore, it can also be obtained by the conventionally known mutagenesis techniques, such as by treating the gene with hydroxylamine or the like in vitro and irradiating the microorganism containing the gene with ultraviolet light, or treating the microorganism with a known mutagen such as N-methyl-N-nitro-N-nitrosoguanidine (NTG) or ethyl methanesulfonate (EMS). Moreover, the substitutions, deletions, insertions, additions, inversions etc. of amino acid residues as described above include those due to a naturally occurring mutation or variation based on the difference of individuals or species of the microorganism containing the gene. Whether the gene(s) encodes pyruvate synthase, ferredoxin-NADP.sup.+ reductase, ferredoxin, or flavodoxin can be confirmed by, for example, introducing each gene into a microorganism, and measuring the activity of each protein.

[0172] The gene may be a DNA which hybridizes with a DNA having any one of the aforementioned nucleotide sequences, or a probe prepared from a DNA which has any one of these nucleotide sequences, under stringent conditions and which encodes pyruvate synthase, ferredoxin-NADP.sup.+ reductase, ferredoxin, or flavodoxin.

[0173] The term "stringent conditions" refers to conditions when a so-called specific hybrid is formed and a non-specific hybrid is not formed. Examples thereof include conditions where DNAs having high homology, for example, at least 70%, preferably 80%, more preferably 90%, and further more preferably 95% homology, hybridize with each other and DNAs having homology less than the value do not hybridize with each other; and specifically include conditions corresponding to a salt concentration and temperature of washing which are typical of Southern hybridization, e.g., washing at 60.degree. C., 1.times.SSC, 0.1% SDS, preferably 60.degree. C., 0.1.times.SSC, 0.1% SDS, more preferably 68.degree. C., 0.1.times.SSC, 0.1% SDS, once or preferably twice or three times.

[0174] The probe may have a partial sequence of the gene. Such a probe can be prepared by PCR using oligonucleotides prepared based on the nucleotide sequence of each gene as primers according to a method well known to a person skilled in the art, and a DNA fragment containing each gene as the template. When a DNA fragment of a length of about 300 by is used as the probe, the conditions of washing after hybridization can be, for example, 50.degree. C., 2.times.SSC, and 0.1% SDS.

[0175] The aforementioned descriptions concerning the conservative variant is also applied to the enzymes and genes described above which are used to impart L-amino acid-producing ability.

[0176] The modification for enhancing expression of the gene can be performed in the same manner as that described to enhance the expression of a target gene which is used to impart the L-amino acid-producing ability. The gene can be obtained by PCR using the chromosomal DNA of the microorganism as the template.

[0177] For example, the pyruvate synthase gene of Chlorobium tepidum can be obtained by PCR (polymerase chain reaction) (see White, T. J., Arnheim, N., and Erlich, H. A. 1989, Trends Genet, 5:185-189) using primers prepared on the basis of the nucleotide sequence of SEQ ID NO: 1, for example, the primers shown in SEQ ID NOS: 35 and 36, and using the chromosomal DNA of Chlorobium tepidum as the template.

[0178] The pyruvate synthase gene of Escherichia coli can be obtained by PCR using primers prepared on the basis of the nucleotide sequence of SEQ ID NO: 3, for example, the primers shown in SEQ ID NOS: 38 and 39, and the chromosomal DNA of Escherichia coli as the template.

[0179] The NADP.sup.+ oxidoreductase gene of Euglena gracilis can be obtained by PCR using primers prepared on the basis of the nucleotide sequence of SEQ ID NO: 5, for example, the primers shown in SEQ ID NOS: 40 and 41, and the chromosomal DNA of Euglena gracilis as the template.

[0180] The flavodoxin NADP.sup.+ reductase gene of Escherichia coli can be obtained by PCR using primers prepared on the basis of the nucleotide sequence of SEQ ID NO: 7, for example, the primers shown in SEQ ID NOS: 42 and 43, and the chromosomal DNA of Escherichia coli as the template.

[0181] The ferredoxin gene fdx of Escherichia coli can be obtained by PCR using primers prepared on the basis of the nucleotide sequence of SEQ ID NO: 9, for example, the primers shown in SEQ ID NOS: 44 and 45, and the chromosomal DNA of Escherichia coli as the template.

[0182] The flavodoxin gene fldA of Escherichia coli can be obtained by PCR using primers prepared on the basis of the nucleotide sequence of SEQ ID NO: 13, and the flavodoxin gene fldB of Escherichia coli can be obtained by PCR using primers prepared on the basis of the nucleotide sequence of SEQ ID NO: 15, and the chromosomal DNA of Escherichia coli as the template, respectively.

[0183] Furthermore, the ferredoxin I gene of Chlorobium tepidum can be obtained by PCR using primers prepared on the basis of the nucleotide sequence of SEQ ID NO: 17, and the ferredoxin II gene of Chlorobium tepidum can be obtained by PCR using primers prepared on the basis of the nucleotide sequence of SEQ ID NO: 19, with using the chromosomal DNA of Chlorobium tepidum as the template in both cases.

[0184] Genes derived from other microorganisms can also be obtained from the chromosomal DNA or a chromosomal DNA library from the chosen microorganism by PCR using, as primers, oligonucleotides prepared based on the sequences of the aforementioned gene or sequences of genes or proteins known in the chosen microorganism; or hybridization using an oligonucleotide prepared based on such sequence as mentioned above as a probe. A chromosomal DNA can be prepared from a microorganism that serves as a DNA donor by the method of Saito and Miura (Saito H. and Miura K., 1963, Biochem. Biophys. Acta, 72:619-629; Experiment Manual for Biotechnology, edited by The Society for Biotechnology, Japan, p97-98, Baifukan Co., Ltd., 1992) or the like.

[0185] The expression of the gene and genes of L-amino acid synthesis systems can be increased by increasing the copy number of the gene by transformation or homologous recombination, or modifying an expression control sequence of the gene as described above. Furthermore, the expression of the gene can also be increased by amplifying an activator which increases expression of the gene, and/or by eliminating or attenuating a regulator which reduces expression of the gene.

[0186] Methods for increasing gene expression will be explained below.

[0187] To increase the copy number of a target gene, for example, the gene can be cloned on an appropriate vector and then used to transform a host microorganism.

[0188] The vector used for transformation may be a plasmid which autonomously replicates in the host microorganism. Examples of a plasmid which is able to autonomously replicate in Enterobacteriaceae include pUC19, pUC18, pBR322, RSF1010, pHSG299, pHSG298, pHSG399, pHSG398, pSTV28, pSTV29 (pHSG and pSTV vectors are available from Takara Bio Inc.), pMW119, pMW118, pMW219, pMW218 (pMW vectors are available from Nippon Gene Co., Ltd.), and so forth. Furthermore, plasmids for coryneform bacteria include pAM330 (Japanese Patent Laid-open No. 58-67699), pHM1519 (Japanese Patent Laid-open No. 58-77895), pSFK6 (Japanese Patent Laid-open No. 2000-262288), pVK7 (USP2003-0175912A), pAJ655, pAJ611, pAJ1844 (Japanese Patent Laid-open No. 58-192900), pCG1 (Japanese Patent Laid-open No. 57-134500), pCG2 (Japanese Patent Laid-open No. 58-35197), pCG4, pCG11 (Japanese Patent Laid-open No. 57-183799), pHK4 (Japanese Patent Laid-open No. 5-7491), and so forth. Moreover, a DNA fragment which is able to impart the ability to autonomously replicate to a plasmid in a coryneform bacterium can be cut from these vectors and inserted into the aforementioned vectors for Escherichia coli, and then can be used as a so-called shuttle vector which is able to autonomously replicate in both Escherichia coli and coryneform bacteria. In addition, a phage DNA may also be used as the vector instead of a plasmid.

[0189] Examples of transformation methods include treating recipient cells with calcium chloride so to increase permeability of the DNA, which has been reported for Escherichia coli K-12 (Mandel, M. and Higa, A., 1970, J. Mol. Biol., 53:159-162), and preparing competent cells from cells which are at the growth phase, followed by transformation with DNA, which has been reported for Bacillus subtilis (Duncan, C. H., Wilson, G. A. and Young, F. E. 1977, Gene, 1:153-167). Alternatively, a method of making DNA-recipient cells into protoplasts or spheroplasts, which can easily take up recombinant DNA, followed by introducing the recombinant DNA into the cells, which is known to be applicable to Bacillus subtilis, actinomycetes and yeasts (Chang, S, and Choen, S. N., 1979, Mol. Gen. Genet, 168:111-115; Bibb, M. J. et al., 1978, Nature, 274:398-400; Hinnen, A., Hicks, J. B. and Fink, G. R. 1978, Proc. Natl. Sci., USA, 75:1929-1933) can also be employed. In addition, microorganisms can also be transformed by the electric pulse method (Japanese Patent Laid-open No. 2-207791).

[0190] The copy number of the target gene can also be increased by introducing multiple copies of the gene into the chromosomal DNA of the microorganism by homologous recombination (Milled, J. H. Experiments in Molecular Genetics, 1972, Cold Spring Harbor Laboratory) using multiple copies of a sequence as targets in the chromosomal DNA. Sequences present in multiple copies on the chromosomal DNA include, but are not limited to, repetitive DNAs, and inverted repeats present at the end of a transposable element. Also, as disclosed in Japanese Patent Laid-open No. 2-109985, it is possible to incorporate the target gene into a transposon, and allow it to be transferred to introduce multiple copies of the gene into the chromosomal DNA. The target gene can also be introduced into the bacterial chromosome by Mu phage (Japanese Patent Laid-open No. 2-109985), or the like. Transfer of a target gene to a chromosome can be confirmed by Southern hybridization using a part of the gene as a probe.

[0191] When the copy number of a gene is increased, the copy number is not particularly limited so long as activity of the product of the target gene is enhanced. However, when the target gene is native to the chosen microorganism, the copy number is preferably 2 or more. When the target gene is not native to the chosen microorganism, the copy number of the gene may be 1, but it may also be 2 or more.

[0192] Expression of the target gene may also be increased by replacing an expression regulatory sequence of the target gene, such as promoter, on the chromosomal DNA or plasmid with a promoter which has an appropriate strength. For example, the thr promoter, lac promoter, tip promoter, trc promoter, pL promoter, tac promoter, etc., are known as promoters frequently used to increase expression of a target gene. Examples of strong promoters and methods for evaluating the strength of promoters are described in an article by Goldstein and Doi (Goldstein, M. A. and Doi R. H., 1995, Biotechnol. Annu. Rev., 1:105-128), etc.

[0193] Moreover, it is also possible to substitute several nucleotides in the promoter region of a gene, so that the promoter has an appropriate strength, as disclosed in International Patent Publication WO00/18935. Substitution of the expression regulatory sequence can be performed, for example, in the same manner as in gene substitution using a temperature-sensitive plasmid. Examples of vectors having a temperature-sensitive replication origin which can be used for Escherichia coli or Pantoea ananatis include, for example, the temperature-sensitive plasmid pMAN997 described in International Publication WO99/03988, its derivatives, and so forth. Furthermore, substitution of an expression regulatory sequence can also be performed by methods which employ linear DNA, such as "Red-driven integration" using Red recombinase of .lamda. phage (Datsenko, K. A. and Wanner, B. L., 2000, Proc. Natl. Acad. Sci. USA., 97:6640-6645), by combining the Red-driven integration method and the .lamda. phage excision system (Cho, E. H., Gumport, R. I., Gardner, J. F. 2002, J. Bacteriol., 184:5200-5203) (WO2005/010175), and so forth. The modification of an expression regulatory sequence can be combined with increasing gene copy number described above.

[0194] Furthermore, it is known that substitution of several nucleotides in a spacer between the ribosome binding site (RBS) and the start codon, in particular, the sequences immediately upstream of the start codon, profoundly affects the mRNA translatability. Translation can be enhanced by modifying these sequences.

[0195] When pyruvate synthase consists of multiple subunits, the expression of the genes encoding the subunits may be individually enhanced, or may be simultaneously enhanced as a polycistron. Furthermore, when the genes are introduced into a microorganism by using a vector, the genes encoding the subunits may be carried on a single vector molecule, or may be separately carried on different vector molecules. Also when the genes encoding the subunits are inserted into the chromosome, the genes may be simultaneously inserted into the same site on the genome, or may be separately inserted at different sites.

[0196] Furthermore, pyruvate dehydrogenase activity may be reduced, in addition to enhancing pyruvate synthase activity or pyruvate:NADH.sup.+ oxidoreductase activity. Pyruvate dehydrogenase (henceforth also referred to as "PDH") activity means an activity for catalyzing the reaction of oxidatively decarboxylating pyruvic acid to produce acetyl-CoA. The aforementioned reaction is catalyzed by three kinds of enzymes, PDH (E1p, pyruvate dehydrogenase, EC:1.2.4.1, aceE gene, SEQ ID NO: 46), dihydrolipoyl transacetylase (E2p, EC:2.3.1.12, aceF gene, SEQ ID NO: 48), and dihydrolipoamide dehydrogenase (E3, EC:1.8.1.4, lpdA gene, SEQ ID NO: 50). That is, these three subunits catalyze the following reactions, respectively, and the activity for catalyzing the total reaction resulting from these three reactions is called PDH activity. PDH activity can be measured according to the method of Visser and Strafing (Visser, J. and Strafing, M., 1982, Methods Enzymol., 89:391-399).

Pyruvate+[dihydrolipoyllysine-residue succinyltransferase]lipoyllysine=[dihydrolipoyllysine-residue acetyltransferase]S-acetyldihydrolipoyllysine+CO.sub.2 E1p

CoA+enzyme N6-(S-acetyldihytholipoyblysine=acetyl-CoA+enzyme N6-(dihydrolipoyl)lysine E2p

Protein N6-(dihydrolipoyl)lysine+NAD.sup.+=protein N6-(lipoyl)lysine+NADH+H.sup.+ E3

[0197] To decrease or eliminate enzyme activity, for example, a part of or the entire coding region may be deleted from one or more of the aceE, aceF and lpdA genes, or an expression control sequence such as a promoter or Shine Dargarno (SD) sequence can be modified, or the like. The expression can also be reduced by modifying a non-translation region other than expression control regions. Furthermore, the entire gene, including the upstream and downstream regions of the genes on the chromosome, may be deleted. In addition, an amino acid substitution (missense mutation), a stop codon (nonsense mutation), or a frame shift mutation which adds or deletes one or two nucleotides may be introduced into the enzyme coding region on the chromosome by genetic recombination (Journal of Biological Chemistry, 272:8611-8617 (1997), Proceedings of the National Academy of Sciences, USA, 95 5511-5515 (1998), Journal of Biological Chemistry, 266, 20833-20839 (1991)).

[0198] To reduce the intracellular enzymatic activity, a part or all of an expression control sequence such as promoter region, a coding region or a non-coding region of the gene on the chromosome may be deleted, or another sequence may be inserted into these regions by homologous recombination. However, these modifications may be accomplished by known mutatagenesis techniques, such as exposure to X-rays or UV irradiation, or treatment with a mutagen such as N-methyl-N'-nitro-N-nitrosoguanidine, etc., so long as the PDH activity is reduced by the modification.

[0199] The expression control sequence is preferably modified by one or more nucleotides, more preferably two or more nucleotides, particularly preferably three or more nucleotides. When a coding region is deleted, it may be in the N-terminus region, an internal region, or the C-terminus region, or even the entire coding region, so long as the function of the enzyme protein is reduced. Deletion of a longer region will usually ensure inactivation of the gene. Furthermore, the reading frames upstream and downstream of the deleted region are not preferably the same.

[0200] Also, when another sequence is inserted into the coding region, the sequence may be inserted anywhere, and inserting a longer region will usually ensure inactivation of the gene. The reading frames upstream and downstream of the insertion site are not preferably the same. The other sequence is not particularly limited so long as the sequence reduces or deletes the function of the enzyme protein, and examples include a transposon carrying an antibiotic resistance gene or a gene useful for L-amino acid production.

[0201] A gene on the chromosome can be modified as described above by, for example, preparing a deletion-type version of the gene in which a partial sequence of the gene is deleted, and transforming a bacterium with a DNA containing the deletion-type gene to cause homologous recombination between the deletion-type gene and the native gene on the chromosome, and thereby substitute the deletion-type gene for the gene on the genome. The enzyme protein encoded by the deletion-type gene has a conformation different from that of the wild-type enzyme protein, if it is even produced, and thus the function is reduced or deleted. These types of gene disruption can be performed by methods using a linear DNA such as Red-driven integration, and Red-driven integration in combination with an excision system derived from .lamda. phage, or by using a plasmid containing a temperature-sensitive replication origin, or a plasmid capable of conjugative transfer, utilizing a suicide vector which does not have a replication origin usable in the chosen host (U.S. Pat. No. 6,303,383, JP 05-007491 A) etc.

[0202] The aforementioned description concerning reduction of the PDH activity is also applied to "reduction of activity" of the other enzymes described above, or "destruction" of the other genes described above.

[0203] When the microorganism is cultured under anaerobic or microaerobic conditions, it may be already have been modified so that it does not produce any organic acid or ethanol under the anaerobic or microaerobic conditions, in addition to enhancing the pyruvate synthase activity or pyruvate: NADH.sup.+ oxidoreductase activity. Examples of the organic acids include lactic acid, formic acid, and acetic acid. The method for modifying a microorganism so that organic acid or ethanol is not produced include by disrupting the gene encoding lactate dehydrogenase (Verumi, G. N. et al., 2002, J. Industrial Microbiol. Biotechnol., 28:325-332; Japanese Patent Laid-open No. 2005-95169).

[0204] <2> Method for Producing an L-Amino Acid

[0205] The microorganism is cultured in a medium to produce and cause accumulation of an L-amino acid in the medium or cells, and collecting the L-amino acid from the medium or cells.

[0206] A batch culture, fed-batch culture, and/or continuous culture may be used. Ethanol or an aliphatic acid may be added to the starting medium or feed medium, or both.

[0207] A fed-batch culture refers to a culture method in which the medium is continuously or intermittently fed into the culture vessel, and the medium is not extracted until the end of the culture. A continuous culture means a method in which the medium is continuously or intermittently fed into the culture vessel, and the medium is extracted from the vessel (usually in a volume equivalent to the volume of the fed medium) at the same time. A starting medium indicates the medium used in the batch culture, the fed-batch culture, or continuous culture before feeding the feed medium, that is, the medium used at the start of the culture. A feed medium indicates the medium which is supplied to the fermentation tank in the fed-batch culture or continuous culture. A batch culture means a method in which fresh medium is prepared for every culture, and the strain is inoculated into the medium, and the medium is not added until harvest.

[0208] A substance from which acetyl-CoA can be produced without a decarboxylation reaction is preferred as the carbon source, and specific examples include ethanol, aliphatic acids, aliphatic acid esters including fats and oils which generate an aliphatic acid upon decomposition, and so forth. Examples of using ethanol or an aliphatic acid as the carbon source will be described below.

[0209] Ethanol is a monohydric alcohol represented by the molecular formula C.sub.2H.sub.5OH, and may be used alone, or may be present as a mixture in the medium, such as the ethanol which is produced in ethanol fermentation in the medium etc.

[0210] Aliphatic acids are monovalent carboxylic acids represented by the general formula C.sub.mH.sub.nCOOH. So long as it is able to be assimilated by the bacteria having L-amino acid-producing ability, it may be of any length, and may contain aliphatic acids of any length at any ratio. Preferred aliphatic acids are oleic acid (C.sub.17H.sub.33COOH) and palmitic acid (C.sub.15H.sub.31COOH), and oleic acid is particularly preferred. A mixture of long chain aliphatic acids containing oleic acid can be obtained by hydrolysis of fats and oils. Oleic acid can be obtained as a hydrolysate of fats and oils such as palm oil, and oleic acid extracted from animal oils, vegetable oils, waste cooking oils, other blended fats and oils, or foodstuffs containing fats such as chocolate may be used. The aliphatic acid may be a free acid, or an alkali metal salt, such as sodium salts and potassium salts, or an ammonium salt.

[0211] Ethanol or aliphatic acids may be present in the medium at any concentration so long as the chosen bacterium can assimilate it as the carbon source. When it is used as the sole carbon source in the medium, it is present in an amount of 20% w/v or less, more preferably 10% w/v or less, still more preferably 2% w/v or less. Furthermore, ethanol or aliphatic acids may be present in the medium at any concentration so long as it can be assimilated as the carbon source by the chosen bacterium. When it is used as the sole carbon source in the medium, it is desirably present in the medium in an amount of 0.001% w/v or more, preferably 0.05% w/v or more, more preferably 0.1% w/v or more.

[0212] As for the feed medium, when ethanol or aliphatic acid is used as the sole carbon source, it is preferably present in the medium in an amount of 10% w/v or less, more preferably 5% w/v or less, still more preferably 1% w/v or less, and it is preferably present in the medium in an amount of 0.001% w/v or more, more preferably 0.05% w/v or more, still more preferably 0.1% w/v or more.

[0213] Although the concentration of ethanol can be measured by various methods, the enzymatic method is convenient and common (Swift R., 2003, Addiction, 98:73-80). The concentration of aliphatic acid can be measured by known methods such as gas chromatography and HPLC (TrAC Trends Anal. Chem., 2002, 21:686-697; Lin J. T., Snyder L. R., and McKeon, T. A., 1998, J. Chromatogr. A., 808:43-49).

[0214] Furthermore, the medium may contain a mixture of ethanol and an aliphatic acid. The concentrations of ethanol and aliphatic acid which are added may be any concentration so long as the chosen bacterium can assimilate them as the carbon source. However, when a mixture of ethanol and an aliphatic acid is used as the sole carbon source in the medium, it is preferably present in an amount of 20% w/v or less, more preferably 10% w/v or less, still more preferably 2% w/v or less, in terms of the total concentration. Furthermore, a mixture of ethanol and an aliphatic acid may be present in the medium at any concentration so long as it can be assimilated as the carbon source by the bacterium. However, when a mixture of ethanol and an aliphatic acid is used as the sole carbon source in the medium, it is desirably contained in the medium in an amount of 0.001% w/v or more, preferably 0.05% w/v or more, more preferably 0.1% w/v or more, in terms of the total concentration of ethanol and oleic acid.

[0215] Any ratio of ethanol and aliphatic acid may be present so long as they are at such concentrations that the chosen bacteria can assimilate them as the carbon source. However, the aliphatic acid is generally mixed at a ratio of about 2 or less, preferably about 1.5 or less, preferably about 1 or less, based on ethanol, which is taken as 1. Although the lower limit of the mixing ratio of the aliphatic acid is not particularly limited in the case of mixing the aliphatic acid, the aliphatic acid is preferably mixed at a ratio of 0.05 or more, desirably 0.1 or more, based on ethanol, which is taken as 1.

[0216] In addition to ethanol or aliphatic acid, or both, other carbon sources may also be added to the medium, for example, such as saccharides such as glucose, fructose, sucrose, lactose, galactose, blackstrap molasses, and starch hydrolysate, polyhydric alcohols such as glycerol, and organic acids such as fumaric acid, citric acid, and succinic acid. Glucose, sucrose, fructose, and glycerol are especially preferred. As glycerol, crude glycerol produced in biodiesel fuel production can also be used. The carbon source may be one kind of substance or a mixture of two or more kinds of substances. When other carbon sources are used, the ratio of ethanol, aliphatic acid, or a mixture of ethanol and aliphatic acid in the carbon source is preferably 10% by weight or more, more preferably 30% by weight or more, still more preferably 50% by weight or more.

[0217] Ethanol or aliphatic acid may be present at a certain constant concentration throughout the culture process, or it may be added only to the starting medium or the feed medium. If other carbon sources are sufficient, there may be a period when ethanol or aliphatic acid temporarily runs short. The term "temporarily" means that, for example, the aliphatic acid may run short for a period corresponding to 10%, 20%, or 30% at most, of the entire fermentation period.

[0218] As for the other components to be added to the medium, typical media ingredients such as a nitrogen source, inorganic ions, and if needed, other organic components in addition to the carbon source can be used. Examples of the nitrogen source present in the medium include ammonia, ammonium salts such as ammonium sulfate, ammonium carbonate, ammonium chloride, ammonium phosphate, ammonium acetate and urea, nitrates, and so forth. Ammonia gas and aqueous ammonia used to adjust the pH can also be utilized as the nitrogen source. Furthermore, peptone, yeast extract, meat extract, malt extract, corn steep liquor, soybean hydrolysate, and so forth can also be utilized. The medium may contain one or more of these nitrogen sources. These nitrogen sources can also be used for both the starting medium and the feed medium. Furthermore, the same nitrogen source can be used for both the starting medium and the feed medium, or the nitrogen source of the feed medium may be different from that of the starting medium.

[0219] The medium preferably contains a phosphoric acid source and a sulfur source in addition to the carbon source, the nitrogen source, and sulfur. As the phosphoric acid source, potassium dihydrogenphosphate, dipotassium hydrogenphosphate, phosphate polymers such as pyrophosphoric acid and so forth can be utilized. Although the sulfur source may be any substance containing sulfur atoms, sulfuric acid salts such as sulfates, thiosulfates and sulfites, and sulfur-containing amino acids such as cysteine, cystine and glutathione are desirable, and ammonium sulfate is especially desirable.

[0220] Furthermore, the medium may contain a growth promoting factor, such as a nutrient with a growth promoting effect, in addition to the carbon source, nitrogen source and sulfur. As the growth promoting factor, trace metals, amino acids, vitamins, nucleic acids as well as peptone, casamino acid, yeast extract, soybean protein degradation product and so forth containing the foregoing substances can be used. Examples of the trace metals include iron, manganese, magnesium, calcium, and so forth. Examples of the vitamins include vitamin B.sub.1, vitamin B.sub.2, vitamin B.sub.6, nicotinic acid, nicotinamide, vitamin B.sub.12, and so forth. These growth promoting factors may be present in the starting medium or the feed medium.

[0221] Furthermore, when an auxotrophic mutant that requires an amino acid or the like for growth thereof is used, it is preferable to supplement the required nutrient to the medium. In particular, since the L-lysine biosynthetic pathway is enhanced and L-lysine degrading ability is often attenuated in L-lysine-producing bacteria, one or more of L-threonine, L-homoserine, L-isoleucine, and L-methionine are preferably added. The starting medium and the feed medium may have the same or different medium composition. Furthermore, when the feed medium is fed at multiple stages, the compositions of the feed medium fed at the various stages may be the same or different.

[0222] The culture is preferably performed as an aeration culture at a fermentation temperature of 20 to 45.degree. C., particularly preferably at 33 to 42.degree. C. The oxygen concentration is adjusted to 5 to 50%, desirably about 10%. Furthermore, the aeration culture is preferably performed with the pH adjusted to 5 to 9. If pH is lowered during the culture, for example, calcium carbonate or an alkali such as ammonia gas and aqueous ammonia is added to neutralize the culture. When culture is performed under such conditions preferably for about 10 to 120 hours, a marked amount of L-amino acid accumulates in the culture medium. Although the concentration of L-amino acid which accumulates is not limited so long as it is higher than that observed with wild-type strains and the L-amino acid can be isolated and collected from the medium, it may be 50 g/L or higher, desirably 75 g/L or higher, more desirably 100 g/L or higher.

[0223] When the target amino acid is a basic amino acid, the fermentation is performed with the pH of the medium controlled to be 6.5 to 9.0 during the culture and to be 7.2 to 9.0 at the end of the culture. Furthermore, the internal pressure in the fermentation tank is controlled to be positive during the fermentation, or carbon dioxide or a mixed gas containing carbon dioxide is supplied to the medium so that there is a culture period that bicarbonate ions and/or carbonate ions are present in an amount of 2 g/L or larger in the medium, and thereby the bicarbonate ions and/or carbonate ions can be used as counter ions of cations mainly consisting of the basic amino acid (refer to JP 2002-065287 A).

[0224] The L-amino acid can be collected by a known collection method from the culture medium after the culture. For example, the L-amino acid can be collected by an ion exchange resin method or precipitation method, or after the bacterial cells are removed from the culture medium by centrifugation or the like, the L-amino acid is collected by concentration for crystallization.

[0225] The culture of the microorganism may be performed as a seed culture and a main culture in order to ensure accumulation of the L-amino acid higher than a certain level. The seed culture may be performed as a shaking culture using a flask or the like, or batch culture, and the main culture may be performed as fed-batch culture or continuous culture. Alternatively, both the seed culture and the main culture may be performed as batch culture.

[0226] When a fed-batch culture or continuous culture is performed, the feed medium may be intermittently fed so that the supply of ethanol, aliphatic acid or other carbon sources is temporarily stopped. The supply of the feed medium is preferably stopped for, at maximum, 30% or less, desirably 20% or less, particularly desirably 10% or less, of the feeding time. When the feed medium is intermittently fed, the feed medium may be initially added over a predetermined time, and the second and following additions may be controlled so that it is started when pH increases or the dissolved oxygen concentration is detected by a computer upon depletion of the carbon source in the fermentation medium during an addition-stopped period prior to a certain medium-addition period, and thus the substrate concentration in the culture tank is always automatically maintained at a low level (U.S. Pat. No. 5,912,113).

[0227] The feed medium used for the fed-batch culture preferably contains ethanol or an aliphatic acid, another carbon source, and a nutrient having a growth promoting effect (growth promoting factor), and may be controlled so that the concentration of the aliphatic acid in the fermentation medium is at a predetermined concentration or lower. The expression "predetermined concentration or lower" means that the medium is prepared so that the aliphatic acid concentration in the medium becomes 10% w/v or lower, preferably 5% w/v or lower, more preferably 1% w/v or lower.

[0228] As the other carbon source, glucose, sucrose, fructose and glycerol are preferred. As the growth promoting factor, nitrogen sources, phosphoric acid, amino acids and so forth are preferred. As the nitrogen source, ammonia, ammonium salts such as ammonium sulfate, ammonium carbonate, ammonium chloride, ammonium phosphate, ammonium acetate and urea, nitrates and so forth can be used. Furthermore, as the phosphoric acid source, potassium dihydrogenphosphate and dipotassium hydrogenphosphate can be used. As for the amino acids, when an auxotrophic mutant strain is used, it is preferable to supplement the required nutrient. Furthermore, the feed medium may consist of one type of medium, or a mixture of two or more types of media. When two or more types of feed media are used, the media may be mixed and fed by using one feed can, or the media may be separately fed by using two or more feed cans.

[0229] When the continuous culture method is used for the present invention, the medium may be extracted and fed simultaneously, or a part of the medium may be extracted, and then the medium may be fed. Furthermore, the method may also be a continuous culture method in which the culture medium containing L-amino acids and bacterial cells is extracted, and only the cells are returned to the fermenter for reuse (French Patent No. 2669935). As the method for continuously or intermittently feeding a nutrient source, the same method as used in the fed-batch culture is used.

[0230] The continuous culture method reusing bacterial cells intermittently or continuously extracts the fermentation medium when the amino acid concentration reaches a predetermined level, extracting only L-amino acid and re-circulating filtration residues containing bacterial cells into the fermenter, and it can be performed by referring to, for example, French Patent No. 2669935.

[0231] When the culture medium is intermittently extracted, it is preferred that some of the L-amino acid is extracted when the L-amino acid concentration reaches a predetermined level, and a fresh medium is fed to continue the culture. Furthermore, as for the volume of the medium to be added, the culture is preferably performed so that the final volume of the medium after the addition of the medium is equal to the volume of the culture medium before the extraction. The term "equal" used herein means that the volume after the addition of the medium corresponds to about 93 to 107% of the volume of the medium before the extraction.

[0232] When the culture medium is continuously extracted, the extraction is preferably started at the same time as, or after the feeding of, the nutrient medium. For example, within 5 hours, desirably 3 hours, more desirably 1 hour, after the start of the feeding, the extraction is started. Furthermore, the extraction volume of the culture medium is preferably equal to the volume of the fed medium.

EXAMPLES

[0233] Hereinafter, the present invention will be more specifically explained with reference to the following non-limiting examples.

Example 1

Construction of Alcohol Dehydrogenase (AdhE) Mutated Strain Derived from Escherichia coli

[0234] An Escherichia coli strain having mutant alcohol dehydrogenase AdhE was constructed so as to obtain an aerobically ethanol assimilable Escherichia coli strain. The nucleotide sequence of the wild-type AdhE gene (adhE) derived from Escherichia coli and the encoded amino acid sequence are shown in SEQ ID NOS: 21 and 22, respectively.

[0235] <1-1> Construction of Escherichia coli MG1655::P.sub.L-tac adhE Strain

[0236] Substitution of the P.sub.L-tac promoter for the promoter region of the Escherichia coli adhE gene was performed by "Red-driven integration", which was developed by Datsenko and Wanner (Datsenko, K. A. and Wanner, B. L., 2000, Proc. Natl. Acad. Sci. USA., 97:6640-6645) using the excision system derived from .lamda. phage (Cho, E. H., Gumport, R. I., and Gardner, J. F., 2002, J. Bacteriol., 184:5200-5203).

[0237] By this technique, a genetic recombinant strain can be constructed in one step using a PCR product obtained by using primers designed so as to contain a part of a target gene at the 5' end and a part of antibiotic resistance gene at the 3' end. By further using the excision system derived from .lamda. phage in combination, it is possible to eliminate the antibiotic resistance gene which had been integrated into the genetic recombinant strain.

[0238] A fragment containing the P.sub.L-tac promoter and the cat gene encoding the chloramphenicol resistance (Cm.sup.R) gene was amplified by PCR using the genome of the Escherichia coli MG1655 P.sub.L-tacxylE strain described in WO2006/043730 as the template and the primers shown in SEQ ID NOS: 23 and 24. The primer of SEQ ID NO: 23 has a sequence complementary to the upstream region of the adhE gene, and the primer of SEQ ID NO: 23 has a sequence complementary to a 5' region of the adhE gene.

[0239] The sequence of the P.sub.L-tac promoter is shown in SEQ ID NO: 25. For PCR, Gene Amp PCR System 2700 Amplificatory (Applied Biosystems) and Taq DNA polymerase (Fermentas) were used. The amplified fragment was purified and collected by agarose gel electrophoresis. This fragment was introduced into the Escherichia coli MG1655/pKD46 strain harboring the plasmid pKD46 having a temperature-sensitive replication ability by electroporation.

[0240] The strain was grown on M9 medium plates (Sambrook J., Fritsch, E. F., and Maniatis, T, 1989, Molecular Cloning A Laboratory Manual/Second Edition, Cold Spring Harbor Laboratory Press, New York) containing 2% ethanol for 36 hours, and about 100 clones appeared. PCR amplification was performed using the primers shown in SEQ ID NOS: 26 and 27, and then the nucleotide sequence of the amplified product was determined. It was confirmed that one of the clones contained the Cm.sup.R gene in the promoter region of the adhE gene, and this clone was cultured at 37.degree. C. to eliminate the temperature-sensitive plasmid pKD46 and thereby obtain an MG1655::P.sub.L-tacadhE strain.

[0241] <1-2> Construction of Escherichia coli MG1655AadhE Strain

[0242] The adhE gene of wild-type Escherichia coli MG1655 (ATCC 700926) was replaced with an inactivated adhE gene by the method developed by Datsenko and Wanner. A fragment containing the kan gene encoding the kanamycin resistance (Kan.sup.R) marker was amplified by PCR using the plasmid pACYC177 (GenBank/EMBL accession number X06402, Fermentas) as the template and the primers shown in SEQ ID NOS: 28 and 29. The primer of SEQ ID NO: 28 has a sequence of 40 bases complementary to the region 318 by upstream of the adhE gene, and the primer of SEQ ID NO: 29 has the sequence of 41 bases complementary to the region on the 3' side of the adhE gene. For PCR, Gene Amp PCR System 2700 Amplificatory (Applied Biosystems) and Taq DNA Polymerase (Fermentas) were used. The amplified fragment was purified and collected by agarose gel electrophoresis. This fragment was introduced into the Escherichia coli MG1655/pKD46 strain harboring the plasmid pKD46 by electroporation.

[0243] PCR amplification was performed by using the primers shown in SEQ ID NOS: 30 and 31 to confirm the presence of the Km.sup.R gene in clones grown on the LB plate medium (Sambrook, J., Fritsch, E. F., and Maniatis, T., 1989, Molecular Cloning A Laboratory Manual/Second Edition, Cold Spring Harbor Laboratory Press, New York) containing 20 .mu.g/ml of kanamycin. One of clones confirmed to contain the Km.sup.R gene in the adhE gene region was cultured at 37.degree. C. to remove the temperature-sensitive plasmid pKD46 and thereby obtain an MG1655.DELTA.adhE strain.

[0244] <1-3> Construction of Mutant Alcohol Dehydrogenase (AdhE*)

[0245] In order to introduce the Glu568Lys (E568K) mutation into AdhE, PCR was performed using the primer of SEQ ID NO: 32 which is complementary to nucleotide sequences of 1662 to 1701 and 1703 to 1730 of the adhE gene and containing a g->a mutation at the nucleotide of position 1702, the primer of SEQ ID NO: 33 which is homologous to the 3' end region of the adhE gene, and the genome of the Escherichia coli MG1655 strain as the template. For PCR, Gene Amp PCR System 2700 Amplificatory (Applied Biosystems) and Pyrobest DNA Polymerase (Takara Shuzo) were used. The amplification fragment of 1.05 kbp was purified and collected by agarose gel electrophoresis.

[0246] PCR was performed using the genome of the Escherichia coli MG1655::P.sub.L-tacadhE strain as the template, the primer shown in SEQ ID NO: 34 and the 1.05 kbp fragment having the mutation as another primer. The primer of SEQ ID NO: 34 corresponds to the sequence from 402 to 425 by upstream from the start codon of the adhE gene. For PCR, Gene Amp PCR System 2700 Amplificatory (Applied Biosystems) and TaKaRa LA DNA Polymerase (Takara Shuzo) were used. The amplification fragment of 4.7 kbp was purified and collected by agarose gel electrophoresis.

[0247] In order to replace the wild-type adhE gene with the mutant adhE gene, the 4.7 kbp fragment containing the Cm.sup.R gene and the mutant adhE gene downstream of the P.sub.L-tac promoter (cat-P.sub.L-tacadhE*) was introduced into the MG1655.DELTA.adhE/pKD46 strain by electroporation according to the method of Datsenko and Wanner. The clones were selected on the M9 plate medium containing 2% ethanol as the sole carbon source. By sequencing the adhE gene of the grown clone, Glu568Lys (gag-aag), Ile554Ser (atc-agc), Glu22Gly (gaa-gga), Met236Val (atg-gtg), Tyr461Cys (tac-tgc) and Ala786Val (gca-gta) were identified, and this clone was designated MG1655::P.sub.L-tacadhE*.

[0248] The MG1655.DELTA.tdh rhtA* strain was transformed via P1 transduction with P1.sub.vir phage (Miller, J. H., 1972, Experiments in Molecular Genetics, Cold Spring Harbor Lab. Press, Plainview, N.Y.) using the Escherichia coli MG1655::P.sub.L-tacadhE* strain as a donor, and MG1655.DELTA.tdh rhtA* P.sub.L-tacadhE* was obtained. The MG1655.DELTA.tdh, rhtA* strain corresponds to the MG1655 strain, but the Oh gene encoding threonine dehydrogenase is disrupted by the method of Datsenko and Wanner and a rhtA23 mutation is introduced therein, which imparts resistance to high concentrations of threonine in a minimal medium to the rhtA gene (Livshits, V. A., Zakataeva, N. P., Aleshin, V. V., Vitushkina, M. V., 2003, Res. Microbiol., 154:123-135).

[0249] <1-4> Construction of Alcohol Dehydrogenase (AdhE) Mutated Strain Derived from Escherichia coli WC196.DELTA.mez Strain

[0250] In order to impart ethanol assimilability to an L-lysine-producing bacterium, the L-lysine-producing bacterium WC196.DELTA.mez/pCABD2 strain described in International Patent Publication WO2005/010175 was subjected to P1 transduction using MG1655.DELTA.tdh rhtA adhE* as a donor to obtain a WC196.DELTA.mez adhE*/pCABD2 strain. pCABD2 is the plasmid described in U.S. Pat. No. 6,040,160, and has the dapA* gene which imparts resistance to feedback inhibition by L-lysine, the lysC* gene which imparts resistance to feedback inhibition by L-lysine, the dapB gene, and ddh gene.

Example 2

Construction of a Plasmid to Express the Pyruvate Synthase Gene of Chlorobium tepidum and Measurement of the Activity

[0251] <2-1> Construction of a Plasmid to Express the Pyruvate Synthase Gene of Chlorobium tepidum

[0252] Chlorobium tepidum is a meso- to thermophilic autotrophic bacterium, and its optimum growth temperature is 48.degree. C. The genome sequence of the Chlorobium tepidum TLS strain has been elucidated by Eisen et al. (Eisen, J. A. et al., 2002, Proc. Natl. Acad. Sci. USA, 99:9509-9514). The pyruvate synthase gene was isolated from this strain, and a plasmid expressing it was constructed.

[0253] <2-2> Measurement of Pyruvate Synthase Activity in a Strain Expressing the Pyruvate Synthase Gene of Chlorobium tepidum

[0254] PCR was performed using the chromosomal DNA of the Chlorobium tepidum TLS strain (ATCC 49652) as the template and the oligonucleotides shown in SEQ ID NOS: 35 and 36 to amplify a pyruvate synthase gene fragment. The gene fragment was digested with Sad, and inserted into the Sad site of pSTV28 (Takara Bio) to construct a plasmid, which was designated pSTV-PS. After it was confirmed that the pyruvate synthase gene contained no PCR error over the full length by using BigDye Terminators v1.1 Cycle Sequencing Kit, the pyruvate synthase gene was excised from pSTV-PS with Sad, and inserted into the Sad site of pMW-Pthr to construct plasmid pMW-Pthr-PS. pMW-Pthr corresponds to the vector pMW219 (Nippon Gene) having the promoter region (Pthr) of the threonine operon (thrABC) of the Escherichia coli K-12 strain between the HindIII site and the XbaI site and which is capable of expressing the gene cloned downstream of the promoter. The promoter sequence of the chosen threonine operon is shown in SEQ ID NO: 37.

[0255] pMW-Pthr-PS and the control vector pMW-Pthr were introduced into the WC196.DELTA.cadA.DELTA.ldc/pCABD2 strain by electroporation, respectively, and transformants were obtained on the basis of the kanamycin resistance, and the presence of the plasmids was confirmed. The strain expressing the pyruvate synthase gene of Chlorobium tepidum was designated WC196.DELTA.cadA.DELTA.ldc/pCABD2/pMW-Pthr-PS, and the control strain was designated WC196.DELTA.cadA.DELTA.ldc/pCABD2/pMW-Pthr.

[0256] The aforementioned strains were each inoculated into LB medium containing 20 mg/l of streptomycin and 40 mg/l of kanamycin, and cultured overnight at 37.degree. C. with shaking. The cells were collected by centrifugation and suspended in a 50 mM HEPES buffer (pH 8.0). The cells in the suspension were disrupted by using an ultrasonicator, the suspension was centrifuged at 15000 rpm for 15 minutes, and the supernatant was used as a crude enzyme solution.

[0257] Protein concentration in the crude enzyme solution was measured by using Protein Assay CBB Solution (Nakalai Tesque), and the crude enzyme solution containing 250 .mu.g of the total protein was used to measure the activity.

[0258] The activity was measured as follows. 2 ml of the following reaction solution was added to the crude enzyme solution. The reaction solution containing all the ingredients except for pyruvic acid was first added to a cell for spectrometry, and the cell was sealed with a rubber stopper and an aluminum cap. The oxygen concentration was reduced in the cell by injecting argon gas into the cell for 5 minutes using a syringe, and then the cell was set on a spectrophotometer (U-3210 Spectrophotometer, Hitachi). A pyruvic acid solution was added by using a syringe to start the reaction. The reaction continued at 37.degree. C. for 30 minutes, and absorbance was periodically measured at 578 nm to examine the change in the reduced methylviologen amount. The results are shown in Table 1. In the table, the unit of the specific activity is U/mg protein. One unit is defined as activity for reducing 1 nmol of methylviologen per 1 minute.

[0259] Reaction mixture:

TABLE-US-00001 MgCl.sub.2 1 mM Dithiothreitol 1 mM Methylviologen 5 mM CoA 0.25 mM Pyruvic acid 10 mM (added immediately before start of measurement) HEPES (pH 8.0) 50 mM

TABLE-US-00002 TABLE 1 Plasmid Specific activity pMW-Pthr 0.0 pMW-Pthr-PS 1.2

Example 3

Construction of a Plasmid to Express the Pyruvate Synthase Gene of Chlorobium tepidum, Flavodoxin NADP.sup.+ Reductase Gene of Escherichia coli, and Ferredoxin Gene of Escherichia coli

[0260] By using the flavodoxin NADP.sup.+ reductase gene of Escherichia coli (fpr) and the ferredoxin gene of Escherichia coli (fdx) as coenzyme regenerating systems, a plasmid simultaneously expressing all three genes, including the pyruvate synthase gene, was constructed.

[0261] <3-1> Construction of a Vector to Amplify the Flavodoxin NADP.sup.+ Reductase Gene of E. coli

[0262] PCR was performed using the chromosomal DNA of the E. coli MG1655 strain as the template and the oligonucleotides shown in SEQ ID NOS: 42 and 43. The gene fragment was digested with SmaI and inserted into the SmaI site of pMW-Pthr to construct a plasmid for amplifying the flavodoxin NADP.sup.+ reductase gene, which was designated pMW-Pthr-fpr.

<3-3> Construction of a Plasmid to Amplify the Ferredoxin (fdx) Gene of E. coli

[0263] PCR was performed using the chromosomal DNA of the E. coli MG1655 strain as the template and the oligonucleotides shown in SEQ ID NOS: 44 and 45. The gene fragment was digested with EcoRI, and inserted into the EcoRI site of pMW-Pthr to construct a plasmid to amplify the ferredoxin (fdx) gene, pMW-Pthr-fdx.

[0264] <3-4> Construction of a Plasmid to Amplify the Pyruvate Synthase Gene of C. tepidum, the Flavodoxin NADP.sup.+ Reductase Gene, and the Ferredoxin (fdx) Gene of E. coli

[0265] pMW-Pthr-Pthr was digested with SmaI, and the fpr gene fragment was ligated with pMW-Pthr-fdx which had been treated with SmaI to obtain pMW-Pthr-fpr-fdx. Then, pMW-Pthr-PS was digested with Sad, and the PS gene fragment was ligated with pMWPthr-fpr-fdx which had been treated with Sad to construct a plasmid to express the pyruvate synthase gene of C. tepidum and enhance expression of the flavodoxin NADP.sup.+ reductase and the ferredoxin (fdx) genes of E. coli, and was named pMW-Pthr-fpr-PS-fdx.

[0266] In the aforementioned plasmids, the pyruvate synthase gene of C. tepidum is transcribed from Pthr, and the other genes are also transcribed by read through from Pthr.

Example 4

Effect on the L-Lysine-Producing Ability of a Strain with Enhanced Expression of the Pyruvate Synthase Gene of Chlorobium tepidum, Flavodoxin NADP.sup.+ Reductase Gene of Escherichia coli, and Ferredoxin Gene of Escherichia coli, Using Oleic Acid as the Carbon Source

[0267] <4-1> Introduction of the Plasmid to Amplify the Pyruvate Synthase Gene of Chlorobium tepidum, Flavodoxin NADP.sup.+ Reductase Gene of Escherichia coli, and Ferredoxin Gene of Escherichia coli into the WC196.DELTA.mez Strain

[0268] pMW-Pthr-Thr-PS-fdx and the control vector pMW-Pthr were introduced into WC196.DELTA.mez/pCABD2 by electroporation, respectively, and transformants were obtained on the basis of the kanamycin resistance, and introduction of the plasmids were confirmed. The strain expressing the pyruvate synthase gene of Chlorobium tepidum, the flavodoxin NADP.sup.+ reductase gene of Escherichia coli and the ferredoxin gene of Escherichia coli was designated WC196.DELTA.mez/pCABD2/pMW-Pthr-fpr-PS-fdx, and the control strain was designated WC196.DELTA.mez/p CABD2/pMW-Pthr.

[0269] <4-2> Effect on L-Lysine-Producing Ability of the Strain with Enhanced Expression of the Pyruvate Synthase Gene of Chlorobium tepidum, Flavodoxin NADP.sup.+ Reductase Gene of Escherichia coli, and Ferredoxin Gene of Escherichia coli Using Oleic Acid as the Carbon Source

[0270] Both WC196.DELTA.mez/pCABD2/pMW-Pthr and WC196.DELTA.mez/pCABD2/pMW-Pthr-Thr-PS-fdx were inoculated onto the LB plate medium, respectively, and precultured overnight at 37.degree. C. The cells corresponding to 1/8 of the plate were inoculated into 20 ml of the oleic acid medium having the following composition in a 500 ml-volume Sakaguchi flask, and aerobically cultured at a stirring rate of 120 mm at 37.degree. C. for 72 hours. The L-lysine that accumulated in the medium was measured by using Biosensor BF-5 (Oji Scientific Instruments). The live cell count in the medium was also measured. Averages of the values obtained in the culture performed in duplicate are shown in Table 2. Improvement in L-lysine accumulation was observed for the strain in which expression of pyruvate synthase gene of Chlorobium tepidum, flavodoxin NADP.sup.+ reductase gene of Escherichia coli and ferredoxin gene of Escherichia coli were enhanced, compared with the control.

[0271] Composition of oleic acid medium:

TABLE-US-00003 Sodium oleate 20 g/L MgSO.sub.4.cndot.7H.sub.2O 1.0 g/L (NH.sub.4).sub.2SO.sub.4 12 g/L KH.sub.2PO.sub.4 0.5 g/L Yeast extract 1.0 g/L FeSO.sub.4.cndot.7H.sub.2O 0.01 g/L MnSO.sub.4.cndot.5H.sub.2O 0.01 g/L Kanamycin 40 mg/L Streptomycin 20 mg/L Calcium carbonate 30 g/L pH 7.0 (adjusted with KOH) Sterilization conditions: 115.degree. C., 10 minutes

TABLE-US-00004 TABLE 2 L-lysine Live cell Strain (g/l) count (10.sup.8/ml) WC196.DELTA.mez/pCABD2/pMW-Pthr 1.77 22.3 WC196.DELTA.mez/pCABD2/pMW-Pthr- 2.35 13.6 fpr-PS-fdx

Example 5

Construction of a Plasmid to Express the Pyruvate Synthase Gene of Escherichia coli and Measurement of Activity

[0272] An expression plasmid for the ydbK gene, which is homologous to the pyruvate synthase gene found in the genome of Escherichia coli MG1655 strain, was constructed, and the activity was measured.

[0273] <5-1> Construction of a Plasmid to Express the Pyruvate Synthase Gene of Escherichia coli

[0274] PCR was performed using the chromosomal DNA of the Escherichia coli MG1655 strain as the template and the oligonucleotides shown in SEQ ID NOS: 38 and 39. The gene fragment was digested with KpnI, and the digested fragment was inserted into the KpnI site of pSTV28 (Takara Bio) to construct a plasmid, which was designated pSTV-ydbK After it was confirmed that the pyruvate synthase gene contained no PCR error over the full length by using BigDye Terminators v1.1 Cycle Sequencing Kit, the pyruvate synthase gene was excised from pSTV-ydbK with KpnI, and inserted into the KpnI site of pMW-Pthr to construct the plasmid pMW-Pthr-ydbK.

[0275] <5-2> Measurement of Pyruvate Synthase Activity in a Strain Expressing the Pyruvate Synthase Gene of Escherichia coli

[0276] pMW-Pthr-ydbK and the control vector pMW-Pthr were introduced into the WC196.DELTA.cadA.DELTA.ldc/pCABD2 strain by electroporation, respectively, and transformants were obtained on the basis of the kanamycin resistance, and introduction of the plasmids was confirmed. The strain expressing the pyruvate synthase gene of Escherichia coli was designated WC196.DELTA.cadA.DELTA.ldc/pCABD2/pMW-Pthr-ydbK, and the control strain was designated WC196.DELTA.cadA.DELTA.ldc/pCABD2/pMW-Pthr.

[0277] The aforementioned strains were each inoculated into LB medium containing 20 mg/l of streptomycin and 40 mg/l of kanamycin, and cultured overnight at 37.degree. C. with shaking. The cells were collected by centrifugation, and the activity was measured in the same manner as that for the strain expressing the pyruvate synthase gene of Chlorobium tepidum described in Example 2. The results are shown in Table 3. Whereas the activity of pyruvate synthase was not confirmed for the control strain WC196.DELTA.cadA.DELTA.ldc/pCABD2/pMW-Pthr, 8.0 U/mg was confirmed for the strain expressing the pyruvate synthase gene of Escherichia coli, WC196.DELTA.cadA.DELTA.ldc/pCABD2/pMW-Pthr-ydbK. The results are shown in Table 3. The unit of the specific activity is the same as that used in Table 1.

TABLE-US-00005 TABLE 3 Plasmid Specific activity pMW-Pthr 0.0 pMW-Pthr-ydbK 8.0

Example 6

Construction of a Plasmid to Express the Pyruvate Synthase Gene of Escherichia coli, Flavodoxin NADP.sup.+ Reductase Gene of Escherichia coli, and Ferredoxin Gene of Escherichia coli

[0278] The plasmid pMW-Pthr-fpr containing the flavodoxin NADP.sup.+ reductase gene of Escherichia coli described in Example 3 was digested with SmaI, and the obtained fpr gene fragment was ligated with the plasmid pMW-Pthr-fdx containing the ferredoxin gene of Escherichia coli treated with SmaI to obtain pMW-Pthr-Thr-fdx. Then, pMW-Pthr-ydbK was digested with KpnI, and the ydbK gene fragment was ligated with pMW-Pthr-Thr-fdx treated with KpnI to construct a plasmid to enhance expression of the pyruvate synthase gene of Escherichia coli, flavodoxin NADP.sup.+ reductase gene of Escherichia coli and ferredoxin fdx gene, pMW-Pthr-fpr-ydbK-fdx.

Example 7

Effect on L-Lysine-Producing Ability of a Strain with Enhanced Expression of the Pyruvate Synthase Gene of Escherichia coli, Flavodoxin NADP.sup.+ Reductase Gene of Escherichia coli and Ferredoxin Gene of Escherichia coli Using Ethanol as the Carbon Source

[0279] <7-1> Introduction of the Plasmid to Amplify the Pyruvate Synthase Gene of Escherichia coli, Flavodoxin NADP.sup.+ Reductase Gene of Escherichia coli and Ferredoxin Gene of Escherichia coli into WC196.DELTA.mez adhE* Strain

[0280] pMW-Pthr-fpr-ydbK-fdx and the control vector pMW-Pthr were introduced into WC196.DELTA.mez adhE*/pCABD2 by electroporation, respectively, and transformants were obtained on the basis of the kanamycin resistance, and introduction of the plasmids were confirmed. The strain expressing the pyruvate synthase gene of Escherichia coli was designated WC196.DELTA.mez adhE*/pCABD2/pMW-Pthr-fpr-ydbK-fdx, and the control strain was designated WC196.DELTA.mez adhE*/pCABD2/pMW-Pthr.

[0281] <7-2> Effect on L-Lysine-Producing Ability of the Strain with Enhanced Expression of the Pyruvate Synthase Gene of Escherichia coli, Flavodoxin NADP.sup.+ Reductase Gene of Escherichia coli and Ferredoxin Gene of Escherichia coli Using Ethanol as the Carbon Source>

[0282] Both WC196.DELTA.mez adhE*/pCABD2/pMW-Pthr and WC196.DELTA.mez adhE*/pCABD2/pMW-Pthr-fpr-ydbK-fdx were inoculated onto LB plate medium, respectively, and cultured overnight at 37.degree. C. The cells corresponding to 1/8 of the plate were inoculated into 20 ml of the ethanol medium having the following composition in a 500 ml-volume Sakaguchi flask, and aerobically cultured at a stirring rate of 120 rpm at 37.degree. C. for 96 hours. L-lysine which accumulated in the medium and residual ethanol were measured by using a Biosensor BF-5 (Oji Scientific Instruments). The turbidity of the medium was also measured. Averages of the values obtained in the culture performed in duplicate are shown in Table 4. Improved production of L-lysine was observed for the strain with enhanced expression of the pyruvate synthase gene of Escherichia coli, flavodoxin NADP.sup.+ reductase gene of Escherichia coli and ferredoxin gene of Escherichia coli, compared with the control.

[0283] Composition of ethanol medium:

TABLE-US-00006 Ethanol 20 ml/L MgSO.sub.4.cndot.7H.sub.2O 1.0 g/L (NH.sub.4).sub.2SO.sub.4 12 g/L KH.sub.2PO.sub.4 0.5 g/L Yeast extract 1.0 g/L FeSO.sub.4.cndot.7H.sub.2O 0.01 g/L MnSO.sub.4.cndot.5H.sub.2O 0.01 g/L Kanamycin 40 mg/L Streptomycin 20 mg/L Calcium carbonate 30 g/L pH 7.0 (adjusted with KOH) Sterilization conditions: 115.degree. C., 10 minutes

TABLE-US-00007 TABLE 4 Lys EtOH Strain (g/l) (V/V %) OD620 WC196.DELTA.mez adhE*/pCABD2/pMW-Pthr 2.47 0.00 14.7 WC196.DELTA.mez adhE*/pCABD2/pMW-Pthr- 2.89 0.00 9.3 fpr-ydbK-fdx

Example 8

Construction of the Plasmid to Express the Pyruvate:NADP.sup.+ Oxidoreductase Gene of Euglena gracilis and Measurement of Activity

[0284] Euglena gracilis is a photosynthetic protist, with an optimum growth temperature of 27.degree. C. The pyruvate:NADP.sup.+ oxidoreductase gene was isolated from this organism, and a plasmid expressing this gene was constructed.

[0285] <8-1> Construction of the Plasmid to Express the Pyruvate:NADP.sup.+ Oxidoreductase Gene of Euglena gracilis

[0286] PCR was performed by using the chromosomal DNA of Euglena gracilis as the template and the oligonucleotides shown in SEQ ID NOS: 40 and 41. The gene fragment was digested with KpnI, and the digested fragment was inserted into the KpnI site of pUC19 (Takara Bio) to construct a plasmid, which was designated pUC-PNO. After it was confirmed that the pyruvate:NADP.sup.+ oxidoreductase gene contained no PCR error over the full length by using BigDye Terminators v1.1 Cycle Sequencing Kit, the pyruvate:NADP.sup.+ oxidoreductase gene was excised from pUC-PNO with KpnI, and inserted into the KpnI site of pMW-Pthr to construct the plasmid pMW-Pthr-PNO. <8-2> Confirmation of expression of pyruvate:NADP.sup.+ oxidoreductase pMW-Pthr-PNO and the control vector pMW-Pthr were introduced into the WC196.DELTA.cadA.DELTA.ldc/pCABD2 strain by electroporation, respectively, and transformants were obtained on the basis of the kanamycin resistance, and introduction of the plasmids was confirmed. The strain expressing the pyruvate:NADP.sup.+ oxidoreductase gene of Euglena gracilis was designated WC196.DELTA.cadA.DELTA.ldc/pCABD2/pMW-Pthr-PNO, and the control strain was designated WC196.DELTA.cadA.DELTA.ldc/pCABD2/pMW-Pthr.

[0287] The aforementioned strains were each inoculated into LB medium containing 20 mg/l of streptomycin and 40 mg/l of kanamycin, and cultured overnight at 37.degree. C. with shaking. 1 ml of the medium was inoculated into 20 ml of LB medium containing 20 mg/l of streptomycin and 40 mg/l of kanamycin, and cultured at 37.degree. C. for 5 hours with shaking. The cells were collected by centrifugation and suspended in 1 ml of PBS. The cells in the suspension were disrupted by using an ultrasonicator, the suspension was centrifuged at 15000 rpm for 15 minutes, and the supernatant was used as a crude extract. Protein concentration in the crude extract was measured by using Protein Assay CBB Solution (Nakalai Tesque), and the crude extract containing 10 .mu.g of protein was used to prepare the samples. Each sample was prepared by adding NuPAGE LDS Sample Buffer (Invitrogen) to the crude extract at a concentration of 1.1.times., then adding NuPAGE Sample Reducing Agent (Invitrogen) to a final concentration of 10%, and heating the mixture at 70.degree. C. for 10 minutes. The prepared sample was subjected to electrophoresis using NuPAGE Tris-Acetate Gel 3-8% (Invitrogen). MagicMark XP Western Protein Standard (Invitrogen) was used as markers.

[0288] The gel after electrophoresis was transferred to a membrane by using iBlot Gel Transfer Device (Invitrogen). After the transfer, the process from blocking to detection were performed by using WesternBreeze Chemiluminescent Western Blot Immunodetection Kit (Invitrogen). First, the membrane was subjected to a blocking treatment for 30 minutes, washed twice with purified water and incubated in an anti-PNO serum solution diluted 1000 times for 1 hour. The membrane was washed 3 times with a washing solution, and incubated in a second antibody solution for 30 minutes. The membrane was washed 3 times with a washing solution and further twice with purified water, sprinkled with a detection reagent, and subjected to detection using Lumino-image Analyzer LAS-1000 (Fuji Photo Film). The results are shown in FIG. 1. A band presumed to be PNO was detected around 200 kD for the WC196.DELTA.cadA.DELTA.ldc/pCABD2/pMW-Pthr-PNO strain, whereas a band was not detected for the control strain WC196.DELTA.cadA.DELTA.ldc/pCABD2/pMW-Pthr.

Example 9

Construction of the Plasmid to Express the Pyruvate:NADP.sup.+ Oxidoreductase Gene of Euglena gracilis

[0289] The pyruvate:NADP.sup.+ oxidoreductase gene fragment was excised from the plasmid pUC-PNO described in Example 8 with KpnI, and inserted into the KpnI site of pMW-Pthr to construct the plasmid pMW-Pthr-PNO.

Example 10

Effect on L-Lysine-Producing Ability of the Strain with Enhanced Expression of the Pyruvate:NADP.sup.+ Oxidoreductase Gene of Euglena gracilis Using Oleic Acid as the Carbon Source

[0290] <10-1> Introduction of the Plasmid for Amplification of Pyruvate:NADP.sup.+ Oxidoreductase Gene of Euglena gracilis into the WC196.DELTA.mez Strain

[0291] pMW-Pthr-PNO and the control vector pMW-Pthr were introduced into WC196.DELTA.mez/pCABD2 by electroporation, respectively, and transformants were obtained on the basis of the kanamycin resistance, and introduction of the plasmids were confirmed. The strain expressing the pyruvate:NADP.sup.+ oxidoreductase gene of Euglena gracilis was designated WC196.DELTA.mez/pCABD2/pMW-Pthr-PNO, and the control strain was designated WC196.DELTA.mez/pCABD2/pMW-Pthr.

[0292] <10-2> Effect on L-Lysine-Producing Ability of the Strain with Enhanced Expression of the Pyruvate:NADP.sup.+ Oxidoreductase Gene of Euglena gracilis Using Oleic Acid as the Carbon Source

[0293] Both WC196.DELTA.mez/pCABD2/pMW-Pthr and WC196.DELTA.mez/pCABD2/pMW-Pthr-PNO were inoculated onto the LB plate medium, respectively, and cultured overnight at 37.degree. C. The cells corresponding to 1/8 of the plate were inoculated into 20 ml of the oleic acid medium having the following composition in a 500 ml-volume Sakaguchi flask, and aerobically cultured at a stirring rate of 120 rpm at 37.degree. C. for 72 hours. L-lysine which accumulated in the medium was measured by using a Biosensor BF-5 (Oji Scientific Instruments). The live cell count in the medium was also measured. Averages of the values obtained in the culture performed in duplicate are shown in Table 5. Improvement in the production of L-lysine was observed for the strain in which expression of pyruvate:NADP.sup.+ oxidoreductase gene of Euglena gracilis was enhanced, compared with the control.

[0294] Composition of oleic acid medium:

TABLE-US-00008 Sodium oleate 20 g/L MgSO.sub.4.cndot.7H.sub.2O 1.0 g/L (NH.sub.4).sub.2SO.sub.4 12 g/L KH.sub.2PO.sub.4 0.5 g/L Yeast extract 1.0 g/L FeSO.sub.4.cndot.7H.sub.2O 0.01 g/L MnSO.sub.4.cndot.5H.sub.2O 0.01 g/L Kanamycin 40 mg/L Streptomycin 20 mg/L Calcium carbonate 30 g/L pH 7.0 (adjusted with KOH) Sterilization conditions: 115.degree. C., 10 minutes

TABLE-US-00009 TABLE 5 Lys Live cell Strain (g/l) count (10.sup.8/ml) WC196.DELTA.mez/pCABD2/pMW-Pthr 1.77 22.3 WC196.DELTA.mez/pCABD2/pMW-Pthr-PNO 2.41 15.9

Example 11

Effect on L-Lysine-Producing Ability of the Strain with Enhanced Expression of the Pyruvate:NADP.sup.+ Oxidoreductase Gene of Euglena gracilis Using Ethanol as the Carbon Source

[0295] <11-1> Introduction of the Plasmid for Amplification of Pyruvate:NADP.sup.+ Oxidoreductase Gene of Euglena gracilis into WC196.DELTA.mez adhE*

[0296] pMW-Pthr-PNO and the control vector pMW-Pthr were introduced into WC196.DELTA.mez adhE*/pCABD2 by electroporation, respectively, and transformants were obtained on the basis of the kanamycin resistance, and introduction of the plasmids was confirmed. The strain expressing the pyruvate:NADP.sup.+ oxidoreductase gene of Euglena gracilis was designated WC196.DELTA.mez adhE*/pCABD2/pMW-Pthr-PNO, and the control strain was designated WC196.DELTA.mez adhE*/pCABD2/pMW-Pthr.

[0297] <11-2> Effect on L-Lysine-Producing Ability of the Strain with Enhanced Expression of the Pyruvate:NADP.sup.+ Oxidoreductase Gene of Euglena gracilis Using Ethanol as the Carbon Source

[0298] Both WC196.DELTA.mez adhE*/pCABD2/pMW-Pthr and WC196.DELTA.mez adhE*/pCABD2/pMW-Pthr-PNO were each inoculated onto LB plate medium, and precultured overnight at 37.degree. C. The cells corresponding to 1/8 of the plate were inoculated into 20 ml of the ethanol medium having the following composition in a 500 ml-volume Sakaguchi flask, and aerobically cultured at a stirring rate of 120 rpm at 37.degree. C. for 96 hours. After 96 hours, 1 ml of the medium was sampled, and L-lysine which had accumulated in the medium was measured by using a Biosensor BF-5 (Oji Scientific Instruments). The turbidity of the medium was also measured. Averages of the values obtained in the culture performed in duplicate are shown in Table 6. Improvement in the production of L-lysine was observed in the strain with enhanced expression of the pyruvate:NADP.sup.+ oxidoreductase gene of Euglena gracilis, compared with the control.

[0299] Composition of ethanol medium:

TABLE-US-00010 Ethanol 20 ml/L MgSO.sub.4.cndot.7H.sub.2O 1.0 g/L (NH.sub.4).sub.2SO.sub.4 12 g/L KH.sub.2PO.sub.4 0.5 g/L Yeast extract 1.0 g/L FeSO.sub.4.cndot.7H.sub.2O 0.01 g/L MnSO.sub.4.cndot.5H.sub.2O 0.01 g/L Kanamycin 40 mg/L Streptomycin 20 mg/L Calcium carbonate 30 g/L pH 7.0 (adjusted with KOH) Sterilization conditions: 115.degree. C., 10 minutes

TABLE-US-00011 TABLE 6 Lys EtOH Strain (g/l) (V/V %) OD620 WC196.DELTA.mez adhE*/pCABD2/pMW-Pthr 2.47 0.00 14.7 WC196.DELTA.mez adhE*/pCABD2/pMW-Pthr- 2.89 0.00 9.3 fpr-ydbK-fdx

[0300] Explanation of Sequence Listing:

[0301] SEQ ID NO: 1: Nucleotide sequence of C. tepidum pyruvate synthase gene

[0302] SEQ ID NO: 2: Amino acid sequence of C. tepidum pyruvate synthase

[0303] SEQ ID NO: 3: Nucleotide sequence of E. coli pyruvate synthase gene

[0304] SEQ ID NO: 4: Amino acid sequence of E. coli pyruvate synthase

[0305] SEQ ID NO: 5: Nucleotide sequence of E. gracilis pyruvate: NAPD.sup.+ oxidoreductase gene

[0306] SEQ ID NO: 6: Amino acid sequence of E. gracilis pyruvate: NADP.sup.+ oxidoreductase gene

[0307] SEQ ID NO: 7: Nucleotide sequence of E. coli flavodoxin NADP.sup.+ reductase(fpr) gene

[0308] SEQ ID NO: 8: Amino acid sequence encoded by E. coli E. coli flavodoxin NADP reductase(fpr) gene

[0309] SEQ ID NO: 9: Nucleotide sequence of E. coli ferredoxin(fdx) gene

[0310] SEQ ID NO: 10: Amino acid sequence encoded by E. coli ferredoxin(fdx) gene

[0311] SEQ ID NO: 11: Nucleotide sequence of E. coli ferredoxin(yfhL) gene

[0312] SEQ ID NO: 12: Amino acid sequence encoded by E. coli ferredoxin(yfhL) gene

[0313] SEQ ID NO: 13: Nucleotide sequence of E. coli flavodoxin(fldA) gene

[0314] SEQ ID NO: 14: Amino acid sequence encoded by E. coli flavodoxin(fldA) gene

[0315] SEQ ID NO: 15: Nucleotide sequence of E. coli flavodoxin(fldB) gene

[0316] SEQ ID NO: 16: Amino acid sequence encoded by E. coli flavodoxin(fldB) gene

[0317] SEQ ID NO: 17: Nucleotide sequence of C. tepidum ferredoxin I gene

[0318] SEQ ID NO: 18: Amino acid sequence encoded by C. tepidum ferredoxin I gene

[0319] SEQ ID NO: 19: Nucleotide sequence of C. tepidum ferredoxin II gene

[0320] SEQ ID NO: 20: Amino acid sequence encoded by C. tepidum ferredoxin II gene

[0321] SEQ ID NO: 21: Nucleotide sequence of E. coli alcohol dehydrogenase gene

[0322] SEQ ID NO: 22: Amino acid sequence encoded by E. coli alcohol dehydrogenase gene

[0323] SEQ ID NO: 23: P.sub.L-tac promoter and chloramphenicol resistance (Cm.sup.R) gene amplification primer 1

[0324] SEQ ID NO: 24: P.sub.L-tac promoter and chloramphenicol resistance (Cm.sup.R) gene amplification primer 2

[0325] SEQ ID NO: 25: Nucleotide sequence of P.sub.L-tac promoter

[0326] SEQ ID NO: 26: P.sub.L-tac promoter and chloramphenicol resistance (Cm.sup.R) gene amplification primer 3

[0327] SEQ ID NO: 27: P.sub.L-tac promoter and chloramphenicol resistance (Cm.sup.R) gene amplification primer 4

[0328] SEQ ID NO: 28: Kanamycin resistance (Cm.sup.R) gene amplification primer 1

[0329] SEQ ID NO: 29: Kanamycin resistance (Cm.sup.R) gene amplification primer 2

[0330] SEQ ID NO: 30: Kanamycin resistance (Cm.sup.R) gene amplification primer 3

[0331] SEQ ID NO: 31: Kanamycin resistance (Cm.sup.R) gene amplification primer 4

[0332] SEQ ID NO: 32: E. coli mutant alcohol dehydrogenase gene amplification primer 1

[0333] SEQ ID NO: 33: E. coli mutant alcohol dehydrogenase gene amplification primer 2

[0334] SEQ ID NO: 34: E. coli mutant alcohol dehydrogenase gene amplification primer 3

[0335] SEQ ID NO: 35: C. tepidum pyruvate synthase gene amplification primer 1

[0336] SEQ ID NO: 36: C. tepidum pyruvate synthase gene amplification primer 2

[0337] SEQ ID NO: 37: Threonine operon promoter sequence

[0338] SEQ ID NO: 38: E. coli pyruvate synthase gene amplification primer 1

[0339] SEQ ID NO: 39: E. coli pyruvate synthase gene amplification primer 2

[0340] SEQ ID NO: 40: E. gracilis pyruvate:NADP.sup.+ oxidoreductase gene amplification primer 1

[0341] SEQ ID NO: 41: E. gracilis pyruvate:NADP.sup.+ oxidoreductase gene amplification primer 2

[0342] SEQ ID NO: 42: E. coli flavodoxin NADP.sup.+ reductase gene amplification primer 1

[0343] SEQ ID NO: 43: E. coli flavodoxin NADP.sup.+ reductase gene amplification primer 2

[0344] SEQ ID NO: 44: E. coli fdx gene amplification primer 1

[0345] SEQ ID NO: 45: E. coli fdx gene amplification primer 2

[0346] SEQ ID NO: 46: Nucleotide sequence of E. coli pyruvate dehydrogenase Ep1 subunit gene (aceE)

[0347] SEQ ID NO: 47: Amino acid sequence of E. coli pyruvate dehydrogenase Ep1 subunit

[0348] SEQ ID NO: 48: Nucleotide sequence of E. coli pyruvate dehydrogenase E2 subunit gene (aceF)

[0349] SEQ ID NO: 49: Amino acid sequence of E. coli pyruvate dehydrogenase E2 subunit

[0350] SEQ ID NO: 50: Nucleotide sequence of E. coli pyruvate dehydrogenase E3 subunit gene (lpdA)

[0351] SEQ ID NO: 51: Amino acid sequence of E. coli pyruvate dehydrogenase E3 subunit

[0352] SEQ ID NO: 52: Nucleotide sequence of gene (sfcA) encoding E. coli malic enzyme

[0353] SEQ ID NO: 53: Amino acid sequence of malic enzyme encoded by E. coli sfcA gene

[0354] SEQ ID NO: 54: Nucleotide sequence of gene (b2463) encoding E. coli malic enzyme

[0355] SEQ ID NO: 55: Amino acid sequence of malic enzyme encoded by E. coli b2463 gene

INDUSTRIAL APPLICABILITY

[0356] By using the microorganism of the present invention, an L-amino acid can be efficiently produced by fermentation. Moreover, according to a preferred embodiment of the method of the present invention, the method of the present invention is an environmentally-friendly method which can reduce carbon dioxide emission by suppressing decarboxylation and utilizing carbon dioxide fixation.

[0357] While the invention has been described in detail with reference to preferred embodiments thereof, it will be apparent to one skilled in the art that various changes can be made, and equivalents employed, without departing from the scope of the invention. Each of the aforementioned documents is incorporated by reference herein in its entirety,

Sequence CWU 1

1

5513558DNAChlorobium tepidumCDS(1)..(3558) 1atg acc cgg aca ttc aag aca atg gag ggg aat gaa gct ctt gct cat 48Met Thr Arg Thr Phe Lys Thr Met Glu Gly Asn Glu Ala Leu Ala His1 5 10 15gtc gcc tat cgc act aat gaa gtc atc tcg ata tac ccg att acc ccg 96Val Ala Tyr Arg Thr Asn Glu Val Ile Ser Ile Tyr Pro Ile Thr Pro 20 25 30gca tct ccg atg gga gag tac tcc gac gca tgg gcc gct gtc gat gta 144Ala Ser Pro Met Gly Glu Tyr Ser Asp Ala Trp Ala Ala Val Asp Val 35 40 45aaa aat atc tgg ggt acc gtg cca ctc gtc aat gag atg cag agc gaa 192Lys Asn Ile Trp Gly Thr Val Pro Leu Val Asn Glu Met Gln Ser Glu 50 55 60gcc ggt gcc gcc gcc gcc gtt cac ggc gcg ttg cag acc ggc gcg ctg 240Ala Gly Ala Ala Ala Ala Val His Gly Ala Leu Gln Thr Gly Ala Leu65 70 75 80acg acc acc ttc acg gcc tct cag ggt ctc tta ctg atg atc ccg aac 288Thr Thr Thr Phe Thr Ala Ser Gln Gly Leu Leu Leu Met Ile Pro Asn 85 90 95atg tac aag atc gcc ggt gaa ctg acc ccc tgc gtg att cac gtg tca 336Met Tyr Lys Ile Ala Gly Glu Leu Thr Pro Cys Val Ile His Val Ser 100 105 110 gcc cgt tcg ctg gcc gcg cag gcg ctc tcg ata ttc tgc gac cac ggt 384Ala Arg Ser Leu Ala Ala Gln Ala Leu Ser Ile Phe Cys Asp His Gly 115 120 125gac gtg atg tcg gtc agg ggc acc ggc ttc gcg ctg ctc gct tcc tgt 432Asp Val Met Ser Val Arg Gly Thr Gly Phe Ala Leu Leu Ala Ser Cys 130 135 140tcg gta cag gag gta atg gac atg gcg ctg att tcg cag gcc gca acg 480Ser Val Gln Glu Val Met Asp Met Ala Leu Ile Ser Gln Ala Ala Thr145 150 155 160ctc gaa tcg cgc gtg cca ttc ctg cac ttc ttc gac ggc ttc cgc acg 528Leu Glu Ser Arg Val Pro Phe Leu His Phe Phe Asp Gly Phe Arg Thr 165 170 175tcg cac gaa atc tcg aaa atc gag gtg ctc tcg gac gaa cag att cgc 576Ser His Glu Ile Ser Lys Ile Glu Val Leu Ser Asp Glu Gln Ile Arg 180 185 190 tcg atg atc aac gac gag ctg gtc ttc gca cac cgc atg cgc cgc atg 624Ser Met Ile Asn Asp Glu Leu Val Phe Ala His Arg Met Arg Arg Met 195 200 205tcg cct gat gca ccg atc atc cgc ggt acc tcg cag aat ccg gac gtc 672Ser Pro Asp Ala Pro Ile Ile Arg Gly Thr Ser Gln Asn Pro Asp Val 210 215 220tat ttc cag gca cgc gag agc gtc aac aaa tat tat gag gcc tgc ccg 720Tyr Phe Gln Ala Arg Glu Ser Val Asn Lys Tyr Tyr Glu Ala Cys Pro225 230 235 240tca atc acc cag aag gcg atg gac cag ttc gcc aaa ctg act ggg cgc 768Ser Ile Thr Gln Lys Ala Met Asp Gln Phe Ala Lys Leu Thr Gly Arg 245 250 255agc tat aaa ctt tac cag tac tac ggc gct ccg gat gcc gac cgt atc 816Ser Tyr Lys Leu Tyr Gln Tyr Tyr Gly Ala Pro Asp Ala Asp Arg Ile 260 265 270 atc atc atg atg ggg tca ggt gcc gag acc gct ctc gaa act gtc gaa 864Ile Ile Met Met Gly Ser Gly Ala Glu Thr Ala Leu Glu Thr Val Glu 275 280 285tac ctc aac aac cac ggc gaa aag gtc ggt ctg gtc aag gta cgc ctt 912Tyr Leu Asn Asn His Gly Glu Lys Val Gly Leu Val Lys Val Arg Leu 290 295 300ttc agg cca ttc gac gtt gca acc ttc atc gca tcg cta cca tcg agc 960Phe Arg Pro Phe Asp Val Ala Thr Phe Ile Ala Ser Leu Pro Ser Ser305 310 315 320gtg aag agt atc gcg gtg ctc gac cgt gtc aag gaa cca ggc agc gct 1008Val Lys Ser Ile Ala Val Leu Asp Arg Val Lys Glu Pro Gly Ser Ala 325 330 335ggc gaa ccg ctc tat ctc gat gta gtc aac gcc gta gcc gaa tcg tac 1056Gly Glu Pro Leu Tyr Leu Asp Val Val Asn Ala Val Ala Glu Ser Tyr 340 345 350 cag gaa ggc aaa tgc gct tcg atg cca agc gtt ttg ggt ggg cgc tat 1104Gln Glu Gly Lys Cys Ala Ser Met Pro Ser Val Leu Gly Gly Arg Tyr 355 360 365ggc ctg tcg tcg aag gag ttc act ccg gcg atg gtc aag gcg atc ttc 1152Gly Leu Ser Ser Lys Glu Phe Thr Pro Ala Met Val Lys Ala Ile Phe 370 375 380gac aat atg aac gcg gaa tct cca aag aat cac ttc acc gtt ggc atc 1200Asp Asn Met Asn Ala Glu Ser Pro Lys Asn His Phe Thr Val Gly Ile385 390 395 400gac gat gac gta acc aag aag agc ctc gcc tac gac gag acc ttc tcg 1248Asp Asp Asp Val Thr Lys Lys Ser Leu Ala Tyr Asp Glu Thr Phe Ser 405 410 415att gag ccg gac tcg gtc ttc cgc gcc ctc ttc tac ggc ctc ggt tca 1296Ile Glu Pro Asp Ser Val Phe Arg Ala Leu Phe Tyr Gly Leu Gly Ser 420 425 430 gac ggc acg gtc ggt gca aac aag aac tcg atc aag atc att ggc gaa 1344Asp Gly Thr Val Gly Ala Asn Lys Asn Ser Ile Lys Ile Ile Gly Glu 435 440 445aac acc gac aac tac gcg cag ggc ttc ttc gtc tac gac tcc aag aaa 1392Asn Thr Asp Asn Tyr Ala Gln Gly Phe Phe Val Tyr Asp Ser Lys Lys 450 455 460gcc ggt tcg atc acg acc tcg cac ctg cgg ttc ggc ccg gag cag atc 1440Ala Gly Ser Ile Thr Thr Ser His Leu Arg Phe Gly Pro Glu Gln Ile465 470 475 480cgc tcg acc tac ctc atc acc gag gcg cag ttc gtc ggc tgc cac cac 1488Arg Ser Thr Tyr Leu Ile Thr Glu Ala Gln Phe Val Gly Cys His His 485 490 495tgg gtc ttt ctc gaa atg atc gac gtt gcc aag aac ctc aag cag ggt 1536Trp Val Phe Leu Glu Met Ile Asp Val Ala Lys Asn Leu Lys Gln Gly 500 505 510 ggt acg ctg ctc atc aac tcg gcc tat gcg ccg gat gtg gtg tgg agc 1584Gly Thr Leu Leu Ile Asn Ser Ala Tyr Ala Pro Asp Val Val Trp Ser 515 520 525aag ctc ccg cgt ccg gtg cag cag cac ttg atc gac aag cag gcg aag 1632Lys Leu Pro Arg Pro Val Gln Gln His Leu Ile Asp Lys Gln Ala Lys 530 535 540ctc tac acc atc gat gcc tac aag gtc gcc cac gaa agc ggc atg ggt 1680Leu Tyr Thr Ile Asp Ala Tyr Lys Val Ala His Glu Ser Gly Met Gly545 550 555 560cag cgc atc aac act atc atg cag gcc tgt ttc ttc gcc att tcg ggc 1728Gln Arg Ile Asn Thr Ile Met Gln Ala Cys Phe Phe Ala Ile Ser Gly 565 570 575gtg ctg ccg cgt gaa gag gca atc gaa aag atc aag gac gcg atc cgc 1776Val Leu Pro Arg Glu Glu Ala Ile Glu Lys Ile Lys Asp Ala Ile Arg 580 585 590 cac acc tac ggc aaa aag ggc gat gag gtc gtt cag cag aac atc aag 1824His Thr Tyr Gly Lys Lys Gly Asp Glu Val Val Gln Gln Asn Ile Lys 595 600 605gca gtt gac aac acg ctt gcc aac ctg cat gaa gtg aaa atc ggc gct 1872Ala Val Asp Asn Thr Leu Ala Asn Leu His Glu Val Lys Ile Gly Ala 610 615 620gtg gca gac agc acc aag gag ctg cgc tcg ccc atc gtt ggc gac gcg 1920Val Ala Asp Ser Thr Lys Glu Leu Arg Ser Pro Ile Val Gly Asp Ala625 630 635 640cca gag ttc gtc tgt aac gtg ctg gca aag att att gcc ggc gag ggc 1968Pro Glu Phe Val Cys Asn Val Leu Ala Lys Ile Ile Ala Gly Glu Gly 645 650 655gac tcg att ccg gtc agc aag ctg cct gcc gat gga acc tat ccg ctc 2016Asp Ser Ile Pro Val Ser Lys Leu Pro Ala Asp Gly Thr Tyr Pro Leu 660 665 670 ggc acc acg aag ttc gag aaa cgc aac ctc gcg cag gag att ccg gtc 2064Gly Thr Thr Lys Phe Glu Lys Arg Asn Leu Ala Gln Glu Ile Pro Val 675 680 685tgg gct ccg gag ctg tgc atc gag tgt ggc aag tgc tcg atg gtc tgc 2112Trp Ala Pro Glu Leu Cys Ile Glu Cys Gly Lys Cys Ser Met Val Cys 690 695 700ccg cac gct gcc atc cgc atc aag gtt tac gag ccg aag cac ctc gaa 2160Pro His Ala Ala Ile Arg Ile Lys Val Tyr Glu Pro Lys His Leu Glu705 710 715 720aac gcc ccg gca acc ttc aag agc ctc gat gcg aaa gca aaa aac tgg 2208Asn Ala Pro Ala Thr Phe Lys Ser Leu Asp Ala Lys Ala Lys Asn Trp 725 730 735gag ggc atg cgc tat acg gtt cag att gca ccg gaa gat tgt acc ggc 2256Glu Gly Met Arg Tyr Thr Val Gln Ile Ala Pro Glu Asp Cys Thr Gly 740 745 750 tgc caa ctc tgc gtc aac gcc tgc ccc gca aga gac aag cag gtt gaa 2304Cys Gln Leu Cys Val Asn Ala Cys Pro Ala Arg Asp Lys Gln Val Glu 755 760 765ggc cgc aaa gcg ctc aac atg cac gag cag gct ccg ctg cgc gaa acc 2352Gly Arg Lys Ala Leu Asn Met His Glu Gln Ala Pro Leu Arg Glu Thr 770 775 780gaa tct gcc tgc tgg agc ttc ttc atc aat ctc ccg gaa ttc gac cgc 2400Glu Ser Ala Cys Trp Ser Phe Phe Ile Asn Leu Pro Glu Phe Asp Arg785 790 795 800aac aag atc aac cag cgc ctc atc aaa gag cag cag ctt cag cag cca 2448Asn Lys Ile Asn Gln Arg Leu Ile Lys Glu Gln Gln Leu Gln Gln Pro 805 810 815ctc ttc gag ttc tcg ggc gca tgc tcg ggc tgc ggc gaa acg cca tac 2496Leu Phe Glu Phe Ser Gly Ala Cys Ser Gly Cys Gly Glu Thr Pro Tyr 820 825 830 gtc aag ctg atg act cag ctc ttc ggt gat cgc ctc gtt atc ggc aac 2544Val Lys Leu Met Thr Gln Leu Phe Gly Asp Arg Leu Val Ile Gly Asn 835 840 845gcc acc ggc tgc tcg tcg atc tac ggc ggc aac ctg ccg acc acg ccg 2592Ala Thr Gly Cys Ser Ser Ile Tyr Gly Gly Asn Leu Pro Thr Thr Pro 850 855 860tat gca gcc aac ccg cag ggc ctt ggg cca acg tgg tcg aac tcg ctt 2640Tyr Ala Ala Asn Pro Gln Gly Leu Gly Pro Thr Trp Ser Asn Ser Leu865 870 875 880ttc gag gac acg gca gag ttc gcg ctt ggt ttc cgg ata tcg atc gac 2688Phe Glu Asp Thr Ala Glu Phe Ala Leu Gly Phe Arg Ile Ser Ile Asp 885 890 895aag cag cag caa ttt gcc aaa gag ctg gtc aaa aag ctc gct ggt gac 2736Lys Gln Gln Gln Phe Ala Lys Glu Leu Val Lys Lys Leu Ala Gly Asp 900 905 910 atc ggt gaa aac ctt gcc acc gcc att ctc aac gcc acg cag aac agt 2784Ile Gly Glu Asn Leu Ala Thr Ala Ile Leu Asn Ala Thr Gln Asn Ser 915 920 925gaa ccg gag att ttc gag cag cgt gag cgc gtg gcc gtg ctg aag gat 2832Glu Pro Glu Ile Phe Glu Gln Arg Glu Arg Val Ala Val Leu Lys Asp 930 935 940aag ctc cag cag atg aaa tcc gac gat gcc aag aac ctg ctt gct gtg 2880Lys Leu Gln Gln Met Lys Ser Asp Asp Ala Lys Asn Leu Leu Ala Val945 950 955 960gct gac atg ctg gtc aag aag agc gtg tgg gct gtc ggc ggc gac ggc 2928Ala Asp Met Leu Val Lys Lys Ser Val Trp Ala Val Gly Gly Asp Gly 965 970 975tgg gcc tac gat atc ggt tac ggg ggt ctc gac cac gtc acc gca tcg 2976Trp Ala Tyr Asp Ile Gly Tyr Gly Gly Leu Asp His Val Thr Ala Ser 980 985 990 ggc aag aac gtc aac atg ctc gtg ctc gac acc gag gtc tat tcc aat 3024Gly Lys Asn Val Asn Met Leu Val Leu Asp Thr Glu Val Tyr Ser Asn 995 1000 1005acc ggc ggt cag gcc tcc aag gct acg ccg aaa gcc gcg atc gcc 3069Thr Gly Gly Gln Ala Ser Lys Ala Thr Pro Lys Ala Ala Ile Ala 1010 1015 1020aag ttt gcc gct gcg ggg cgc atc gct acc aag aaa gac ctt ggt 3114Lys Phe Ala Ala Ala Gly Arg Ile Ala Thr Lys Lys Asp Leu Gly 1025 1030 1035ctg atc tcg atg agc tac ggc aat gcc tat gtg gcc agt gtt gca 3159Leu Ile Ser Met Ser Tyr Gly Asn Ala Tyr Val Ala Ser Val Ala 1040 1045 1050ctt ggc gca cgt gac gag cag aca ctc aga gct ttc atc gaa gcc 3204Leu Gly Ala Arg Asp Glu Gln Thr Leu Arg Ala Phe Ile Glu Ala 1055 1060 1065gag gcg tac gat ggc ccg tcg att atc atc gcc tac tcg cac tgc 3249Glu Ala Tyr Asp Gly Pro Ser Ile Ile Ile Ala Tyr Ser His Cys 1070 1075 1080att gca cac ggc ttt gac ttg tct atg ggt ctg gag cac cag aaa 3294Ile Ala His Gly Phe Asp Leu Ser Met Gly Leu Glu His Gln Lys 1085 1090 1095gca gcg gtc gat tcc ggc cac tgg ctg ctg tat cgc tac aat ccc 3339Ala Ala Val Asp Ser Gly His Trp Leu Leu Tyr Arg Tyr Asn Pro 1100 1105 1110gac aga ctc aag gag gga ctg aat ccg ctg cag ctc gac tcc aaa 3384Asp Arg Leu Lys Glu Gly Leu Asn Pro Leu Gln Leu Asp Ser Lys 1115 1120 1125aag ccg aaa atg ccg gtc gcg gag ttc ctg aac atg gag aac cgc 3429Lys Pro Lys Met Pro Val Ala Glu Phe Leu Asn Met Glu Asn Arg 1130 1135 1140ttc aga ata ctg aag aag acc cac ccc gat ctg gcc aag aag tac 3474Phe Arg Ile Leu Lys Lys Thr His Pro Asp Leu Ala Lys Lys Tyr 1145 1150 1155ttc gag gca atc cag cac gag gtc aat gcc cgc tgg gca cac tac 3519Phe Glu Ala Ile Gln His Glu Val Asn Ala Arg Trp Ala His Tyr 1160 1165 1170gaa cac ctc gcc aac cgt tcg att gaa ggc gaa gca taa 3558Glu His Leu Ala Asn Arg Ser Ile Glu Gly Glu Ala 1175 1180 118521185PRTChlorobium tepidum 2Met Thr Arg Thr Phe Lys Thr Met Glu Gly Asn Glu Ala Leu Ala His1 5 10 15Val Ala Tyr Arg Thr Asn Glu Val Ile Ser Ile Tyr Pro Ile Thr Pro 20 25 30Ala Ser Pro Met Gly Glu Tyr Ser Asp Ala Trp Ala Ala Val Asp Val 35 40 45Lys Asn Ile Trp Gly Thr Val Pro Leu Val Asn Glu Met Gln Ser Glu 50 55 60Ala Gly Ala Ala Ala Ala Val His Gly Ala Leu Gln Thr Gly Ala Leu65 70 75 80Thr Thr Thr Phe Thr Ala Ser Gln Gly Leu Leu Leu Met Ile Pro Asn 85 90 95Met Tyr Lys Ile Ala Gly Glu Leu Thr Pro Cys Val Ile His Val Ser 100 105 110Ala Arg Ser Leu Ala Ala Gln Ala Leu Ser Ile Phe Cys Asp His Gly 115 120 125Asp Val Met Ser Val Arg Gly Thr Gly Phe Ala Leu Leu Ala Ser Cys 130 135 140Ser Val Gln Glu Val Met Asp Met Ala Leu Ile Ser Gln Ala Ala Thr145 150 155 160Leu Glu Ser Arg Val Pro Phe Leu His Phe Phe Asp Gly Phe Arg Thr 165 170 175Ser His Glu Ile Ser Lys Ile Glu Val Leu Ser Asp Glu Gln Ile Arg 180 185 190Ser Met Ile Asn Asp Glu Leu Val Phe Ala His Arg Met Arg Arg Met 195 200 205Ser Pro Asp Ala Pro Ile Ile Arg Gly Thr Ser Gln Asn Pro Asp Val 210 215 220Tyr Phe Gln Ala Arg Glu Ser Val Asn Lys Tyr Tyr Glu Ala Cys Pro225 230 235 240Ser Ile Thr Gln Lys Ala Met Asp Gln Phe Ala Lys Leu Thr Gly Arg 245 250 255Ser Tyr Lys Leu Tyr Gln Tyr Tyr Gly Ala Pro Asp Ala Asp Arg Ile 260 265 270Ile Ile Met Met Gly Ser Gly Ala Glu Thr Ala Leu Glu Thr Val Glu 275 280 285Tyr Leu Asn Asn His Gly Glu Lys Val Gly Leu Val Lys Val Arg Leu 290 295 300Phe Arg Pro Phe Asp Val Ala Thr Phe Ile Ala Ser Leu Pro Ser Ser305 310 315 320Val Lys Ser Ile Ala Val Leu Asp Arg Val Lys Glu Pro Gly Ser Ala 325 330 335Gly Glu Pro Leu Tyr Leu Asp Val Val Asn Ala Val Ala Glu Ser Tyr 340 345 350Gln Glu Gly Lys Cys Ala Ser Met Pro Ser Val Leu Gly Gly Arg Tyr 355 360 365Gly Leu Ser Ser Lys Glu Phe Thr Pro Ala Met Val Lys Ala Ile Phe 370 375 380Asp Asn Met Asn Ala Glu Ser Pro Lys Asn His Phe Thr Val Gly Ile385 390 395 400Asp Asp Asp Val Thr Lys Lys Ser Leu Ala Tyr Asp Glu Thr Phe Ser 405 410 415Ile Glu Pro Asp Ser Val Phe Arg Ala Leu Phe Tyr Gly Leu Gly Ser 420 425 430Asp Gly Thr Val Gly Ala Asn Lys Asn Ser Ile Lys Ile Ile Gly Glu 435 440 445Asn Thr Asp Asn Tyr Ala Gln Gly Phe Phe Val Tyr Asp Ser Lys Lys 450 455 460Ala Gly Ser Ile Thr Thr Ser His Leu Arg Phe Gly Pro Glu Gln Ile465 470 475 480Arg Ser Thr Tyr Leu Ile Thr Glu Ala Gln Phe Val Gly Cys His His 485 490 495Trp Val Phe Leu Glu Met Ile Asp Val Ala Lys Asn Leu Lys Gln Gly 500 505 510Gly Thr Leu Leu Ile Asn Ser Ala Tyr Ala Pro Asp Val Val Trp Ser 515 520 525Lys Leu Pro Arg Pro Val Gln Gln His Leu Ile Asp Lys Gln Ala Lys 530 535 540Leu Tyr Thr Ile Asp Ala Tyr Lys Val Ala

His Glu Ser Gly Met Gly545 550 555 560Gln Arg Ile Asn Thr Ile Met Gln Ala Cys Phe Phe Ala Ile Ser Gly 565 570 575Val Leu Pro Arg Glu Glu Ala Ile Glu Lys Ile Lys Asp Ala Ile Arg 580 585 590His Thr Tyr Gly Lys Lys Gly Asp Glu Val Val Gln Gln Asn Ile Lys 595 600 605Ala Val Asp Asn Thr Leu Ala Asn Leu His Glu Val Lys Ile Gly Ala 610 615 620Val Ala Asp Ser Thr Lys Glu Leu Arg Ser Pro Ile Val Gly Asp Ala625 630 635 640Pro Glu Phe Val Cys Asn Val Leu Ala Lys Ile Ile Ala Gly Glu Gly 645 650 655Asp Ser Ile Pro Val Ser Lys Leu Pro Ala Asp Gly Thr Tyr Pro Leu 660 665 670Gly Thr Thr Lys Phe Glu Lys Arg Asn Leu Ala Gln Glu Ile Pro Val 675 680 685Trp Ala Pro Glu Leu Cys Ile Glu Cys Gly Lys Cys Ser Met Val Cys 690 695 700Pro His Ala Ala Ile Arg Ile Lys Val Tyr Glu Pro Lys His Leu Glu705 710 715 720Asn Ala Pro Ala Thr Phe Lys Ser Leu Asp Ala Lys Ala Lys Asn Trp 725 730 735Glu Gly Met Arg Tyr Thr Val Gln Ile Ala Pro Glu Asp Cys Thr Gly 740 745 750Cys Gln Leu Cys Val Asn Ala Cys Pro Ala Arg Asp Lys Gln Val Glu 755 760 765Gly Arg Lys Ala Leu Asn Met His Glu Gln Ala Pro Leu Arg Glu Thr 770 775 780Glu Ser Ala Cys Trp Ser Phe Phe Ile Asn Leu Pro Glu Phe Asp Arg785 790 795 800Asn Lys Ile Asn Gln Arg Leu Ile Lys Glu Gln Gln Leu Gln Gln Pro 805 810 815Leu Phe Glu Phe Ser Gly Ala Cys Ser Gly Cys Gly Glu Thr Pro Tyr 820 825 830Val Lys Leu Met Thr Gln Leu Phe Gly Asp Arg Leu Val Ile Gly Asn 835 840 845Ala Thr Gly Cys Ser Ser Ile Tyr Gly Gly Asn Leu Pro Thr Thr Pro 850 855 860Tyr Ala Ala Asn Pro Gln Gly Leu Gly Pro Thr Trp Ser Asn Ser Leu865 870 875 880Phe Glu Asp Thr Ala Glu Phe Ala Leu Gly Phe Arg Ile Ser Ile Asp 885 890 895Lys Gln Gln Gln Phe Ala Lys Glu Leu Val Lys Lys Leu Ala Gly Asp 900 905 910Ile Gly Glu Asn Leu Ala Thr Ala Ile Leu Asn Ala Thr Gln Asn Ser 915 920 925Glu Pro Glu Ile Phe Glu Gln Arg Glu Arg Val Ala Val Leu Lys Asp 930 935 940Lys Leu Gln Gln Met Lys Ser Asp Asp Ala Lys Asn Leu Leu Ala Val945 950 955 960Ala Asp Met Leu Val Lys Lys Ser Val Trp Ala Val Gly Gly Asp Gly 965 970 975Trp Ala Tyr Asp Ile Gly Tyr Gly Gly Leu Asp His Val Thr Ala Ser 980 985 990Gly Lys Asn Val Asn Met Leu Val Leu Asp Thr Glu Val Tyr Ser Asn 995 1000 1005Thr Gly Gly Gln Ala Ser Lys Ala Thr Pro Lys Ala Ala Ile Ala 1010 1015 1020Lys Phe Ala Ala Ala Gly Arg Ile Ala Thr Lys Lys Asp Leu Gly 1025 1030 1035Leu Ile Ser Met Ser Tyr Gly Asn Ala Tyr Val Ala Ser Val Ala 1040 1045 1050Leu Gly Ala Arg Asp Glu Gln Thr Leu Arg Ala Phe Ile Glu Ala 1055 1060 1065Glu Ala Tyr Asp Gly Pro Ser Ile Ile Ile Ala Tyr Ser His Cys 1070 1075 1080Ile Ala His Gly Phe Asp Leu Ser Met Gly Leu Glu His Gln Lys 1085 1090 1095Ala Ala Val Asp Ser Gly His Trp Leu Leu Tyr Arg Tyr Asn Pro 1100 1105 1110Asp Arg Leu Lys Glu Gly Leu Asn Pro Leu Gln Leu Asp Ser Lys 1115 1120 1125Lys Pro Lys Met Pro Val Ala Glu Phe Leu Asn Met Glu Asn Arg 1130 1135 1140Phe Arg Ile Leu Lys Lys Thr His Pro Asp Leu Ala Lys Lys Tyr 1145 1150 1155Phe Glu Ala Ile Gln His Glu Val Asn Ala Arg Trp Ala His Tyr 1160 1165 1170Glu His Leu Ala Asn Arg Ser Ile Glu Gly Glu Ala 1175 1180 118533525DNAEscherichia coliCDS(1)..(3525) 3atg att act att gac ggt aat ggc gcg gtt gct tcg gtc gca ttt cgc 48Met Ile Thr Ile Asp Gly Asn Gly Ala Val Ala Ser Val Ala Phe Arg1 5 10 15acc agt gaa gtt atc gcc atc tac cct att acc ccc agt tcc acg atg 96Thr Ser Glu Val Ile Ala Ile Tyr Pro Ile Thr Pro Ser Ser Thr Met 20 25 30gca gaa cag gct gat gcc tgg gcc gga aac ggc tta aag aac gtt tgg 144Ala Glu Gln Ala Asp Ala Trp Ala Gly Asn Gly Leu Lys Asn Val Trp 35 40 45gga gac aca cca cgc gtg gtt gaa atg cag tcg gaa gcg ggt gct atc 192Gly Asp Thr Pro Arg Val Val Glu Met Gln Ser Glu Ala Gly Ala Ile 50 55 60gct acc gtg cat ggc gct ttg cag acg ggt gcc ctt tca aca tcg ttt 240Ala Thr Val His Gly Ala Leu Gln Thr Gly Ala Leu Ser Thr Ser Phe65 70 75 80acg tca tcg cag ggt ttg ctg ctg atg atc ccg acg ctg tac aaa ctg 288Thr Ser Ser Gln Gly Leu Leu Leu Met Ile Pro Thr Leu Tyr Lys Leu 85 90 95gca ggc gaa cta aca ccg ttt gtc ctg cat gta gcg gca cgt acc gtt 336Ala Gly Glu Leu Thr Pro Phe Val Leu His Val Ala Ala Arg Thr Val 100 105 110gcc aca cat gca ctc tct att ttt ggc gat cat tcc gac gtt atg gcg 384Ala Thr His Ala Leu Ser Ile Phe Gly Asp His Ser Asp Val Met Ala 115 120 125gtg cgc cag acg ggt tgc gcg atg ttg tgt gca gca aac gtc cag gaa 432Val Arg Gln Thr Gly Cys Ala Met Leu Cys Ala Ala Asn Val Gln Glu 130 135 140gcg caa gac ttt gct ctc att tcg caa atc gcg acg ctg aaa agc cgc 480Ala Gln Asp Phe Ala Leu Ile Ser Gln Ile Ala Thr Leu Lys Ser Arg145 150 155 160gtg cca ttt att cat ttc ttt gat ggt ttc cgc acg tcc cac gaa atc 528Val Pro Phe Ile His Phe Phe Asp Gly Phe Arg Thr Ser His Glu Ile 165 170 175aat aaa att gtc ccg ctg gcc gat gac acg att ctt gat ctc atg ccg 576Asn Lys Ile Val Pro Leu Ala Asp Asp Thr Ile Leu Asp Leu Met Pro 180 185 190cag gtc gaa att gat gct cat cgc gcc cgg gca ctc aac ccg gaa cat 624Gln Val Glu Ile Asp Ala His Arg Ala Arg Ala Leu Asn Pro Glu His 195 200 205ccg gtg atc cgc ggt acg tcc gcc aat cct gac act tat ttc cag tct 672Pro Val Ile Arg Gly Thr Ser Ala Asn Pro Asp Thr Tyr Phe Gln Ser 210 215 220cgc gaa gcc acc aac cca tgg tac aac gcg gtc tat gac cat gtt gaa 720Arg Glu Ala Thr Asn Pro Trp Tyr Asn Ala Val Tyr Asp His Val Glu225 230 235 240cag gcg atg aat gat ttc tct gcc gcg aca ggt cgt cag tat cag ccg 768Gln Ala Met Asn Asp Phe Ser Ala Ala Thr Gly Arg Gln Tyr Gln Pro 245 250 255ttt gaa tat tac ggg cat ccg caa gcg gaa cgg gtg att atc ctg atg 816Phe Glu Tyr Tyr Gly His Pro Gln Ala Glu Arg Val Ile Ile Leu Met 260 265 270ggc tct gcc att ggc acc tgt gaa gaa gtg gtt gat gaa ttg cta acc 864Gly Ser Ala Ile Gly Thr Cys Glu Glu Val Val Asp Glu Leu Leu Thr 275 280 285cgt ggc gaa aaa gtt ggc gtg ctg aaa gtt cgc ctg tac cgc ccc ttc 912Arg Gly Glu Lys Val Gly Val Leu Lys Val Arg Leu Tyr Arg Pro Phe 290 295 300tcc gct aaa cat tta ctg caa gct ctg ccg gga tcc gta cgc agc gtg 960Ser Ala Lys His Leu Leu Gln Ala Leu Pro Gly Ser Val Arg Ser Val305 310 315 320gcg gta ctg gac aga acc aaa gaa ccc ggt gcc cag gca gaa ccg ctc 1008Ala Val Leu Asp Arg Thr Lys Glu Pro Gly Ala Gln Ala Glu Pro Leu 325 330 335tat ctg gat gta atg acc gca ctg gca gaa gcc ttt aat aat ggc gag 1056Tyr Leu Asp Val Met Thr Ala Leu Ala Glu Ala Phe Asn Asn Gly Glu 340 345 350cgc gaa act ctg ccc cgt gtc att ggt ggg cgc tat ggt ctt tca tcc 1104Arg Glu Thr Leu Pro Arg Val Ile Gly Gly Arg Tyr Gly Leu Ser Ser 355 360 365aaa gaa ttt ggc cca gac tgt gta ctg gcg gta ttt gcc gag ctc aac 1152Lys Glu Phe Gly Pro Asp Cys Val Leu Ala Val Phe Ala Glu Leu Asn 370 375 380gcg gct aaa ccg aaa gcg cgc ttt acg gtt ggt att tac gat gat gtg 1200Ala Ala Lys Pro Lys Ala Arg Phe Thr Val Gly Ile Tyr Asp Asp Val385 390 395 400acc aat ctg tca ctg ccg ttg ccg gaa aac acc ctg cca aac tcg gcg 1248Thr Asn Leu Ser Leu Pro Leu Pro Glu Asn Thr Leu Pro Asn Ser Ala 405 410 415aaa ctg gaa gcc ttg ttt tat ggc ctt ggt agt gat ggc agc gtt tcc 1296Lys Leu Glu Ala Leu Phe Tyr Gly Leu Gly Ser Asp Gly Ser Val Ser 420 425 430gcg acc aaa aac aat atc aag att atc ggt aat tcc acg ccg tgg tac 1344Ala Thr Lys Asn Asn Ile Lys Ile Ile Gly Asn Ser Thr Pro Trp Tyr 435 440 445gca cag ggc tat ttt gtt tac gac tcc aaa aag gcg ggc ggc ctg acg 1392Ala Gln Gly Tyr Phe Val Tyr Asp Ser Lys Lys Ala Gly Gly Leu Thr 450 455 460gtt tct cac ctt cga gtg agc gaa cag ccg att cgt tcc gct tat ctc 1440Val Ser His Leu Arg Val Ser Glu Gln Pro Ile Arg Ser Ala Tyr Leu465 470 475 480att tcc cag gct gat ttt gtt ggc tgc cac cag ttg cag ttt atc gat 1488Ile Ser Gln Ala Asp Phe Val Gly Cys His Gln Leu Gln Phe Ile Asp 485 490 495aaa tat cag atg gct gag cgt tta aaa cct ggc ggc att ttc ctg ctc 1536Lys Tyr Gln Met Ala Glu Arg Leu Lys Pro Gly Gly Ile Phe Leu Leu 500 505 510aac acg ccg tac agc gca gat gaa gtg tgg tcg cgc ttg ccg caa gaa 1584Asn Thr Pro Tyr Ser Ala Asp Glu Val Trp Ser Arg Leu Pro Gln Glu 515 520 525gtt cag gcc gtg tta aac cag aaa aaa gcg cgc ttc tat gtg att aac 1632Val Gln Ala Val Leu Asn Gln Lys Lys Ala Arg Phe Tyr Val Ile Asn 530 535 540gcg gcg aaa atc gcc cgc gaa tgt ggc ctg gcg gcc cgt att aat acc 1680Ala Ala Lys Ile Ala Arg Glu Cys Gly Leu Ala Ala Arg Ile Asn Thr545 550 555 560gtc atg cag atg gct ttt ttc cat ctg acg caa att ctg cct ggc gat 1728Val Met Gln Met Ala Phe Phe His Leu Thr Gln Ile Leu Pro Gly Asp 565 570 575agc gcc ctc gca gaa ttg cag ggt gcg att gcc aaa agt tac agt agc 1776Ser Ala Leu Ala Glu Leu Gln Gly Ala Ile Ala Lys Ser Tyr Ser Ser 580 585 590aaa ggc cag gat ctg gtg gaa cgc aac tgg cag gct ctg gcg ctg gcg 1824Lys Gly Gln Asp Leu Val Glu Arg Asn Trp Gln Ala Leu Ala Leu Ala 595 600 605cgt gaa tcc gta gaa gaa gtt ccg ttg caa ccg gta aat ccg cac agc 1872Arg Glu Ser Val Glu Glu Val Pro Leu Gln Pro Val Asn Pro His Ser 610 615 620gcc aat cga ccg cca gtg gtt tcc gat gcc gcc cct gat ttc gtg aaa 1920Ala Asn Arg Pro Pro Val Val Ser Asp Ala Ala Pro Asp Phe Val Lys625 630 635 640acc gta acc gct gcg atg ctc gcc ggg ctt ggt gac gcc ctc ccc gtt 1968Thr Val Thr Ala Ala Met Leu Ala Gly Leu Gly Asp Ala Leu Pro Val 645 650 655tcg gcg ctg ccg cca gac ggc acc tgg ccg atg ggc act acg cgc tgg 2016Ser Ala Leu Pro Pro Asp Gly Thr Trp Pro Met Gly Thr Thr Arg Trp 660 665 670gaa aaa cgc aat atc gcc gaa gag atc ccc atc tgg aaa gag gaa ctc 2064Glu Lys Arg Asn Ile Ala Glu Glu Ile Pro Ile Trp Lys Glu Glu Leu 675 680 685tgt acc caa tgt aac cac tgc gtt gcc gct tgc cca cac tca gct att 2112Cys Thr Gln Cys Asn His Cys Val Ala Ala Cys Pro His Ser Ala Ile 690 695 700cgc gca aaa gtg gtg ccg cct gaa gcg atg gaa aac gcc cct gcc agc 2160Arg Ala Lys Val Val Pro Pro Glu Ala Met Glu Asn Ala Pro Ala Ser705 710 715 720ctg cat tcg ctg gat gtg aaa tcg cgt gat atg cgc ggg cag aaa tat 2208Leu His Ser Leu Asp Val Lys Ser Arg Asp Met Arg Gly Gln Lys Tyr 725 730 735gtc ttg cag gtg gca ccg gaa gat tgc acc ggt tgt aac ctg tgc gtc 2256Val Leu Gln Val Ala Pro Glu Asp Cys Thr Gly Cys Asn Leu Cys Val 740 745 750gaa gtt tgc ccg gcg aaa gac cgt cag aat cca gag att aaa gcc atc 2304Glu Val Cys Pro Ala Lys Asp Arg Gln Asn Pro Glu Ile Lys Ala Ile 755 760 765aat atg atg tct cgc ctg gaa cat gtc gaa gaa gag aaa atc aat tac 2352Asn Met Met Ser Arg Leu Glu His Val Glu Glu Glu Lys Ile Asn Tyr 770 775 780gat ttc ttc ctc aac ctg cca gaa atc gac cgt agc aaa ctg gaa cgt 2400Asp Phe Phe Leu Asn Leu Pro Glu Ile Asp Arg Ser Lys Leu Glu Arg785 790 795 800att gat att cgt aca tcg cag ctg att aca ccg ctg ttt gaa tat tca 2448Ile Asp Ile Arg Thr Ser Gln Leu Ile Thr Pro Leu Phe Glu Tyr Ser 805 810 815ggt gct tgc tcc ggt tgt ggc gag acg ccg tat att aaa tta ctg act 2496Gly Ala Cys Ser Gly Cys Gly Glu Thr Pro Tyr Ile Lys Leu Leu Thr 820 825 830cag ctc tat ggc gac cgg atg ttg atc gct aac gcc act ggc tgt tct 2544Gln Leu Tyr Gly Asp Arg Met Leu Ile Ala Asn Ala Thr Gly Cys Ser 835 840 845tca att tat ggc ggt aac ctg ccc tct aca ccg tat acc acc gat gcc 2592Ser Ile Tyr Gly Gly Asn Leu Pro Ser Thr Pro Tyr Thr Thr Asp Ala 850 855 860aac ggt cgt ggg ccg gca tgg gcg aac tct cta ttt gaa gat aat gcc 2640Asn Gly Arg Gly Pro Ala Trp Ala Asn Ser Leu Phe Glu Asp Asn Ala865 870 875 880gaa ttt ggc ctt ggt ttc cgc ctg acg gtc gat caa cac cgt gtc cgc 2688Glu Phe Gly Leu Gly Phe Arg Leu Thr Val Asp Gln His Arg Val Arg 885 890 895gtg ctg cgt ctg ctg gat caa ttt gcc gat aaa atc ccg gcg gaa tta 2736Val Leu Arg Leu Leu Asp Gln Phe Ala Asp Lys Ile Pro Ala Glu Leu 900 905 910ctg acg gcg ttg aaa tca gac gcc acg cca gag gtt cgt cgt gaa cag 2784Leu Thr Ala Leu Lys Ser Asp Ala Thr Pro Glu Val Arg Arg Glu Gln 915 920 925gtt gca gct tta cgc cag caa ctc aac gat gtt gcc gaa gca cat gaa 2832Val Ala Ala Leu Arg Gln Gln Leu Asn Asp Val Ala Glu Ala His Glu 930 935 940ctg cta cgt gat gca gat gca ctg gtg gaa aaa tca atc tgg ctg att 2880Leu Leu Arg Asp Ala Asp Ala Leu Val Glu Lys Ser Ile Trp Leu Ile945 950 955 960ggt ggt gat ggc tgg gct tac gat atc ggc ttt ggc ggt ctg gat cat 2928Gly Gly Asp Gly Trp Ala Tyr Asp Ile Gly Phe Gly Gly Leu Asp His 965 970 975gta ttg agt ttg acg gaa aac gtc aac att ctg gtg ctg gat acg caa 2976Val Leu Ser Leu Thr Glu Asn Val Asn Ile Leu Val Leu Asp Thr Gln 980 985 990tgc tat tcc aac acc ggt ggt cag gcg tcg aaa gcg aca ccg ctg ggt 3024Cys Tyr Ser Asn Thr Gly Gly Gln Ala Ser Lys Ala Thr Pro Leu Gly 995 1000 1005gca gta act aaa ttt ggc gag cac ggc aaa cgt aaa gcg cgt aaa gat 3072Ala Val Thr Lys Phe Gly Glu His Gly Lys Arg Lys Ala Arg Lys Asp 1010 1015 1020ctt ggc gtc agt atg atg atg tac ggt cat gtt tat gtg gcg cag att 3120Leu Gly Val Ser Met Met Met Tyr Gly His Val Tyr Val Ala Gln Ile1025 1030 1035 1040tct ctc ggc gcg cag ctg aac cag acg gtg aaa gcg att cag gaa gcg 3168Ser Leu Gly Ala Gln Leu Asn Gln Thr Val Lys Ala Ile Gln Glu Ala 1045 1050 1055gaa gcg tat ccg ggg cca tcg ctg atc att gct tat agc ccg tgt gaa 3216Glu Ala Tyr Pro Gly Pro Ser Leu Ile Ile Ala Tyr Ser Pro Cys Glu 1060 1065 1070gag cat ggt tac gat ctg gca ctc agc cac gac cag atg cgc caa ctc 3264Glu His Gly Tyr Asp Leu Ala Leu Ser His Asp Gln Met Arg Gln Leu 1075 1080 1085aca gct acc ggc ttc tgg ccg cta tat cgc ttt gat ccg cgt cgt gcc 3312Thr Ala Thr Gly Phe Trp Pro Leu Tyr Arg Phe Asp Pro Arg Arg Ala 1090 1095 1100gat gaa ggc aaa ctg ccg ctg gcc ttg gat tca cgc ccg ccg tca gaa 3360Asp Glu Gly Lys Leu Pro Leu Ala Leu Asp Ser Arg Pro Pro Ser Glu1105 1110 1115 1120gca ccg gaa gaa acg tta ctt cac gag caa cgt ttc cgt cgg ctg aat 3408Ala Pro Glu Glu Thr Leu Leu His Glu Gln Arg Phe Arg Arg Leu Asn 1125 1130 1135tcg cag cag cca gaa

gtg gca gaa cag tta tgg aaa gat gct gca gct 3456Ser Gln Gln Pro Glu Val Ala Glu Gln Leu Trp Lys Asp Ala Ala Ala 1140 1145 1150gat ttg caa aaa cgc tat gac ttc ctg gca caa atg gcc gga aaa gcg 3504Asp Leu Gln Lys Arg Tyr Asp Phe Leu Ala Gln Met Ala Gly Lys Ala 1155 1160 1165gaa aaa agc aac acc gat taa 3525Glu Lys Ser Asn Thr Asp 117041174PRTEscherichia coli 4Met Ile Thr Ile Asp Gly Asn Gly Ala Val Ala Ser Val Ala Phe Arg1 5 10 15Thr Ser Glu Val Ile Ala Ile Tyr Pro Ile Thr Pro Ser Ser Thr Met 20 25 30Ala Glu Gln Ala Asp Ala Trp Ala Gly Asn Gly Leu Lys Asn Val Trp 35 40 45Gly Asp Thr Pro Arg Val Val Glu Met Gln Ser Glu Ala Gly Ala Ile 50 55 60Ala Thr Val His Gly Ala Leu Gln Thr Gly Ala Leu Ser Thr Ser Phe65 70 75 80Thr Ser Ser Gln Gly Leu Leu Leu Met Ile Pro Thr Leu Tyr Lys Leu 85 90 95Ala Gly Glu Leu Thr Pro Phe Val Leu His Val Ala Ala Arg Thr Val 100 105 110Ala Thr His Ala Leu Ser Ile Phe Gly Asp His Ser Asp Val Met Ala 115 120 125Val Arg Gln Thr Gly Cys Ala Met Leu Cys Ala Ala Asn Val Gln Glu 130 135 140Ala Gln Asp Phe Ala Leu Ile Ser Gln Ile Ala Thr Leu Lys Ser Arg145 150 155 160Val Pro Phe Ile His Phe Phe Asp Gly Phe Arg Thr Ser His Glu Ile 165 170 175Asn Lys Ile Val Pro Leu Ala Asp Asp Thr Ile Leu Asp Leu Met Pro 180 185 190Gln Val Glu Ile Asp Ala His Arg Ala Arg Ala Leu Asn Pro Glu His 195 200 205Pro Val Ile Arg Gly Thr Ser Ala Asn Pro Asp Thr Tyr Phe Gln Ser 210 215 220Arg Glu Ala Thr Asn Pro Trp Tyr Asn Ala Val Tyr Asp His Val Glu225 230 235 240Gln Ala Met Asn Asp Phe Ser Ala Ala Thr Gly Arg Gln Tyr Gln Pro 245 250 255Phe Glu Tyr Tyr Gly His Pro Gln Ala Glu Arg Val Ile Ile Leu Met 260 265 270Gly Ser Ala Ile Gly Thr Cys Glu Glu Val Val Asp Glu Leu Leu Thr 275 280 285Arg Gly Glu Lys Val Gly Val Leu Lys Val Arg Leu Tyr Arg Pro Phe 290 295 300Ser Ala Lys His Leu Leu Gln Ala Leu Pro Gly Ser Val Arg Ser Val305 310 315 320Ala Val Leu Asp Arg Thr Lys Glu Pro Gly Ala Gln Ala Glu Pro Leu 325 330 335Tyr Leu Asp Val Met Thr Ala Leu Ala Glu Ala Phe Asn Asn Gly Glu 340 345 350Arg Glu Thr Leu Pro Arg Val Ile Gly Gly Arg Tyr Gly Leu Ser Ser 355 360 365Lys Glu Phe Gly Pro Asp Cys Val Leu Ala Val Phe Ala Glu Leu Asn 370 375 380Ala Ala Lys Pro Lys Ala Arg Phe Thr Val Gly Ile Tyr Asp Asp Val385 390 395 400Thr Asn Leu Ser Leu Pro Leu Pro Glu Asn Thr Leu Pro Asn Ser Ala 405 410 415Lys Leu Glu Ala Leu Phe Tyr Gly Leu Gly Ser Asp Gly Ser Val Ser 420 425 430Ala Thr Lys Asn Asn Ile Lys Ile Ile Gly Asn Ser Thr Pro Trp Tyr 435 440 445Ala Gln Gly Tyr Phe Val Tyr Asp Ser Lys Lys Ala Gly Gly Leu Thr 450 455 460Val Ser His Leu Arg Val Ser Glu Gln Pro Ile Arg Ser Ala Tyr Leu465 470 475 480Ile Ser Gln Ala Asp Phe Val Gly Cys His Gln Leu Gln Phe Ile Asp 485 490 495Lys Tyr Gln Met Ala Glu Arg Leu Lys Pro Gly Gly Ile Phe Leu Leu 500 505 510Asn Thr Pro Tyr Ser Ala Asp Glu Val Trp Ser Arg Leu Pro Gln Glu 515 520 525Val Gln Ala Val Leu Asn Gln Lys Lys Ala Arg Phe Tyr Val Ile Asn 530 535 540Ala Ala Lys Ile Ala Arg Glu Cys Gly Leu Ala Ala Arg Ile Asn Thr545 550 555 560Val Met Gln Met Ala Phe Phe His Leu Thr Gln Ile Leu Pro Gly Asp 565 570 575Ser Ala Leu Ala Glu Leu Gln Gly Ala Ile Ala Lys Ser Tyr Ser Ser 580 585 590Lys Gly Gln Asp Leu Val Glu Arg Asn Trp Gln Ala Leu Ala Leu Ala 595 600 605Arg Glu Ser Val Glu Glu Val Pro Leu Gln Pro Val Asn Pro His Ser 610 615 620Ala Asn Arg Pro Pro Val Val Ser Asp Ala Ala Pro Asp Phe Val Lys625 630 635 640Thr Val Thr Ala Ala Met Leu Ala Gly Leu Gly Asp Ala Leu Pro Val 645 650 655Ser Ala Leu Pro Pro Asp Gly Thr Trp Pro Met Gly Thr Thr Arg Trp 660 665 670Glu Lys Arg Asn Ile Ala Glu Glu Ile Pro Ile Trp Lys Glu Glu Leu 675 680 685Cys Thr Gln Cys Asn His Cys Val Ala Ala Cys Pro His Ser Ala Ile 690 695 700Arg Ala Lys Val Val Pro Pro Glu Ala Met Glu Asn Ala Pro Ala Ser705 710 715 720Leu His Ser Leu Asp Val Lys Ser Arg Asp Met Arg Gly Gln Lys Tyr 725 730 735Val Leu Gln Val Ala Pro Glu Asp Cys Thr Gly Cys Asn Leu Cys Val 740 745 750Glu Val Cys Pro Ala Lys Asp Arg Gln Asn Pro Glu Ile Lys Ala Ile 755 760 765Asn Met Met Ser Arg Leu Glu His Val Glu Glu Glu Lys Ile Asn Tyr 770 775 780Asp Phe Phe Leu Asn Leu Pro Glu Ile Asp Arg Ser Lys Leu Glu Arg785 790 795 800Ile Asp Ile Arg Thr Ser Gln Leu Ile Thr Pro Leu Phe Glu Tyr Ser 805 810 815Gly Ala Cys Ser Gly Cys Gly Glu Thr Pro Tyr Ile Lys Leu Leu Thr 820 825 830Gln Leu Tyr Gly Asp Arg Met Leu Ile Ala Asn Ala Thr Gly Cys Ser 835 840 845Ser Ile Tyr Gly Gly Asn Leu Pro Ser Thr Pro Tyr Thr Thr Asp Ala 850 855 860Asn Gly Arg Gly Pro Ala Trp Ala Asn Ser Leu Phe Glu Asp Asn Ala865 870 875 880Glu Phe Gly Leu Gly Phe Arg Leu Thr Val Asp Gln His Arg Val Arg 885 890 895Val Leu Arg Leu Leu Asp Gln Phe Ala Asp Lys Ile Pro Ala Glu Leu 900 905 910Leu Thr Ala Leu Lys Ser Asp Ala Thr Pro Glu Val Arg Arg Glu Gln 915 920 925Val Ala Ala Leu Arg Gln Gln Leu Asn Asp Val Ala Glu Ala His Glu 930 935 940Leu Leu Arg Asp Ala Asp Ala Leu Val Glu Lys Ser Ile Trp Leu Ile945 950 955 960Gly Gly Asp Gly Trp Ala Tyr Asp Ile Gly Phe Gly Gly Leu Asp His 965 970 975Val Leu Ser Leu Thr Glu Asn Val Asn Ile Leu Val Leu Asp Thr Gln 980 985 990Cys Tyr Ser Asn Thr Gly Gly Gln Ala Ser Lys Ala Thr Pro Leu Gly 995 1000 1005Ala Val Thr Lys Phe Gly Glu His Gly Lys Arg Lys Ala Arg Lys 1010 1015 1020Asp Leu Gly Val Ser Met Met Met Tyr Gly His Val Tyr Val Ala 1025 1030 1035Gln Ile Ser Leu Gly Ala Gln Leu Asn Gln Thr Val Lys Ala Ile 1040 1045 1050 Gln Glu Ala Glu Ala Tyr Pro Gly Pro Ser Leu Ile Ile Ala Tyr 1055 1060 1065Ser Pro Cys Glu Glu His Gly Tyr Asp Leu Ala Leu Ser His Asp 1070 1075 1080Gln Met Arg Gln Leu Thr Ala Thr Gly Phe Trp Pro Leu Tyr Arg 1085 1090 1095Phe Asp Pro Arg Arg Ala Asp Glu Gly Lys Leu Pro Leu Ala Leu 1100 1105 1110Asp Ser Arg Pro Pro Ser Glu Ala Pro Glu Glu Thr Leu Leu His 1115 1120 1125Glu Gln Arg Phe Arg Arg Leu Asn Ser Gln Gln Pro Glu Val Ala 1130 1135 1140Glu Gln Leu Trp Lys Asp Ala Ala Ala Asp Leu Gln Lys Arg Tyr 1145 1150 1155Asp Phe Leu Ala Gln Met Ala Gly Lys Ala Glu Lys Ser Asn Thr 1160 1165 1170Asp55412DNAEuglena gracilisCDS(1)..(5412) 5atg aag cag tct gtc cgc cca att att tcc aat gta ctg cgc aag gag 48Met Lys Gln Ser Val Arg Pro Ile Ile Ser Asn Val Leu Arg Lys Glu1 5 10 15gtt gct ctg tac tca aca atc att gga caa gac aag ggg aag gaa cca 96Val Ala Leu Tyr Ser Thr Ile Ile Gly Gln Asp Lys Gly Lys Glu Pro 20 25 30act ggt cga aca tac acc agt ggc cca aaa ccg gca tct cac att gaa 144Thr Gly Arg Thr Tyr Thr Ser Gly Pro Lys Pro Ala Ser His Ile Glu 35 40 45gtt ccc cat cat gtg act gtg cct gcc act gac cgc acc ccg aat ccc 192Val Pro His His Val Thr Val Pro Ala Thr Asp Arg Thr Pro Asn Pro 50 55 60gat gct caa ttc ttt cag tct gta gat ggg tca caa gcc acc agt cac 240Asp Ala Gln Phe Phe Gln Ser Val Asp Gly Ser Gln Ala Thr Ser His65 70 75 80gtt gcg tac gct ctg tct gac aca gcg ttc att tac cca att aca ccc 288Val Ala Tyr Ala Leu Ser Asp Thr Ala Phe Ile Tyr Pro Ile Thr Pro 85 90 95agt tct gtg atg ggc gag ctg gct gat gtt tgg atg gct caa ggg agg 336Ser Ser Val Met Gly Glu Leu Ala Asp Val Trp Met Ala Gln Gly Arg 100 105 110aag aac gcc ttt ggt cag gtt gtg gat gtc cgt gag atg caa tct gag 384Lys Asn Ala Phe Gly Gln Val Val Asp Val Arg Glu Met Gln Ser Glu 115 120 125gct gga gcc gca ggc gcc ctg cat ggg gca ctg gct gct gga gct att 432Ala Gly Ala Ala Gly Ala Leu His Gly Ala Leu Ala Ala Gly Ala Ile 130 135 140gct aca acc ttc act gcc tct caa ggg ttg ttg ttg atg att ccc aac 480Ala Thr Thr Phe Thr Ala Ser Gln Gly Leu Leu Leu Met Ile Pro Asn145 150 155 160atg tat aag att gca ggt gag ctg atg ccc tct gtc atc cac gtt gca 528Met Tyr Lys Ile Ala Gly Glu Leu Met Pro Ser Val Ile His Val Ala 165 170 175gcc cga gag ctt gca ggc cac gct ctg tcc att ttt gga gga cac gct 576Ala Arg Glu Leu Ala Gly His Ala Leu Ser Ile Phe Gly Gly His Ala 180 185 190gat gtc atg gct gtc cgc caa aca gga tgg gct atg ctg tgc tcc cac 624Asp Val Met Ala Val Arg Gln Thr Gly Trp Ala Met Leu Cys Ser His 195 200 205aca gtg cag cag tct cac gac atg gct ctc atc tcc cac gtg gcc acc 672Thr Val Gln Gln Ser His Asp Met Ala Leu Ile Ser His Val Ala Thr 210 215 220ctc aag tcc agc atc ccc ttc gtt cac ttc ttt gat ggt ttc cgc aca 720Leu Lys Ser Ser Ile Pro Phe Val His Phe Phe Asp Gly Phe Arg Thr225 230 235 240agc cac gaa gtg aac aaa atc aaa atg ctg cct tat gca gaa ctg aag 768Ser His Glu Val Asn Lys Ile Lys Met Leu Pro Tyr Ala Glu Leu Lys 245 250 255aaa ctg gtg cct cct ggc acc atg gaa cag cac tgg gct cgt tcg ctg 816Lys Leu Val Pro Pro Gly Thr Met Glu Gln His Trp Ala Arg Ser Leu 260 265 270aac ccc atg cac ccc acc atc cga gga aca aac cag tct gca gac atc 864Asn Pro Met His Pro Thr Ile Arg Gly Thr Asn Gln Ser Ala Asp Ile 275 280 285tac ttc cag aat atg gaa agt gca aac cag tac tac act gat ctg gcc 912Tyr Phe Gln Asn Met Glu Ser Ala Asn Gln Tyr Tyr Thr Asp Leu Ala 290 295 300gag gtc gtt cag gag aca atg gac gaa gtt gca cca tac atc ggt cgc 960Glu Val Val Gln Glu Thr Met Asp Glu Val Ala Pro Tyr Ile Gly Arg305 310 315 320cac tac aag atc ttt gag tat gtt ggt gca cca gat gca gaa gaa gtg 1008His Tyr Lys Ile Phe Glu Tyr Val Gly Ala Pro Asp Ala Glu Glu Val 325 330 335aca gtg ctc atg ggt tct ggt gca acc aca gtc aac gag gca gtg gac 1056Thr Val Leu Met Gly Ser Gly Ala Thr Thr Val Asn Glu Ala Val Asp 340 345 350ctt ctt gtg aag cgt gga aag aag gtt ggt gca gtc ttg gtg cac ctc 1104Leu Leu Val Lys Arg Gly Lys Lys Val Gly Ala Val Leu Val His Leu 355 360 365tac cga cca tgg tca aca aag gca ttt gaa aag gtc ctg ccc aag aca 1152Tyr Arg Pro Trp Ser Thr Lys Ala Phe Glu Lys Val Leu Pro Lys Thr 370 375 380gtg aag cgc att gct gct ctg gat cgc tgc aag gag gtg act gca ctg 1200Val Lys Arg Ile Ala Ala Leu Asp Arg Cys Lys Glu Val Thr Ala Leu385 390 395 400ggt gag cct ctg tat ctg gat gtg tcg gca act ctg aat ttg ttc ccg 1248Gly Glu Pro Leu Tyr Leu Asp Val Ser Ala Thr Leu Asn Leu Phe Pro 405 410 415gaa cgc cag aat gtg aaa gtc att gga gga cgt tac gga ttg ggc tca 1296Glu Arg Gln Asn Val Lys Val Ile Gly Gly Arg Tyr Gly Leu Gly Ser 420 425 430aag gat ttc atc ccg gag cat gcc ctg gca att tac gcc aac ttg gcc 1344Lys Asp Phe Ile Pro Glu His Ala Leu Ala Ile Tyr Ala Asn Leu Ala 435 440 445agc gag aac ccc att caa aga ttc act gtg ggt atc aca gat gat gtc 1392Ser Glu Asn Pro Ile Gln Arg Phe Thr Val Gly Ile Thr Asp Asp Val 450 455 460act ggc aca tcc gtt cct ttc gtc aac gag cgt gtt gac acg ttg ccc 1440Thr Gly Thr Ser Val Pro Phe Val Asn Glu Arg Val Asp Thr Leu Pro465 470 475 480gag ggc acc cgc cag tgt gtc ttc tgg gga att ggt tca gat gga aca 1488Glu Gly Thr Arg Gln Cys Val Phe Trp Gly Ile Gly Ser Asp Gly Thr 485 490 495gtg gga gcc aat cgc tct gcc gtg aga atc att gga gac aac agc gat 1536Val Gly Ala Asn Arg Ser Ala Val Arg Ile Ile Gly Asp Asn Ser Asp 500 505 510ttg atg gtt cag gcc tac ttc caa ttt gat gct ttc aag tca ggt ggt 1584Leu Met Val Gln Ala Tyr Phe Gln Phe Asp Ala Phe Lys Ser Gly Gly 515 520 525gtc act tcc tcg cat ctc cgt ttt gga cca aag ccc atc aca gcg caa 1632Val Thr Ser Ser His Leu Arg Phe Gly Pro Lys Pro Ile Thr Ala Gln 530 535 540tac ctt gtt acc aat gct gac tac atc gcg tgc cac ttc cag gag tat 1680Tyr Leu Val Thr Asn Ala Asp Tyr Ile Ala Cys His Phe Gln Glu Tyr545 550 555 560gtc aag cgc ttt gac atg ctt gat gcc atc cgt gag ggg ggc acc ttt 1728Val Lys Arg Phe Asp Met Leu Asp Ala Ile Arg Glu Gly Gly Thr Phe 565 570 575gtt ctc aat tct cgg tgg acc acg gag gac atg gag aag gag att ccg 1776Val Leu Asn Ser Arg Trp Thr Thr Glu Asp Met Glu Lys Glu Ile Pro 580 585 590gct gac ttc cgg cgc aag ctg gca cag aag aag gtc cgc ttc tac aat 1824Ala Asp Phe Arg Arg Lys Leu Ala Gln Lys Lys Val Arg Phe Tyr Asn 595 600 605gtg gat gct cga aag atc tgt gac agt ttt ggt ctt ggg aag cgc atc 1872Val Asp Ala Arg Lys Ile Cys Asp Ser Phe Gly Leu Gly Lys Arg Ile 610 615 620aat atg ctg atg cag gct tgt ttc ttc aag ctg tct ggg gtg ctc cca 1920Asn Met Leu Met Gln Ala Cys Phe Phe Lys Leu Ser Gly Val Leu Pro625 630 635 640ctg gcc gaa gct cag cgg ctg ctg aac gag tcc att gtg cat gag tat 1968Leu Ala Glu Ala Gln Arg Leu Leu Asn Glu Ser Ile Val His Glu Tyr 645 650 655gga aag aag ggt ggc aag gtg gtg gag atg aac caa gca gtg gtg aat 2016Gly Lys Lys Gly Gly Lys Val Val Glu Met Asn Gln Ala Val Val Asn 660 665 670gct gtc ttt gct ggt gac ctg ccc cag gaa gtt caa gtc cct gcc gcc 2064Ala Val Phe Ala Gly Asp Leu Pro Gln Glu Val Gln Val Pro Ala Ala 675 680 685tgg gca aac gca gtt gat aca tcc acc cgt acc ccc acc ggg att gag 2112Trp Ala Asn Ala Val Asp Thr Ser Thr Arg Thr Pro Thr Gly Ile Glu 690 695 700ttt gtt gac aag atc atg cgc ccg ctg atg gat ttc aag ggt gac cag 2160Phe Val Asp Lys Ile Met Arg Pro Leu Met Asp Phe Lys Gly Asp Gln705 710 715 720ctc cca gtc agt gtg atg act cct ggt gga acc ttc cct gtc ggg aca 2208Leu Pro Val Ser Val Met Thr Pro Gly Gly Thr Phe Pro Val Gly Thr 725 730 735aca cag tat gcc aag cgt gca att gct gct ttc att ccc cag tgg att 2256Thr Gln Tyr Ala Lys Arg Ala Ile Ala Ala Phe Ile Pro Gln Trp Ile 740 745 750cct gcc aac tgc aca cag tgc aac tat tgt tcg tat gtt tgc ccc cac 2304Pro Ala Asn Cys Thr Gln Cys Asn Tyr Cys Ser Tyr Val Cys Pro His

755 760 765gcc acc atc cga cct ttc gtg ctg aca gac cag gag gtg cag ctg gcc 2352Ala Thr Ile Arg Pro Phe Val Leu Thr Asp Gln Glu Val Gln Leu Ala 770 775 780ccg gag agc ttt gtg aca cgc aag gcg aag ggt gat tac cag ggg atg 2400Pro Glu Ser Phe Val Thr Arg Lys Ala Lys Gly Asp Tyr Gln Gly Met785 790 795 800aat ttc cgc atc caa gtt gct cct gag gat tgc act ggc tgc cag gtg 2448Asn Phe Arg Ile Gln Val Ala Pro Glu Asp Cys Thr Gly Cys Gln Val 805 810 815tgc gtg gag acg tgc ccc gat gat gcc ctg gag atg acc gac gct ttc 2496Cys Val Glu Thr Cys Pro Asp Asp Ala Leu Glu Met Thr Asp Ala Phe 820 825 830acc gcc acc cct gtg caa cgc acc aac tgg gag ttc gcc atc aag gtg 2544Thr Ala Thr Pro Val Gln Arg Thr Asn Trp Glu Phe Ala Ile Lys Val 835 840 845ccc aac cgc ggc acc atg acg gac cgc tac tcc ctg aag ggc agc cag 2592Pro Asn Arg Gly Thr Met Thr Asp Arg Tyr Ser Leu Lys Gly Ser Gln 850 855 860ttc cag cag ccc ctc ctg gag ttc tcc ggg gcc tgc gag ggc tgc ggc 2640Phe Gln Gln Pro Leu Leu Glu Phe Ser Gly Ala Cys Glu Gly Cys Gly865 870 875 880gag acc cca tat gtc aag ctg ctc acc cag ctc ttc ggc gag cgg acg 2688Glu Thr Pro Tyr Val Lys Leu Leu Thr Gln Leu Phe Gly Glu Arg Thr 885 890 895gtc atc gcc aac gcc acc ggc tgc agt tcc atc tgg ggt ggc act gcc 2736Val Ile Ala Asn Ala Thr Gly Cys Ser Ser Ile Trp Gly Gly Thr Ala 900 905 910ggc ctg gcg ccg tac acc acc aac gcc aag ggc cag ggc ccg gcc tgg 2784Gly Leu Ala Pro Tyr Thr Thr Asn Ala Lys Gly Gln Gly Pro Ala Trp 915 920 925ggc aac agc ctg ttc gag gac aac gcc gag ttc ggc ttt ggc att gca 2832Gly Asn Ser Leu Phe Glu Asp Asn Ala Glu Phe Gly Phe Gly Ile Ala 930 935 940gtg gcc aac gcc cag aag agg tcc cgc gtg agg gac tgc atc ctg cag 2880Val Ala Asn Ala Gln Lys Arg Ser Arg Val Arg Asp Cys Ile Leu Gln945 950 955 960gca gtg gag aag aag gtc gcc gat gag ggt ttg acc aca ttg ttg gcg 2928Ala Val Glu Lys Lys Val Ala Asp Glu Gly Leu Thr Thr Leu Leu Ala 965 970 975caa tgg ctg cag gat tgg aac aca gga gac aag acc ttg aag tac caa 2976Gln Trp Leu Gln Asp Trp Asn Thr Gly Asp Lys Thr Leu Lys Tyr Gln 980 985 990gac cag atc att gca ggg ctg gca cag cag cgc agc aag gat ccc ctt 3024Asp Gln Ile Ile Ala Gly Leu Ala Gln Gln Arg Ser Lys Asp Pro Leu 995 1000 1005ctg gag cag atc tat ggc atg aag gac atg ctg cct aac atc agc cag 3072Leu Glu Gln Ile Tyr Gly Met Lys Asp Met Leu Pro Asn Ile Ser Gln 1010 1015 1020tgg atc att ggt ggt gat ggc tgg gcc aac gac att ggt ttc ggt ggg 3120Trp Ile Ile Gly Gly Asp Gly Trp Ala Asn Asp Ile Gly Phe Gly Gly1025 1030 1035 1040ctg gac cac gtg ctg gcc tct ggg cag aac ctc aac gtc ctg gtg ctg 3168Leu Asp His Val Leu Ala Ser Gly Gln Asn Leu Asn Val Leu Val Leu 1045 1050 1055gac acc gag atg tac agc aac acc ggt ggg cag gcc tcc aag tcc acc 3216Asp Thr Glu Met Tyr Ser Asn Thr Gly Gly Gln Ala Ser Lys Ser Thr 1060 1065 1070cac atg gcc tct gtg gcc aag ttt gcc ctg gga ggg aag cgc acc aac 3264His Met Ala Ser Val Ala Lys Phe Ala Leu Gly Gly Lys Arg Thr Asn 1075 1080 1085aag aag aac ttg acg gag atg gca atg agc tat ggc aac gtc tat gtg 3312Lys Lys Asn Leu Thr Glu Met Ala Met Ser Tyr Gly Asn Val Tyr Val 1090 1095 1100gcc acc gtc tcc cat ggc aac atg gcc cag tgc gtc aag gcg ttt gtg 3360Ala Thr Val Ser His Gly Asn Met Ala Gln Cys Val Lys Ala Phe Val1105 1110 1115 1120gag gct gag tct tat gat gga cct tcg ctc att gtt ggc tat gcg cca 3408Glu Ala Glu Ser Tyr Asp Gly Pro Ser Leu Ile Val Gly Tyr Ala Pro 1125 1130 1135tgc atc gag cat ggt ctg cgt gct ggt atg gca agg atg gtt caa gag 3456Cys Ile Glu His Gly Leu Arg Ala Gly Met Ala Arg Met Val Gln Glu 1140 1145 1150tct gag gct gcc atc gcc acg gga tac tgg ccc ctg tac cgc ttt gac 3504Ser Glu Ala Ala Ile Ala Thr Gly Tyr Trp Pro Leu Tyr Arg Phe Asp 1155 1160 1165ccc cgc ctg gcg acc gag ggc aag aac ccc ttc cag ctg gac tcc aag 3552Pro Arg Leu Ala Thr Glu Gly Lys Asn Pro Phe Gln Leu Asp Ser Lys 1170 1175 1180cgc atc aag ggc aac ctg cag gag tac ctg gac cgc cag aac cgg tat 3600Arg Ile Lys Gly Asn Leu Gln Glu Tyr Leu Asp Arg Gln Asn Arg Tyr1185 1190 1195 1200gtc aac ctg aag aag aac aac ccg aag ggt gcg gat ctg ctg aag tct 3648Val Asn Leu Lys Lys Asn Asn Pro Lys Gly Ala Asp Leu Leu Lys Ser 1205 1210 1215cag atg gcc gac aac atc acc gcc cgg ttc aac cgc tac cga cgc atg 3696Gln Met Ala Asp Asn Ile Thr Ala Arg Phe Asn Arg Tyr Arg Arg Met 1220 1225 1230ttg gag ggc ccc aat aca aaa gcc gcc gcc ccc agc ggc aac cat gtg 3744Leu Glu Gly Pro Asn Thr Lys Ala Ala Ala Pro Ser Gly Asn His Val 1235 1240 1245acc atc ctg tac ggc tcc gaa act ggc aac agt gag ggt ctg gca aag 3792Thr Ile Leu Tyr Gly Ser Glu Thr Gly Asn Ser Glu Gly Leu Ala Lys 1250 1255 1260gag ctg gcc acc gac ttc gag cgc cgg gag tac tcc gtc gca gtg cag 3840Glu Leu Ala Thr Asp Phe Glu Arg Arg Glu Tyr Ser Val Ala Val Gln1265 1270 1275 1280gct ttg gat gac atc gac gtt gct gac ttg gag aac atg ggc ttc gtg 3888Ala Leu Asp Asp Ile Asp Val Ala Asp Leu Glu Asn Met Gly Phe Val 1285 1290 1295gtc att gcg gtg tcc acc tgt ggg cag gga cag ttc ccc cgc aac agc 3936Val Ile Ala Val Ser Thr Cys Gly Gln Gly Gln Phe Pro Arg Asn Ser 1300 1305 1310cag ctg ttc tgg cgg gag ctg cag cgg gac aag cct gag ggc tgg ctg 3984Gln Leu Phe Trp Arg Glu Leu Gln Arg Asp Lys Pro Glu Gly Trp Leu 1315 1320 1325aag aac ttg aag tac act gtc ttc ggg ctg ggc gac agc aca tac tac 4032Lys Asn Leu Lys Tyr Thr Val Phe Gly Leu Gly Asp Ser Thr Tyr Tyr 1330 1335 1340ttc tac tgc cac acc gcc aag cag atc gac gct cgc ctg gcc gcc ttg 4080Phe Tyr Cys His Thr Ala Lys Gln Ile Asp Ala Arg Leu Ala Ala Leu1345 1350 1355 1360ggc gct cag cgg gtg gtg ccc att ggc ttc ggc gac gat ggg gat gag 4128Gly Ala Gln Arg Val Val Pro Ile Gly Phe Gly Asp Asp Gly Asp Glu 1365 1370 1375gac atg ttc cac acc ggc ttc aac aac tgg atc ccc agt gtg tgg aat 4176Asp Met Phe His Thr Gly Phe Asn Asn Trp Ile Pro Ser Val Trp Asn 1380 1385 1390gag ctc aag acc aag act ccg gag gaa gcg ctg ttc acc ccg agc atc 4224Glu Leu Lys Thr Lys Thr Pro Glu Glu Ala Leu Phe Thr Pro Ser Ile 1395 1400 1405gcc gtg cag ctc acc ccc aac gcc acc ccg cag gat ttc cat ttc gcc 4272Ala Val Gln Leu Thr Pro Asn Ala Thr Pro Gln Asp Phe His Phe Ala 1410 1415 1420aag tcc acc cca gtg ctg tcc atc acc ggt gcc gaa cgc atc acg ccg 4320Lys Ser Thr Pro Val Leu Ser Ile Thr Gly Ala Glu Arg Ile Thr Pro1425 1430 1435 1440gca gac cac acc cgc aac ttc gtc act atc cga tgg aag acc gat ttg 4368Ala Asp His Thr Arg Asn Phe Val Thr Ile Arg Trp Lys Thr Asp Leu 1445 1450 1455tcg tac cag gtg ggt gac tct ctt ggt gtc ttc cct gag aac acc cgg 4416Ser Tyr Gln Val Gly Asp Ser Leu Gly Val Phe Pro Glu Asn Thr Arg 1460 1465 1470tca gtg gtg gag gag ttc ctg cag tat tac ggc ttg aac ccc aag gac 4464Ser Val Val Glu Glu Phe Leu Gln Tyr Tyr Gly Leu Asn Pro Lys Asp 1475 1480 1485gtc atc acc atc gaa aac aag ggc agc cgg gag ttg ccc cac tgc atg 4512Val Ile Thr Ile Glu Asn Lys Gly Ser Arg Glu Leu Pro His Cys Met 1490 1495 1500gct gtt ggg gat ctc ttc acg aag gtg ttg gac atc ttg ggc aaa ccc 4560Ala Val Gly Asp Leu Phe Thr Lys Val Leu Asp Ile Leu Gly Lys Pro1505 1510 1515 1520aac aac cgg ttc tac aag acc ctt tct tac ttt gca gtg gac aag gcc 4608Asn Asn Arg Phe Tyr Lys Thr Leu Ser Tyr Phe Ala Val Asp Lys Ala 1525 1530 1535gag aag gag cgc ttg ttg aag atc gcc gag atg ggg ccg gag tac agc 4656Glu Lys Glu Arg Leu Leu Lys Ile Ala Glu Met Gly Pro Glu Tyr Ser 1540 1545 1550aac atc ctg tct gag acg tac cac tac gcg gac atc ttc cac atg ttc 4704Asn Ile Leu Ser Glu Thr Tyr His Tyr Ala Asp Ile Phe His Met Phe 1555 1560 1565ccg tcc gcc cgg ccc acg ctg cag tac ctc atc gag atg atc ccc aac 4752Pro Ser Ala Arg Pro Thr Leu Gln Tyr Leu Ile Glu Met Ile Pro Asn 1570 1575 1580atc aag ccc cgg tac tac tcc atc tcc tcc gcc ccc atc cac acc cct 4800Ile Lys Pro Arg Tyr Tyr Ser Ile Ser Ser Ala Pro Ile His Thr Pro1585 1590 1595 1600ggc gag gtc cac agc ctg gtg ctc atc gac acc tgg atc acg ctg tcc 4848Gly Glu Val His Ser Leu Val Leu Ile Asp Thr Trp Ile Thr Leu Ser 1605 1610 1615ggc aag cac cgc acg ggg ctg acc tgc acc atg ctg gag cac ctg cag 4896Gly Lys His Arg Thr Gly Leu Thr Cys Thr Met Leu Glu His Leu Gln 1620 1625 1630gcg ggc cag gtg gtg gat ggc tgc atc cac ccc acg gcg atg gag ttc 4944Ala Gly Gln Val Val Asp Gly Cys Ile His Pro Thr Ala Met Glu Phe 1635 1640 1645ccc gac cac gag aag ccg gtg gtg atg tgc gcc atg ggc agt ggc ctg 4992Pro Asp His Glu Lys Pro Val Val Met Cys Ala Met Gly Ser Gly Leu 1650 1655 1660gca ccg ttc gtt gct ttc ctg cgc gac ggc tcc acg ctg cgg aag cag 5040Ala Pro Phe Val Ala Phe Leu Arg Asp Gly Ser Thr Leu Arg Lys Gln1665 1670 1675 1680ggc aag aag acc ggg aac atg gca ttg tac ttc ggc aac agg tat gag 5088Gly Lys Lys Thr Gly Asn Met Ala Leu Tyr Phe Gly Asn Arg Tyr Glu 1685 1690 1695aag acg gag ttc ctg atg aag gag gag ctg aag ggt cac atc aac gat 5136Lys Thr Glu Phe Leu Met Lys Glu Glu Leu Lys Gly His Ile Asn Asp 1700 1705 1710ggt ttg ctg aca ctt cga tgc gct ttc agc cga gat gac ccc aag aag 5184Gly Leu Leu Thr Leu Arg Cys Ala Phe Ser Arg Asp Asp Pro Lys Lys 1715 1720 1725aag gtg tat gtg cag gac ctt atc aag atg gac gaa aag atg atg tac 5232Lys Val Tyr Val Gln Asp Leu Ile Lys Met Asp Glu Lys Met Met Tyr 1730 1735 1740gat tac ctc gtg gtg cag aag ggt tct atg tat tgc tgt gga tcc cgc 5280Asp Tyr Leu Val Val Gln Lys Gly Ser Met Tyr Cys Cys Gly Ser Arg1745 1750 1755 1760agt ttc atc aag cct gtc cag gag tca ttg aaa cat tgc ttc atg aaa 5328Ser Phe Ile Lys Pro Val Gln Glu Ser Leu Lys His Cys Phe Met Lys 1765 1770 1775gct ggt ggg ctg act gca gag caa gct gag aac gag gtc atc gat atg 5376Ala Gly Gly Leu Thr Ala Glu Gln Ala Glu Asn Glu Val Ile Asp Met 1780 1785 1790ttc acg acc ggg cgg tac aat atc gag gca tgg taa 5412Phe Thr Thr Gly Arg Tyr Asn Ile Glu Ala Trp 1795 180061803PRTEuglena gracilis 6Met Lys Gln Ser Val Arg Pro Ile Ile Ser Asn Val Leu Arg Lys Glu1 5 10 15Val Ala Leu Tyr Ser Thr Ile Ile Gly Gln Asp Lys Gly Lys Glu Pro 20 25 30Thr Gly Arg Thr Tyr Thr Ser Gly Pro Lys Pro Ala Ser His Ile Glu 35 40 45Val Pro His His Val Thr Val Pro Ala Thr Asp Arg Thr Pro Asn Pro 50 55 60Asp Ala Gln Phe Phe Gln Ser Val Asp Gly Ser Gln Ala Thr Ser His65 70 75 80Val Ala Tyr Ala Leu Ser Asp Thr Ala Phe Ile Tyr Pro Ile Thr Pro 85 90 95Ser Ser Val Met Gly Glu Leu Ala Asp Val Trp Met Ala Gln Gly Arg 100 105 110Lys Asn Ala Phe Gly Gln Val Val Asp Val Arg Glu Met Gln Ser Glu 115 120 125Ala Gly Ala Ala Gly Ala Leu His Gly Ala Leu Ala Ala Gly Ala Ile 130 135 140Ala Thr Thr Phe Thr Ala Ser Gln Gly Leu Leu Leu Met Ile Pro Asn145 150 155 160Met Tyr Lys Ile Ala Gly Glu Leu Met Pro Ser Val Ile His Val Ala 165 170 175Ala Arg Glu Leu Ala Gly His Ala Leu Ser Ile Phe Gly Gly His Ala 180 185 190Asp Val Met Ala Val Arg Gln Thr Gly Trp Ala Met Leu Cys Ser His 195 200 205Thr Val Gln Gln Ser His Asp Met Ala Leu Ile Ser His Val Ala Thr 210 215 220Leu Lys Ser Ser Ile Pro Phe Val His Phe Phe Asp Gly Phe Arg Thr225 230 235 240Ser His Glu Val Asn Lys Ile Lys Met Leu Pro Tyr Ala Glu Leu Lys 245 250 255Lys Leu Val Pro Pro Gly Thr Met Glu Gln His Trp Ala Arg Ser Leu 260 265 270Asn Pro Met His Pro Thr Ile Arg Gly Thr Asn Gln Ser Ala Asp Ile 275 280 285Tyr Phe Gln Asn Met Glu Ser Ala Asn Gln Tyr Tyr Thr Asp Leu Ala 290 295 300Glu Val Val Gln Glu Thr Met Asp Glu Val Ala Pro Tyr Ile Gly Arg305 310 315 320His Tyr Lys Ile Phe Glu Tyr Val Gly Ala Pro Asp Ala Glu Glu Val 325 330 335Thr Val Leu Met Gly Ser Gly Ala Thr Thr Val Asn Glu Ala Val Asp 340 345 350Leu Leu Val Lys Arg Gly Lys Lys Val Gly Ala Val Leu Val His Leu 355 360 365Tyr Arg Pro Trp Ser Thr Lys Ala Phe Glu Lys Val Leu Pro Lys Thr 370 375 380Val Lys Arg Ile Ala Ala Leu Asp Arg Cys Lys Glu Val Thr Ala Leu385 390 395 400Gly Glu Pro Leu Tyr Leu Asp Val Ser Ala Thr Leu Asn Leu Phe Pro 405 410 415Glu Arg Gln Asn Val Lys Val Ile Gly Gly Arg Tyr Gly Leu Gly Ser 420 425 430Lys Asp Phe Ile Pro Glu His Ala Leu Ala Ile Tyr Ala Asn Leu Ala 435 440 445Ser Glu Asn Pro Ile Gln Arg Phe Thr Val Gly Ile Thr Asp Asp Val 450 455 460Thr Gly Thr Ser Val Pro Phe Val Asn Glu Arg Val Asp Thr Leu Pro465 470 475 480Glu Gly Thr Arg Gln Cys Val Phe Trp Gly Ile Gly Ser Asp Gly Thr 485 490 495Val Gly Ala Asn Arg Ser Ala Val Arg Ile Ile Gly Asp Asn Ser Asp 500 505 510Leu Met Val Gln Ala Tyr Phe Gln Phe Asp Ala Phe Lys Ser Gly Gly 515 520 525Val Thr Ser Ser His Leu Arg Phe Gly Pro Lys Pro Ile Thr Ala Gln 530 535 540Tyr Leu Val Thr Asn Ala Asp Tyr Ile Ala Cys His Phe Gln Glu Tyr545 550 555 560Val Lys Arg Phe Asp Met Leu Asp Ala Ile Arg Glu Gly Gly Thr Phe 565 570 575Val Leu Asn Ser Arg Trp Thr Thr Glu Asp Met Glu Lys Glu Ile Pro 580 585 590Ala Asp Phe Arg Arg Lys Leu Ala Gln Lys Lys Val Arg Phe Tyr Asn 595 600 605Val Asp Ala Arg Lys Ile Cys Asp Ser Phe Gly Leu Gly Lys Arg Ile 610 615 620Asn Met Leu Met Gln Ala Cys Phe Phe Lys Leu Ser Gly Val Leu Pro625 630 635 640Leu Ala Glu Ala Gln Arg Leu Leu Asn Glu Ser Ile Val His Glu Tyr 645 650 655Gly Lys Lys Gly Gly Lys Val Val Glu Met Asn Gln Ala Val Val Asn 660 665 670Ala Val Phe Ala Gly Asp Leu Pro Gln Glu Val Gln Val Pro Ala Ala 675 680 685Trp Ala Asn Ala Val Asp Thr Ser Thr Arg Thr Pro Thr Gly Ile Glu 690 695 700Phe Val Asp Lys Ile Met Arg Pro Leu Met Asp Phe Lys Gly Asp Gln705 710 715 720Leu Pro Val Ser Val Met Thr Pro Gly Gly Thr Phe Pro Val Gly Thr 725 730 735Thr Gln Tyr Ala Lys Arg Ala Ile Ala Ala Phe Ile Pro Gln Trp Ile 740 745 750Pro Ala Asn Cys Thr Gln Cys Asn Tyr Cys Ser Tyr Val Cys Pro His 755 760 765Ala Thr Ile Arg Pro Phe Val Leu Thr Asp Gln Glu Val Gln Leu Ala 770 775 780Pro Glu Ser Phe Val Thr Arg Lys

Ala Lys Gly Asp Tyr Gln Gly Met785 790 795 800Asn Phe Arg Ile Gln Val Ala Pro Glu Asp Cys Thr Gly Cys Gln Val 805 810 815Cys Val Glu Thr Cys Pro Asp Asp Ala Leu Glu Met Thr Asp Ala Phe 820 825 830Thr Ala Thr Pro Val Gln Arg Thr Asn Trp Glu Phe Ala Ile Lys Val 835 840 845Pro Asn Arg Gly Thr Met Thr Asp Arg Tyr Ser Leu Lys Gly Ser Gln 850 855 860Phe Gln Gln Pro Leu Leu Glu Phe Ser Gly Ala Cys Glu Gly Cys Gly865 870 875 880Glu Thr Pro Tyr Val Lys Leu Leu Thr Gln Leu Phe Gly Glu Arg Thr 885 890 895Val Ile Ala Asn Ala Thr Gly Cys Ser Ser Ile Trp Gly Gly Thr Ala 900 905 910Gly Leu Ala Pro Tyr Thr Thr Asn Ala Lys Gly Gln Gly Pro Ala Trp 915 920 925Gly Asn Ser Leu Phe Glu Asp Asn Ala Glu Phe Gly Phe Gly Ile Ala 930 935 940Val Ala Asn Ala Gln Lys Arg Ser Arg Val Arg Asp Cys Ile Leu Gln945 950 955 960Ala Val Glu Lys Lys Val Ala Asp Glu Gly Leu Thr Thr Leu Leu Ala 965 970 975Gln Trp Leu Gln Asp Trp Asn Thr Gly Asp Lys Thr Leu Lys Tyr Gln 980 985 990Asp Gln Ile Ile Ala Gly Leu Ala Gln Gln Arg Ser Lys Asp Pro Leu 995 1000 1005Leu Glu Gln Ile Tyr Gly Met Lys Asp Met Leu Pro Asn Ile Ser Gln 1010 1015 1020Trp Ile Ile Gly Gly Asp Gly Trp Ala Asn Asp Ile Gly Phe Gly Gly1025 1030 1035 1040Leu Asp His Val Leu Ala Ser Gly Gln Asn Leu Asn Val Leu Val Leu 1045 1050 1055Asp Thr Glu Met Tyr Ser Asn Thr Gly Gly Gln Ala Ser Lys Ser Thr 1060 1065 1070His Met Ala Ser Val Ala Lys Phe Ala Leu Gly Gly Lys Arg Thr Asn 1075 1080 1085Lys Lys Asn Leu Thr Glu Met Ala Met Ser Tyr Gly Asn Val Tyr Val 1090 1095 1100Ala Thr Val Ser His Gly Asn Met Ala Gln Cys Val Lys Ala Phe Val1105 1110 1115 1120Glu Ala Glu Ser Tyr Asp Gly Pro Ser Leu Ile Val Gly Tyr Ala Pro 1125 1130 1135Cys Ile Glu His Gly Leu Arg Ala Gly Met Ala Arg Met Val Gln Glu 1140 1145 1150Ser Glu Ala Ala Ile Ala Thr Gly Tyr Trp Pro Leu Tyr Arg Phe Asp 1155 1160 1165Pro Arg Leu Ala Thr Glu Gly Lys Asn Pro Phe Gln Leu Asp Ser Lys 1170 1175 1180Arg Ile Lys Gly Asn Leu Gln Glu Tyr Leu Asp Arg Gln Asn Arg Tyr1185 1190 1195 1200Val Asn Leu Lys Lys Asn Asn Pro Lys Gly Ala Asp Leu Leu Lys Ser 1205 1210 1215Gln Met Ala Asp Asn Ile Thr Ala Arg Phe Asn Arg Tyr Arg Arg Met 1220 1225 1230Leu Glu Gly Pro Asn Thr Lys Ala Ala Ala Pro Ser Gly Asn His Val 1235 1240 1245Thr Ile Leu Tyr Gly Ser Glu Thr Gly Asn Ser Glu Gly Leu Ala Lys 1250 1255 1260Glu Leu Ala Thr Asp Phe Glu Arg Arg Glu Tyr Ser Val Ala Val Gln1265 1270 1275 1280Ala Leu Asp Asp Ile Asp Val Ala Asp Leu Glu Asn Met Gly Phe Val 1285 1290 1295Val Ile Ala Val Ser Thr Cys Gly Gln Gly Gln Phe Pro Arg Asn Ser 1300 1305 1310Gln Leu Phe Trp Arg Glu Leu Gln Arg Asp Lys Pro Glu Gly Trp Leu 1315 1320 1325Lys Asn Leu Lys Tyr Thr Val Phe Gly Leu Gly Asp Ser Thr Tyr Tyr 1330 1335 1340Phe Tyr Cys His Thr Ala Lys Gln Ile Asp Ala Arg Leu Ala Ala Leu1345 1350 1355 1360Gly Ala Gln Arg Val Val Pro Ile Gly Phe Gly Asp Asp Gly Asp Glu 1365 1370 1375Asp Met Phe His Thr Gly Phe Asn Asn Trp Ile Pro Ser Val Trp Asn 1380 1385 1390Glu Leu Lys Thr Lys Thr Pro Glu Glu Ala Leu Phe Thr Pro Ser Ile 1395 1400 1405Ala Val Gln Leu Thr Pro Asn Ala Thr Pro Gln Asp Phe His Phe Ala 1410 1415 1420Lys Ser Thr Pro Val Leu Ser Ile Thr Gly Ala Glu Arg Ile Thr Pro1425 1430 1435 1440Ala Asp His Thr Arg Asn Phe Val Thr Ile Arg Trp Lys Thr Asp Leu 1445 1450 1455Ser Tyr Gln Val Gly Asp Ser Leu Gly Val Phe Pro Glu Asn Thr Arg 1460 1465 1470Ser Val Val Glu Glu Phe Leu Gln Tyr Tyr Gly Leu Asn Pro Lys Asp 1475 1480 1485Val Ile Thr Ile Glu Asn Lys Gly Ser Arg Glu Leu Pro His Cys Met 1490 1495 1500Ala Val Gly Asp Leu Phe Thr Lys Val Leu Asp Ile Leu Gly Lys Pro1505 1510 1515 1520Asn Asn Arg Phe Tyr Lys Thr Leu Ser Tyr Phe Ala Val Asp Lys Ala 1525 1530 1535Glu Lys Glu Arg Leu Leu Lys Ile Ala Glu Met Gly Pro Glu Tyr Ser 1540 1545 1550Asn Ile Leu Ser Glu Thr Tyr His Tyr Ala Asp Ile Phe His Met Phe 1555 1560 1565Pro Ser Ala Arg Pro Thr Leu Gln Tyr Leu Ile Glu Met Ile Pro Asn 1570 1575 1580Ile Lys Pro Arg Tyr Tyr Ser Ile Ser Ser Ala Pro Ile His Thr Pro1585 1590 1595 1600Gly Glu Val His Ser Leu Val Leu Ile Asp Thr Trp Ile Thr Leu Ser 1605 1610 1615Gly Lys His Arg Thr Gly Leu Thr Cys Thr Met Leu Glu His Leu Gln 1620 1625 1630Ala Gly Gln Val Val Asp Gly Cys Ile His Pro Thr Ala Met Glu Phe 1635 1640 1645Pro Asp His Glu Lys Pro Val Val Met Cys Ala Met Gly Ser Gly Leu 1650 1655 1660Ala Pro Phe Val Ala Phe Leu Arg Asp Gly Ser Thr Leu Arg Lys Gln1665 1670 1675 1680Gly Lys Lys Thr Gly Asn Met Ala Leu Tyr Phe Gly Asn Arg Tyr Glu 1685 1690 1695Lys Thr Glu Phe Leu Met Lys Glu Glu Leu Lys Gly His Ile Asn Asp 1700 1705 1710Gly Leu Leu Thr Leu Arg Cys Ala Phe Ser Arg Asp Asp Pro Lys Lys 1715 1720 1725Lys Val Tyr Val Gln Asp Leu Ile Lys Met Asp Glu Lys Met Met Tyr 1730 1735 1740Asp Tyr Leu Val Val Gln Lys Gly Ser Met Tyr Cys Cys Gly Ser Arg1745 1750 1755 1760Ser Phe Ile Lys Pro Val Gln Glu Ser Leu Lys His Cys Phe Met Lys 1765 1770 1775Ala Gly Gly Leu Thr Ala Glu Gln Ala Glu Asn Glu Val Ile Asp Met 1780 1785 1790Phe Thr Thr Gly Arg Tyr Asn Ile Glu Ala Trp 1795 18007747DNAEscherichia coliCDS(1)..(747) 7atg gct gat tgg gta aca ggc aaa gtc act aaa gtg cag aac tgg acc 48Met Ala Asp Trp Val Thr Gly Lys Val Thr Lys Val Gln Asn Trp Thr1 5 10 15gac gcc ctg ttt agt ctc acc gtt cac gcc ccc gtg ctt ccg ttt acc 96Asp Ala Leu Phe Ser Leu Thr Val His Ala Pro Val Leu Pro Phe Thr 20 25 30gcc ggg caa ttt acc aag ctt ggc ctt gaa atc gac ggc gaa cgc gtc 144Ala Gly Gln Phe Thr Lys Leu Gly Leu Glu Ile Asp Gly Glu Arg Val 35 40 45cag cgc gcc tac tcc tat gta aac tcg ccc gat aat ccc gat ctg gag 192Gln Arg Ala Tyr Ser Tyr Val Asn Ser Pro Asp Asn Pro Asp Leu Glu 50 55 60ttt tac ctg gtc acc gtc ccc gat ggc aaa tta agc cca cga ctg gcg 240Phe Tyr Leu Val Thr Val Pro Asp Gly Lys Leu Ser Pro Arg Leu Ala65 70 75 80gca ctg aaa cca ggc gat gaa gtg cag gtg gtt agc gaa gcg gca gga 288Ala Leu Lys Pro Gly Asp Glu Val Gln Val Val Ser Glu Ala Ala Gly 85 90 95ttc ttt gtg ctc gat gaa gtg ccg cac tgc gaa acg cta tgg atg ctg 336Phe Phe Val Leu Asp Glu Val Pro His Cys Glu Thr Leu Trp Met Leu 100 105 110gca acc ggt aca gcg att ggc cct tat tta tcg att ctg caa cta ggt 384Ala Thr Gly Thr Ala Ile Gly Pro Tyr Leu Ser Ile Leu Gln Leu Gly 115 120 125aaa gat tta gat cgc ttc aaa aat ctg gtc ctg gtg cac gcc gca cgt 432Lys Asp Leu Asp Arg Phe Lys Asn Leu Val Leu Val His Ala Ala Arg 130 135 140tat gcc gcc gac tta agc tat ttg cca ctg atg cag gaa ctg gaa aaa 480Tyr Ala Ala Asp Leu Ser Tyr Leu Pro Leu Met Gln Glu Leu Glu Lys145 150 155 160cgc tac gaa gga aaa ctg cgc att cag acg gtg gtc agt cgg gaa acg 528Arg Tyr Glu Gly Lys Leu Arg Ile Gln Thr Val Val Ser Arg Glu Thr 165 170 175gca gcg ggg tcg ctc acc gga cgg ata ccg gca tta att gaa agt ggg 576Ala Ala Gly Ser Leu Thr Gly Arg Ile Pro Ala Leu Ile Glu Ser Gly 180 185 190gaa ctg gaa agc acg att ggc ctg ccg atg aat aaa gaa acc agc cat 624Glu Leu Glu Ser Thr Ile Gly Leu Pro Met Asn Lys Glu Thr Ser His 195 200 205gtg atg ctg tgc ggc aat cca cag atg gtg cgc gat aca caa cag ttg 672Val Met Leu Cys Gly Asn Pro Gln Met Val Arg Asp Thr Gln Gln Leu 210 215 220ctg aaa gag acc cgg cag atg acg aaa cat tta cgt cgc cga ccg ggc 720Leu Lys Glu Thr Arg Gln Met Thr Lys His Leu Arg Arg Arg Pro Gly225 230 235 240cat atg aca gcg gag cat tac tgg taa 747His Met Thr Ala Glu His Tyr Trp 2458248PRTEscherichia coli 8Met Ala Asp Trp Val Thr Gly Lys Val Thr Lys Val Gln Asn Trp Thr1 5 10 15 Asp Ala Leu Phe Ser Leu Thr Val His Ala Pro Val Leu Pro Phe Thr 20 25 30Ala Gly Gln Phe Thr Lys Leu Gly Leu Glu Ile Asp Gly Glu Arg Val 35 40 45Gln Arg Ala Tyr Ser Tyr Val Asn Ser Pro Asp Asn Pro Asp Leu Glu 50 55 60Phe Tyr Leu Val Thr Val Pro Asp Gly Lys Leu Ser Pro Arg Leu Ala65 70 75 80Ala Leu Lys Pro Gly Asp Glu Val Gln Val Val Ser Glu Ala Ala Gly 85 90 95 Phe Phe Val Leu Asp Glu Val Pro His Cys Glu Thr Leu Trp Met Leu 100 105 110Ala Thr Gly Thr Ala Ile Gly Pro Tyr Leu Ser Ile Leu Gln Leu Gly 115 120 125Lys Asp Leu Asp Arg Phe Lys Asn Leu Val Leu Val His Ala Ala Arg 130 135 140Tyr Ala Ala Asp Leu Ser Tyr Leu Pro Leu Met Gln Glu Leu Glu Lys145 150 155 160Arg Tyr Glu Gly Lys Leu Arg Ile Gln Thr Val Val Ser Arg Glu Thr 165 170 175 Ala Ala Gly Ser Leu Thr Gly Arg Ile Pro Ala Leu Ile Glu Ser Gly 180 185 190Glu Leu Glu Ser Thr Ile Gly Leu Pro Met Asn Lys Glu Thr Ser His 195 200 205Val Met Leu Cys Gly Asn Pro Gln Met Val Arg Asp Thr Gln Gln Leu 210 215 220Leu Lys Glu Thr Arg Gln Met Thr Lys His Leu Arg Arg Arg Pro Gly225 230 235 240His Met Thr Ala Glu His Tyr Trp 2459336DNAEscherichia coliCDS(1)..(336) 9atg cca aag att gtt att ttg cct cat cag gat ctc tgc cct gat ggc 48Met Pro Lys Ile Val Ile Leu Pro His Gln Asp Leu Cys Pro Asp Gly1 5 10 15gct gtt ctg gaa gct aat agc ggt gaa acc att ctc gac gca gct ctg 96Ala Val Leu Glu Ala Asn Ser Gly Glu Thr Ile Leu Asp Ala Ala Leu 20 25 30cgt aac ggt atc gag att gaa cac gcc tgt gaa aaa tcc tgt gct tgc 144Arg Asn Gly Ile Glu Ile Glu His Ala Cys Glu Lys Ser Cys Ala Cys 35 40 45acc acc tgc cac tgc atc gtt cgt gaa ggt ttt gac tca ctg ccg gaa 192Thr Thr Cys His Cys Ile Val Arg Glu Gly Phe Asp Ser Leu Pro Glu 50 55 60agc tca gag cag gaa gac gac atg ctg gac aaa gcc tgg gga ctg gag 240Ser Ser Glu Gln Glu Asp Asp Met Leu Asp Lys Ala Trp Gly Leu Glu65 70 75 80ccg gaa agc cgt tta agc tgc cag gcg cgc gtt acc gac gaa gat tta 288Pro Glu Ser Arg Leu Ser Cys Gln Ala Arg Val Thr Asp Glu Asp Leu 85 90 95gta gtc gaa atc ccg cgt tac act atc aac cat gcg cgt gag cat taa 336Val Val Glu Ile Pro Arg Tyr Thr Ile Asn His Ala Arg Glu His 100 105 11010111PRTEscherichia coli 10Met Pro Lys Ile Val Ile Leu Pro His Gln Asp Leu Cys Pro Asp Gly1 5 10 15Ala Val Leu Glu Ala Asn Ser Gly Glu Thr Ile Leu Asp Ala Ala Leu 20 25 30 Arg Asn Gly Ile Glu Ile Glu His Ala Cys Glu Lys Ser Cys Ala Cys 35 40 45Thr Thr Cys His Cys Ile Val Arg Glu Gly Phe Asp Ser Leu Pro Glu 50 55 60Ser Ser Glu Gln Glu Asp Asp Met Leu Asp Lys Ala Trp Gly Leu Glu65 70 75 80Pro Glu Ser Arg Leu Ser Cys Gln Ala Arg Val Thr Asp Glu Asp Leu 85 90 95Val Val Glu Ile Pro Arg Tyr Thr Ile Asn His Ala Arg Glu His 100 105 11011261DNAEscherichia coliCDS(1)..(261) 11atg gcg ttg tta atc act aaa aaa tgc atc aat tgt gat atg tgt gaa 48Met Ala Leu Leu Ile Thr Lys Lys Cys Ile Asn Cys Asp Met Cys Glu1 5 10 15ccc gaa tgc ccg aat gag gcg att tca atg gga gat cat atc tac gag 96Pro Glu Cys Pro Asn Glu Ala Ile Ser Met Gly Asp His Ile Tyr Glu 20 25 30att aac agc gat aag tgt acc gaa tgc gta ggg cac tac gag aca cca 144Ile Asn Ser Asp Lys Cys Thr Glu Cys Val Gly His Tyr Glu Thr Pro 35 40 45acc tgc cag aag gtg tgc ccg atc ccc aat act att gtg aaa gat ccg 192Thr Cys Gln Lys Val Cys Pro Ile Pro Asn Thr Ile Val Lys Asp Pro 50 55 60gcg cat gtc gag aca gaa gaa cag ttg tgg gat aaa ttt gtg ctg atg 240Ala His Val Glu Thr Glu Glu Gln Leu Trp Asp Lys Phe Val Leu Met65 70 75 80cac cac gcg gat aaa att taa 261His His Ala Asp Lys Ile 851286PRTEscherichia coli 12Met Ala Leu Leu Ile Thr Lys Lys Cys Ile Asn Cys Asp Met Cys Glu1 5 10 15Pro Glu Cys Pro Asn Glu Ala Ile Ser Met Gly Asp His Ile Tyr Glu 20 25 30Ile Asn Ser Asp Lys Cys Thr Glu Cys Val Gly His Tyr Glu Thr Pro 35 40 45Thr Cys Gln Lys Val Cys Pro Ile Pro Asn Thr Ile Val Lys Asp Pro 50 55 60Ala His Val Glu Thr Glu Glu Gln Leu Trp Asp Lys Phe Val Leu Met65 70 75 80His His Ala Asp Lys Ile 8513531DNAEscherichia coliCDS(1)..(531) 13atg gct atc act ggc atc ttt ttc ggc agc gac acc ggt aat acc gaa 48Met Ala Ile Thr Gly Ile Phe Phe Gly Ser Asp Thr Gly Asn Thr Glu1 5 10 15aat atc gca aaa atg att caa aaa cag ctt ggt aaa gac gtt gcc gat 96Asn Ile Ala Lys Met Ile Gln Lys Gln Leu Gly Lys Asp Val Ala Asp 20 25 30gtc cat gac att gca aaa agc agc aaa gaa gat ctg gaa gct tat gac 144Val His Asp Ile Ala Lys Ser Ser Lys Glu Asp Leu Glu Ala Tyr Asp 35 40 45att ctg ctg ctg ggc atc cca acc tgg tat tac ggc gaa gcg cag tgt 192Ile Leu Leu Leu Gly Ile Pro Thr Trp Tyr Tyr Gly Glu Ala Gln Cys 50 55 60gac tgg gat gac ttc ttc ccg act ctc gaa gag att gat ttc aac ggc 240Asp Trp Asp Asp Phe Phe Pro Thr Leu Glu Glu Ile Asp Phe Asn Gly65 70 75 80aaa ctg gtt gcg ctg ttt ggt tgt ggt gac cag gaa gat tac gcc gaa 288Lys Leu Val Ala Leu Phe Gly Cys Gly Asp Gln Glu Asp Tyr Ala Glu 85 90 95 tat ttc tgc gac gca ttg ggc acc atc cgc gac atc att gaa ccg cgc 336Tyr Phe Cys Asp Ala Leu Gly Thr Ile Arg Asp Ile Ile Glu Pro Arg 100 105 110ggt gca acc atc gtt ggt cac tgg cca act gcg ggc tat cat ttc gaa 384Gly Ala Thr Ile Val Gly His Trp Pro Thr Ala Gly Tyr His Phe Glu 115 120 125gca tca aaa ggt ctg gca gat gac gac cac ttt gtc ggt ctg gct atc 432Ala Ser Lys Gly Leu Ala Asp Asp Asp His Phe Val Gly Leu Ala Ile 130 135 140gac gaa gac cgt cag ccg gaa ctg acc gct gaa cgt gta gaa aaa tgg 480Asp Glu Asp Arg Gln Pro Glu Leu Thr Ala Glu Arg Val Glu Lys Trp145

150 155 160gtt aaa cag att tct gaa gag ttg cat ctc gac gaa att ctc aat gcc 528Val Lys Gln Ile Ser Glu Glu Leu His Leu Asp Glu Ile Leu Asn Ala 165 170 175tga 53114176PRTEscherichia coli 14Met Ala Ile Thr Gly Ile Phe Phe Gly Ser Asp Thr Gly Asn Thr Glu1 5 10 15Asn Ile Ala Lys Met Ile Gln Lys Gln Leu Gly Lys Asp Val Ala Asp 20 25 30Val His Asp Ile Ala Lys Ser Ser Lys Glu Asp Leu Glu Ala Tyr Asp 35 40 45Ile Leu Leu Leu Gly Ile Pro Thr Trp Tyr Tyr Gly Glu Ala Gln Cys 50 55 60Asp Trp Asp Asp Phe Phe Pro Thr Leu Glu Glu Ile Asp Phe Asn Gly65 70 75 80Lys Leu Val Ala Leu Phe Gly Cys Gly Asp Gln Glu Asp Tyr Ala Glu 85 90 95Tyr Phe Cys Asp Ala Leu Gly Thr Ile Arg Asp Ile Ile Glu Pro Arg 100 105 110Gly Ala Thr Ile Val Gly His Trp Pro Thr Ala Gly Tyr His Phe Glu 115 120 125Ala Ser Lys Gly Leu Ala Asp Asp Asp His Phe Val Gly Leu Ala Ile 130 135 140Asp Glu Asp Arg Gln Pro Glu Leu Thr Ala Glu Arg Val Glu Lys Trp145 150 155 160Val Lys Gln Ile Ser Glu Glu Leu His Leu Asp Glu Ile Leu Asn Ala 165 170 17515522DNAEscherichia coliCDS(1)..(522) 15atg aat atg ggt ctt ttt tac ggt tcc agc acc tgt tac acc gaa atg 48Met Asn Met Gly Leu Phe Tyr Gly Ser Ser Thr Cys Tyr Thr Glu Met1 5 10 15gcg gca gaa aaa atc cgc gat att atc ggc cca gaa ctg gtg acc tta 96Ala Ala Glu Lys Ile Arg Asp Ile Ile Gly Pro Glu Leu Val Thr Leu 20 25 30cat aac ctc aag gac gac tcc ccg aaa tta atg gag cag tac gat gtg 144His Asn Leu Lys Asp Asp Ser Pro Lys Leu Met Glu Gln Tyr Asp Val 35 40 45ctc att ctg ggt atc ccg acc tgg gat ttt ggt gaa atc cag gaa gac 192Leu Ile Leu Gly Ile Pro Thr Trp Asp Phe Gly Glu Ile Gln Glu Asp 50 55 60tgg gaa gcc gtc tgg gat cag ctc gac gac ctg aac ctt gaa ggt aaa 240Trp Glu Ala Val Trp Asp Gln Leu Asp Asp Leu Asn Leu Glu Gly Lys65 70 75 80att gtt gcg ctg tat ggg ctt ggc gat caa ctg gga tac ggc gag tgg 288Ile Val Ala Leu Tyr Gly Leu Gly Asp Gln Leu Gly Tyr Gly Glu Trp 85 90 95ttc ctc gat gcg ctc ggt atg ctg cat gac aaa ctc tcg acc aaa ggc 336Phe Leu Asp Ala Leu Gly Met Leu His Asp Lys Leu Ser Thr Lys Gly 100 105 110gtg aag ttc gtc ggc tac tgg cca acg gaa gga tat gaa ttt acc agc 384Val Lys Phe Val Gly Tyr Trp Pro Thr Glu Gly Tyr Glu Phe Thr Ser 115 120 125ccg aaa ccg gtg att gct gac ggg caa ctg ttc gtg ggt ctg gcg ctg 432Pro Lys Pro Val Ile Ala Asp Gly Gln Leu Phe Val Gly Leu Ala Leu 130 135 140gat gaa act aac cag tat gac ctt agc gac gag cgt att cag agc tgg 480Asp Glu Thr Asn Gln Tyr Asp Leu Ser Asp Glu Arg Ile Gln Ser Trp145 150 155 160tgc gag caa atc ctc aac gaa atg gca gag cat tac gcc tga 522Cys Glu Gln Ile Leu Asn Glu Met Ala Glu His Tyr Ala 165 17016173PRTEscherichia coli 16Met Asn Met Gly Leu Phe Tyr Gly Ser Ser Thr Cys Tyr Thr Glu Met1 5 10 15Ala Ala Glu Lys Ile Arg Asp Ile Ile Gly Pro Glu Leu Val Thr Leu 20 25 30His Asn Leu Lys Asp Asp Ser Pro Lys Leu Met Glu Gln Tyr Asp Val 35 40 45Leu Ile Leu Gly Ile Pro Thr Trp Asp Phe Gly Glu Ile Gln Glu Asp 50 55 60Trp Glu Ala Val Trp Asp Gln Leu Asp Asp Leu Asn Leu Glu Gly Lys65 70 75 80Ile Val Ala Leu Tyr Gly Leu Gly Asp Gln Leu Gly Tyr Gly Glu Trp 85 90 95Phe Leu Asp Ala Leu Gly Met Leu His Asp Lys Leu Ser Thr Lys Gly 100 105 110Val Lys Phe Val Gly Tyr Trp Pro Thr Glu Gly Tyr Glu Phe Thr Ser 115 120 125 Pro Lys Pro Val Ile Ala Asp Gly Gln Leu Phe Val Gly Leu Ala Leu 130 135 140Asp Glu Thr Asn Gln Tyr Asp Leu Ser Asp Glu Arg Ile Gln Ser Trp145 150 155 160Cys Glu Gln Ile Leu Asn Glu Met Ala Glu His Tyr Ala 165 17017522DNAChlorobium tepidumCDS(1)..(522) 17atg aat atg ggt ctt ttt tac ggt tcc agc acc tgt tac acc gaa atg 48Met Asn Met Gly Leu Phe Tyr Gly Ser Ser Thr Cys Tyr Thr Glu Met1 5 10 15gcg gca gaa aaa atc cgc gat att atc ggc cca gaa ctg gtg acc tta 96Ala Ala Glu Lys Ile Arg Asp Ile Ile Gly Pro Glu Leu Val Thr Leu 20 25 30cat aac ctc aag gac gac tcc ccg aaa tta atg gag cag tac gat gtg 144His Asn Leu Lys Asp Asp Ser Pro Lys Leu Met Glu Gln Tyr Asp Val 35 40 45ctc att ctg ggt atc ccg acc tgg gat ttt ggt gaa atc cag gaa gac 192Leu Ile Leu Gly Ile Pro Thr Trp Asp Phe Gly Glu Ile Gln Glu Asp 50 55 60tgg gaa gcc gtc tgg gat cag ctc gac gac ctg aac ctt gaa ggt aaa 240Trp Glu Ala Val Trp Asp Gln Leu Asp Asp Leu Asn Leu Glu Gly Lys65 70 75 80att gtt gcg ctg tat ggg ctt ggc gat caa ctg gga tac ggc gag tgg 288Ile Val Ala Leu Tyr Gly Leu Gly Asp Gln Leu Gly Tyr Gly Glu Trp 85 90 95ttc ctc gat gcg ctc ggt atg ctg cat gac aaa ctc tcg acc aaa ggc 336Phe Leu Asp Ala Leu Gly Met Leu His Asp Lys Leu Ser Thr Lys Gly 100 105 110gtg aag ttc gtc ggc tac tgg cca acg gaa gga tat gaa ttt acc agc 384Val Lys Phe Val Gly Tyr Trp Pro Thr Glu Gly Tyr Glu Phe Thr Ser 115 120 125ccg aaa ccg gtg att gct gac ggg caa ctg ttc gtg ggt ctg gcg ctg 432Pro Lys Pro Val Ile Ala Asp Gly Gln Leu Phe Val Gly Leu Ala Leu 130 135 140gat gaa act aac cag tat gac ctt agc gac gag cgt att cag agc tgg 480Asp Glu Thr Asn Gln Tyr Asp Leu Ser Asp Glu Arg Ile Gln Ser Trp145 150 155 160tgc gag caa atc ctc aac gaa atg gca gag cat tac gcc tga 522Cys Glu Gln Ile Leu Asn Glu Met Ala Glu His Tyr Ala 165 17018173PRTChlorobium tepidum 18Met Asn Met Gly Leu Phe Tyr Gly Ser Ser Thr Cys Tyr Thr Glu Met1 5 10 15Ala Ala Glu Lys Ile Arg Asp Ile Ile Gly Pro Glu Leu Val Thr Leu 20 25 30His Asn Leu Lys Asp Asp Ser Pro Lys Leu Met Glu Gln Tyr Asp Val 35 40 45Leu Ile Leu Gly Ile Pro Thr Trp Asp Phe Gly Glu Ile Gln Glu Asp 50 55 60Trp Glu Ala Val Trp Asp Gln Leu Asp Asp Leu Asn Leu Glu Gly Lys65 70 75 80Ile Val Ala Leu Tyr Gly Leu Gly Asp Gln Leu Gly Tyr Gly Glu Trp 85 90 95Phe Leu Asp Ala Leu Gly Met Leu His Asp Lys Leu Ser Thr Lys Gly 100 105 110Val Lys Phe Val Gly Tyr Trp Pro Thr Glu Gly Tyr Glu Phe Thr Ser 115 120 125Pro Lys Pro Val Ile Ala Asp Gly Gln Leu Phe Val Gly Leu Ala Leu 130 135 140Asp Glu Thr Asn Gln Tyr Asp Leu Ser Asp Glu Arg Ile Gln Ser Trp145 150 155 160Cys Glu Gln Ile Leu Asn Glu Met Ala Glu His Tyr Ala 165 17019189DNAChlorobium tepidumCDS(1)..(189) 19atg gca ctg tat atc acc gaa gaa tgc acc tac tgc ggt gct tgc gaa 48Met Ala Leu Tyr Ile Thr Glu Glu Cys Thr Tyr Cys Gly Ala Cys Glu1 5 10 15ccc gaa tgc ccg acc aac gct atc tcc gct ggc agc gag atc tac gtt 96Pro Glu Cys Pro Thr Asn Ala Ile Ser Ala Gly Ser Glu Ile Tyr Val 20 25 30atc gat gcc gca tcc tgc aac gag tgc gcc ggt ttt gct gac tct cct 144Ile Asp Ala Ala Ser Cys Asn Glu Cys Ala Gly Phe Ala Asp Ser Pro 35 40 45gct tgc gtt gct gtc tgc ccg gca gag tgc atc gtt cag ggc tga 189Ala Cys Val Ala Val Cys Pro Ala Glu Cys Ile Val Gln Gly 50 55 602062PRTChlorobium tepidum 20Met Ala Leu Tyr Ile Thr Glu Glu Cys Thr Tyr Cys Gly Ala Cys Glu1 5 10 15Pro Glu Cys Pro Thr Asn Ala Ile Ser Ala Gly Ser Glu Ile Tyr Val 20 25 30Ile Asp Ala Ala Ser Cys Asn Glu Cys Ala Gly Phe Ala Asp Ser Pro 35 40 45Ala Cys Val Ala Val Cys Pro Ala Glu Cys Ile Val Gln Gly 50 55 60212676DNAEscherichia coliCDS(1)..(2676) 21atg gct gtt act aat gtc gct gaa ctt aac gca ctc gta gag cgt gta 48Met Ala Val Thr Asn Val Ala Glu Leu Asn Ala Leu Val Glu Arg Val1 5 10 15aaa aaa gcc cag cgt gaa tat gcc agt ttc act caa gag caa gta gac 96Lys Lys Ala Gln Arg Glu Tyr Ala Ser Phe Thr Gln Glu Gln Val Asp 20 25 30aaa atc ttc cgc gcc gcc gct ctg gct gct gca gat gct cga atc cca 144Lys Ile Phe Arg Ala Ala Ala Leu Ala Ala Ala Asp Ala Arg Ile Pro 35 40 45ctc gcg aaa atg gcc gtt gcc gaa tcc ggc atg ggt atc gtc gaa gat 192Leu Ala Lys Met Ala Val Ala Glu Ser Gly Met Gly Ile Val Glu Asp 50 55 60aaa gtg atc aaa aac cac ttt gct tct gaa tat atc tac aac gcc tat 240Lys Val Ile Lys Asn His Phe Ala Ser Glu Tyr Ile Tyr Asn Ala Tyr65 70 75 80aaa gat gaa aaa acc tgt ggt gtt ctg tct gaa gac gac act ttt ggt 288Lys Asp Glu Lys Thr Cys Gly Val Leu Ser Glu Asp Asp Thr Phe Gly 85 90 95acc atc act atc gct gaa cca atc ggt att att tgc ggt atc gtt ccg 336Thr Ile Thr Ile Ala Glu Pro Ile Gly Ile Ile Cys Gly Ile Val Pro 100 105 110acc act aac ccg act tca act gct atc ttc aaa tcg ctg atc agt ctg 384Thr Thr Asn Pro Thr Ser Thr Ala Ile Phe Lys Ser Leu Ile Ser Leu 115 120 125aag acc cgt aac gcc att atc ttc tcc ccg cac ccg cgt gca aaa gat 432Lys Thr Arg Asn Ala Ile Ile Phe Ser Pro His Pro Arg Ala Lys Asp 130 135 140gcc acc aac aaa gcg gct gat atc gtt ctg cag gct gct atc gct gcc 480Ala Thr Asn Lys Ala Ala Asp Ile Val Leu Gln Ala Ala Ile Ala Ala145 150 155 160ggt gct ccg aaa gat ctg atc ggc tgg atc gat caa cct tct gtt gaa 528Gly Ala Pro Lys Asp Leu Ile Gly Trp Ile Asp Gln Pro Ser Val Glu 165 170 175ctg tct aac gca ctg atg cac cac cca gac atc aac ctg atc ctc gcg 576Leu Ser Asn Ala Leu Met His His Pro Asp Ile Asn Leu Ile Leu Ala 180 185 190act ggt ggt ccg ggc atg gtt aaa gcc gca tac agc tcc ggt aaa cca 624Thr Gly Gly Pro Gly Met Val Lys Ala Ala Tyr Ser Ser Gly Lys Pro 195 200 205gct atc ggt gta ggc gcg ggc aac act cca gtt gtt atc gat gaa act 672Ala Ile Gly Val Gly Ala Gly Asn Thr Pro Val Val Ile Asp Glu Thr 210 215 220gct gat atc aaa cgt gca gtt gca tct gta ctg atg tcc aaa acc ttc 720Ala Asp Ile Lys Arg Ala Val Ala Ser Val Leu Met Ser Lys Thr Phe225 230 235 240gac aac ggc gta atc tgt gct tct gaa cag tct gtt gtt gtt gtt gac 768Asp Asn Gly Val Ile Cys Ala Ser Glu Gln Ser Val Val Val Val Asp 245 250 255tct gtt tat gac gct gta cgt gaa cgt ttt gca acc cac ggc ggc tat 816Ser Val Tyr Asp Ala Val Arg Glu Arg Phe Ala Thr His Gly Gly Tyr 260 265 270ctg ttg cag ggt aaa gag ctg aaa gct gtt cag gat gtt atc ctg aaa 864Leu Leu Gln Gly Lys Glu Leu Lys Ala Val Gln Asp Val Ile Leu Lys 275 280 285aac ggt gcg ctg aac gcg gct atc gtt ggt cag cca gcc tat aaa att 912Asn Gly Ala Leu Asn Ala Ala Ile Val Gly Gln Pro Ala Tyr Lys Ile 290 295 300gct gaa ctg gca ggc ttc tct gta cca gaa aac acc aag att ctg atc 960Ala Glu Leu Ala Gly Phe Ser Val Pro Glu Asn Thr Lys Ile Leu Ile305 310 315 320ggt gaa gtg acc gtt gtt gat gaa agc gaa ccg ttc gca cat gaa aaa 1008Gly Glu Val Thr Val Val Asp Glu Ser Glu Pro Phe Ala His Glu Lys 325 330 335ctg tcc ccg act ctg gca atg tac cgc gct aaa gat ttc gaa gac gcg 1056Leu Ser Pro Thr Leu Ala Met Tyr Arg Ala Lys Asp Phe Glu Asp Ala 340 345 350gta gaa aaa gca gag aaa ctg gtt gct atg ggc ggt atc ggt cat acc 1104Val Glu Lys Ala Glu Lys Leu Val Ala Met Gly Gly Ile Gly His Thr 355 360 365tct tgc ctg tac act gac cag gat aac caa ccg gct cgc gtt tct tac 1152Ser Cys Leu Tyr Thr Asp Gln Asp Asn Gln Pro Ala Arg Val Ser Tyr 370 375 380ttc ggt cag aaa atg aaa acg gcg cgt atc ctg att aac acc cca gcg 1200Phe Gly Gln Lys Met Lys Thr Ala Arg Ile Leu Ile Asn Thr Pro Ala385 390 395 400tct cag ggt ggt atc ggt gac ctg tat aac ttc aaa ctc gca cct tcc 1248Ser Gln Gly Gly Ile Gly Asp Leu Tyr Asn Phe Lys Leu Ala Pro Ser 405 410 415ctg act ctg ggt tgt ggt tct tgg ggt ggt aac tcc atc tct gaa aac 1296Leu Thr Leu Gly Cys Gly Ser Trp Gly Gly Asn Ser Ile Ser Glu Asn 420 425 430gtt ggt ccg aaa cac ctg atc aac aag aaa acc gtt gct aag cga gct 1344Val Gly Pro Lys His Leu Ile Asn Lys Lys Thr Val Ala Lys Arg Ala 435 440 445gaa aac atg ttg tgg cac aaa ctt ccg aaa tct atc tac ttc cgc cgt 1392Glu Asn Met Leu Trp His Lys Leu Pro Lys Ser Ile Tyr Phe Arg Arg 450 455 460ggc tcc ctg cca atc gcg ctg gat gaa gtg att act gat ggc cac aaa 1440Gly Ser Leu Pro Ile Ala Leu Asp Glu Val Ile Thr Asp Gly His Lys465 470 475 480cgt gcg ctc atc gtg act gac cgc ttc ctg ttc aac aat ggt tat gct 1488Arg Ala Leu Ile Val Thr Asp Arg Phe Leu Phe Asn Asn Gly Tyr Ala 485 490 495gat cag atc act tcc gta ctg aaa gca gca ggc gtt gaa act gaa gtc 1536Asp Gln Ile Thr Ser Val Leu Lys Ala Ala Gly Val Glu Thr Glu Val 500 505 510ttc ttc gaa gta gaa gcg gac ccg acc ctg agc atc gtt cgt aaa ggt 1584Phe Phe Glu Val Glu Ala Asp Pro Thr Leu Ser Ile Val Arg Lys Gly 515 520 525gca gaa ctg gca aac tcc ttc aaa cca gac gtg att atc gcg ctg ggt 1632Ala Glu Leu Ala Asn Ser Phe Lys Pro Asp Val Ile Ile Ala Leu Gly 530 535 540ggt ggt tcc ccg atg gac gcc gcg aag atc atg tgg gtt atg tac gaa 1680Gly Gly Ser Pro Met Asp Ala Ala Lys Ile Met Trp Val Met Tyr Glu545 550 555 560cat ccg gaa act cac ttc gaa gag ctg gcg ctg cgc ttt atg gat atc 1728His Pro Glu Thr His Phe Glu Glu Leu Ala Leu Arg Phe Met Asp Ile 565 570 575cgt aaa cgt atc tac aag ttc ccg aaa atg ggc gtg aaa gcg aaa atg 1776Arg Lys Arg Ile Tyr Lys Phe Pro Lys Met Gly Val Lys Ala Lys Met 580 585 590atc gct gtc acc acc act tct ggt aca ggt tct gaa gtc act ccg ttt 1824Ile Ala Val Thr Thr Thr Ser Gly Thr Gly Ser Glu Val Thr Pro Phe 595 600 605gcg gtt gta act gac gac gct act ggt cag aaa tat ccg ctg gca gac 1872Ala Val Val Thr Asp Asp Ala Thr Gly Gln Lys Tyr Pro Leu Ala Asp 610 615 620tat gcg ctg act ccg gat atg gcg att gtc gac gcc aac ctg gtt atg 1920Tyr Ala Leu Thr Pro Asp Met Ala Ile Val Asp Ala Asn Leu Val Met625 630 635 640gac atg ccg aag tcc ctg tgt gct ttc ggt ggt ctg gac gca gta act 1968Asp Met Pro Lys Ser Leu Cys Ala Phe Gly Gly Leu Asp Ala Val Thr 645 650 655cac gcc atg gaa gct tat gtt tct gta ctg gca tct gag ttc tct gat 2016His Ala Met Glu Ala Tyr Val Ser Val Leu Ala Ser Glu Phe Ser Asp 660 665 670ggt cag gct ctg cag gca ctg aaa ctg ctg aaa gaa tat ctg cca gcg 2064Gly Gln Ala Leu Gln Ala Leu Lys Leu Leu Lys Glu Tyr Leu Pro Ala 675 680 685tcc tac cac gaa ggg tct aaa aat ccg gta gcg cgt gaa cgt gtt cac 2112Ser Tyr His Glu Gly Ser Lys Asn Pro Val Ala Arg Glu Arg Val His 690 695 700agt gca gcg act atc gcg ggt atc gcg ttt gcg aac gcc ttc ctg ggt 2160Ser Ala Ala Thr Ile Ala Gly Ile Ala Phe Ala Asn Ala Phe Leu Gly705 710

715 720gta tgt cac tca atg gcg cac aaa ctg ggt tcc cag ttc cat att ccg 2208Val Cys His Ser Met Ala His Lys Leu Gly Ser Gln Phe His Ile Pro 725 730 735cac ggt ctg gca aac gcc ctg ctg att tgt aac gtt att cgc tac aat 2256His Gly Leu Ala Asn Ala Leu Leu Ile Cys Asn Val Ile Arg Tyr Asn 740 745 750gcg aac gac aac ccg acc aag cag act gca ttc agc cag tat gac cgt 2304Ala Asn Asp Asn Pro Thr Lys Gln Thr Ala Phe Ser Gln Tyr Asp Arg 755 760 765ccg cag gct cgc cgt cgt tat gct gaa att gcc gac cac ttg ggt ctg 2352Pro Gln Ala Arg Arg Arg Tyr Ala Glu Ile Ala Asp His Leu Gly Leu 770 775 780agc gca ccg ggc gac cgt act gct gct aag atc gag aaa ctg ctg gca 2400Ser Ala Pro Gly Asp Arg Thr Ala Ala Lys Ile Glu Lys Leu Leu Ala785 790 795 800tgg ctg gaa acg ctg aaa gct gaa ctg ggt att ccg aaa tct atc cgt 2448Trp Leu Glu Thr Leu Lys Ala Glu Leu Gly Ile Pro Lys Ser Ile Arg 805 810 815gaa gct ggc gtt cag gaa gca gac ttc ctg gcg aac gtg gat aaa ctg 2496Glu Ala Gly Val Gln Glu Ala Asp Phe Leu Ala Asn Val Asp Lys Leu 820 825 830tct gaa gat gca ttc gat gac cag tgc acc ggc gct aac ccg cgt tac 2544Ser Glu Asp Ala Phe Asp Asp Gln Cys Thr Gly Ala Asn Pro Arg Tyr 835 840 845ccg ctg atc tcc gag ctg aaa cag att ctg ctg gat acc tac tac ggt 2592Pro Leu Ile Ser Glu Leu Lys Gln Ile Leu Leu Asp Thr Tyr Tyr Gly 850 855 860cgt gat tat gta gaa ggt gaa act gca gcg aag aaa gaa gct gct ccg 2640Arg Asp Tyr Val Glu Gly Glu Thr Ala Ala Lys Lys Glu Ala Ala Pro865 870 875 880gct aaa gct gag aaa aaa gcg aaa aaa tcc gct taa 2676Ala Lys Ala Glu Lys Lys Ala Lys Lys Ser Ala 885 89022891PRTEscherichia coli 22Met Ala Val Thr Asn Val Ala Glu Leu Asn Ala Leu Val Glu Arg Val1 5 10 15Lys Lys Ala Gln Arg Glu Tyr Ala Ser Phe Thr Gln Glu Gln Val Asp 20 25 30Lys Ile Phe Arg Ala Ala Ala Leu Ala Ala Ala Asp Ala Arg Ile Pro 35 40 45Leu Ala Lys Met Ala Val Ala Glu Ser Gly Met Gly Ile Val Glu Asp 50 55 60Lys Val Ile Lys Asn His Phe Ala Ser Glu Tyr Ile Tyr Asn Ala Tyr65 70 75 80Lys Asp Glu Lys Thr Cys Gly Val Leu Ser Glu Asp Asp Thr Phe Gly 85 90 95Thr Ile Thr Ile Ala Glu Pro Ile Gly Ile Ile Cys Gly Ile Val Pro 100 105 110Thr Thr Asn Pro Thr Ser Thr Ala Ile Phe Lys Ser Leu Ile Ser Leu 115 120 125Lys Thr Arg Asn Ala Ile Ile Phe Ser Pro His Pro Arg Ala Lys Asp 130 135 140Ala Thr Asn Lys Ala Ala Asp Ile Val Leu Gln Ala Ala Ile Ala Ala145 150 155 160Gly Ala Pro Lys Asp Leu Ile Gly Trp Ile Asp Gln Pro Ser Val Glu 165 170 175Leu Ser Asn Ala Leu Met His His Pro Asp Ile Asn Leu Ile Leu Ala 180 185 190Thr Gly Gly Pro Gly Met Val Lys Ala Ala Tyr Ser Ser Gly Lys Pro 195 200 205Ala Ile Gly Val Gly Ala Gly Asn Thr Pro Val Val Ile Asp Glu Thr 210 215 220Ala Asp Ile Lys Arg Ala Val Ala Ser Val Leu Met Ser Lys Thr Phe225 230 235 240Asp Asn Gly Val Ile Cys Ala Ser Glu Gln Ser Val Val Val Val Asp 245 250 255Ser Val Tyr Asp Ala Val Arg Glu Arg Phe Ala Thr His Gly Gly Tyr 260 265 270Leu Leu Gln Gly Lys Glu Leu Lys Ala Val Gln Asp Val Ile Leu Lys 275 280 285Asn Gly Ala Leu Asn Ala Ala Ile Val Gly Gln Pro Ala Tyr Lys Ile 290 295 300Ala Glu Leu Ala Gly Phe Ser Val Pro Glu Asn Thr Lys Ile Leu Ile305 310 315 320Gly Glu Val Thr Val Val Asp Glu Ser Glu Pro Phe Ala His Glu Lys 325 330 335Leu Ser Pro Thr Leu Ala Met Tyr Arg Ala Lys Asp Phe Glu Asp Ala 340 345 350Val Glu Lys Ala Glu Lys Leu Val Ala Met Gly Gly Ile Gly His Thr 355 360 365Ser Cys Leu Tyr Thr Asp Gln Asp Asn Gln Pro Ala Arg Val Ser Tyr 370 375 380Phe Gly Gln Lys Met Lys Thr Ala Arg Ile Leu Ile Asn Thr Pro Ala385 390 395 400Ser Gln Gly Gly Ile Gly Asp Leu Tyr Asn Phe Lys Leu Ala Pro Ser 405 410 415Leu Thr Leu Gly Cys Gly Ser Trp Gly Gly Asn Ser Ile Ser Glu Asn 420 425 430Val Gly Pro Lys His Leu Ile Asn Lys Lys Thr Val Ala Lys Arg Ala 435 440 445Glu Asn Met Leu Trp His Lys Leu Pro Lys Ser Ile Tyr Phe Arg Arg 450 455 460Gly Ser Leu Pro Ile Ala Leu Asp Glu Val Ile Thr Asp Gly His Lys465 470 475 480Arg Ala Leu Ile Val Thr Asp Arg Phe Leu Phe Asn Asn Gly Tyr Ala 485 490 495Asp Gln Ile Thr Ser Val Leu Lys Ala Ala Gly Val Glu Thr Glu Val 500 505 510Phe Phe Glu Val Glu Ala Asp Pro Thr Leu Ser Ile Val Arg Lys Gly 515 520 525Ala Glu Leu Ala Asn Ser Phe Lys Pro Asp Val Ile Ile Ala Leu Gly 530 535 540Gly Gly Ser Pro Met Asp Ala Ala Lys Ile Met Trp Val Met Tyr Glu545 550 555 560His Pro Glu Thr His Phe Glu Glu Leu Ala Leu Arg Phe Met Asp Ile 565 570 575Arg Lys Arg Ile Tyr Lys Phe Pro Lys Met Gly Val Lys Ala Lys Met 580 585 590Ile Ala Val Thr Thr Thr Ser Gly Thr Gly Ser Glu Val Thr Pro Phe 595 600 605Ala Val Val Thr Asp Asp Ala Thr Gly Gln Lys Tyr Pro Leu Ala Asp 610 615 620Tyr Ala Leu Thr Pro Asp Met Ala Ile Val Asp Ala Asn Leu Val Met625 630 635 640Asp Met Pro Lys Ser Leu Cys Ala Phe Gly Gly Leu Asp Ala Val Thr 645 650 655His Ala Met Glu Ala Tyr Val Ser Val Leu Ala Ser Glu Phe Ser Asp 660 665 670Gly Gln Ala Leu Gln Ala Leu Lys Leu Leu Lys Glu Tyr Leu Pro Ala 675 680 685Ser Tyr His Glu Gly Ser Lys Asn Pro Val Ala Arg Glu Arg Val His 690 695 700Ser Ala Ala Thr Ile Ala Gly Ile Ala Phe Ala Asn Ala Phe Leu Gly705 710 715 720Val Cys His Ser Met Ala His Lys Leu Gly Ser Gln Phe His Ile Pro 725 730 735His Gly Leu Ala Asn Ala Leu Leu Ile Cys Asn Val Ile Arg Tyr Asn 740 745 750Ala Asn Asp Asn Pro Thr Lys Gln Thr Ala Phe Ser Gln Tyr Asp Arg 755 760 765Pro Gln Ala Arg Arg Arg Tyr Ala Glu Ile Ala Asp His Leu Gly Leu 770 775 780Ser Ala Pro Gly Asp Arg Thr Ala Ala Lys Ile Glu Lys Leu Leu Ala785 790 795 800Trp Leu Glu Thr Leu Lys Ala Glu Leu Gly Ile Pro Lys Ser Ile Arg 805 810 815Glu Ala Gly Val Gln Glu Ala Asp Phe Leu Ala Asn Val Asp Lys Leu 820 825 830Ser Glu Asp Ala Phe Asp Asp Gln Cys Thr Gly Ala Asn Pro Arg Tyr 835 840 845Pro Leu Ile Ser Glu Leu Lys Gln Ile Leu Leu Asp Thr Tyr Tyr Gly 850 855 860Arg Asp Tyr Val Glu Gly Glu Thr Ala Ala Lys Lys Glu Ala Ala Pro865 870 875 880Ala Lys Ala Glu Lys Lys Ala Lys Lys Ser Ala 885 8902369DNAArtificialprimer 23cgttattgtt atctagttgt gcaaaacatg ctaatgtagc attacgcccc gccctgccac 60tcatcgcag 692458DNAArtificialprimer 24attagtaaca gccataatgc tctcctgata atgttaaacc gctcacaatt ccacacat 5825183DNAArtificialhybrid promoter 25ctagatctct cacctaccaa acaatgcccc cctgcaaaaa ataaattcat aaaaaacata 60cagataacca tctgcggtga taaattatct ctggcggtgt tgacaattaa tcatcggctc 120gtataatgtg tggaattgtg agcggtttaa cattatcagg agagcattat ggctgttact 180aat 1832624DNAArtificialprimer 26acttgttctt gagtgaaact ggca 242722DNAArtificialprimer 27aagacgcgct gacaatacgc ct 222869DNAArtificialprimer 28cgttattgtt atctagttgt gcaaaacatg ctaatgtagc atcagaaaaa ctcatcgagc 60atcaaatga 692965DNAArtificialprimer 29agccggagca gcttctttct tcgctgcagt ttcaccttct acgttgtgtc tcaaaatctc 60tgatg 653024DNAArtificialprimer 30aagacgcgct gacaatacgc cttt 243124DNAArtificialprimer 31aaggggccgt ttatgttgcc agac 243269DNAArtificialprimer 32catgtgggtt atgtacgaac atccggaaac tcacttcgaa aagctggcgc tgcgctttat 60ggatatccg 693324DNAArtificialprimer 33aaggggccgt ttatgttgcc agac 243424DNAArtificialprimer 34aagacgcgct gacaatacgc cttt 243551DNAArtificialprimer 35ttttctagat aaggaggaat gacgtatgac ccggacattc aagacaatgg a 513639DNAArtificialprimer 36aaatctagat tcagcttatg cttcgccttc aatcgaacg 3937344DNAEscherichia coli 37aagctttacg cgaacgagcc atgacattgc tgacgactct ggcagtggca gatgacataa 60aactggtcga ctggttacaa caacgcctgg ggcttttaga gcaacgagac acggcaatgt 120tgcaccgttt gctgcatgat attgaaaaaa atatcaccaa ataaaaaacg ccttagtaag 180tatttttcag cttttcattc tgactgcaac gggcaatatg tctctgtgtg gattaaaaaa 240agagtgtctg atagcagctt ctgaactggt tacctgccgt gagtaaatta aaattttatt 300gacttaggtc actaaatact ttaaccaata taggcgactc taga 3443853DNAArtificialprimer 38ttttctggta cctaaggagg aatgacgtat gattactatt gacggtaatg gcg 533940DNAArtificialprimer 39gagagaccgg gtaccttaat cggtgttgct tttttccgct 404049DNAArtificialprimer 40aattggtacc taaggaggaa tgacgtatga ccagtggccc aaaaccggc 494142DNAArtificialprimer 41gcgacgccta gcttagggta ccttaccatg cctcgatatt gt 424235DNAArtificialprimer 42ctctctggcc ccgggctgat tgatttgatc gattg 354333DNAArtificialprimer 43gagagacccc gggttaccag taatgctccg ctg 334430DNAArtificialprimer 44gcgcgaattc gggcgatgat gttgacgcca 304530DNAArtificialprimer 45gcgcgaattc gtcccatact aacctctgtt 30462664DNAEscherichia coliCDS(1)..(2664) 46atg tca gaa cgt ttc cca aat gac gtg gat ccg atc gaa act cgc gac 48Met Ser Glu Arg Phe Pro Asn Asp Val Asp Pro Ile Glu Thr Arg Asp1 5 10 15tgg ctc cag gcg atc gaa tcg gtc atc cgt gaa gaa ggt gtt gag cgt 96Trp Leu Gln Ala Ile Glu Ser Val Ile Arg Glu Glu Gly Val Glu Arg 20 25 30gct cag tat ctg atc gac caa ctg ctt gct gaa gcc cgc aaa ggc ggt 144Ala Gln Tyr Leu Ile Asp Gln Leu Leu Ala Glu Ala Arg Lys Gly Gly 35 40 45gta aac gta gcc gca ggc aca ggt atc agc aac tac atc aac acc atc 192Val Asn Val Ala Ala Gly Thr Gly Ile Ser Asn Tyr Ile Asn Thr Ile 50 55 60ccc gtt gaa gaa caa ccg gag tat ccg ggt aat ctg gaa ctg gaa cgc 240Pro Val Glu Glu Gln Pro Glu Tyr Pro Gly Asn Leu Glu Leu Glu Arg65 70 75 80cgt att cgt tca gct atc cgc tgg aac gcc atc atg acg gtg ctg cgt 288Arg Ile Arg Ser Ala Ile Arg Trp Asn Ala Ile Met Thr Val Leu Arg 85 90 95gcg tcg aaa aaa gac ctc gaa ctg ggc ggc cat atg gcg tcc ttc cag 336Ala Ser Lys Lys Asp Leu Glu Leu Gly Gly His Met Ala Ser Phe Gln 100 105 110tct tcc gca acc att tat gat gtg tgc ttt aac cac ttc ttc cgt gca 384Ser Ser Ala Thr Ile Tyr Asp Val Cys Phe Asn His Phe Phe Arg Ala 115 120 125cgc aac gag cag gat ggc ggc gac ctg gtt tac ttc cag ggc cac atc 432Arg Asn Glu Gln Asp Gly Gly Asp Leu Val Tyr Phe Gln Gly His Ile 130 135 140tcc ccg ggc gtg tac gct cgt gct ttc ctg gaa ggt cgt ctg act cag 480Ser Pro Gly Val Tyr Ala Arg Ala Phe Leu Glu Gly Arg Leu Thr Gln145 150 155 160gag cag ctg gat aac ttc cgt cag gaa gtt cac ggc aat ggc ctc tct 528Glu Gln Leu Asp Asn Phe Arg Gln Glu Val His Gly Asn Gly Leu Ser 165 170 175tcc tat ccg cac ccg aaa ctg atg ccg gaa ttc tgg cag ttc ccg acc 576Ser Tyr Pro His Pro Lys Leu Met Pro Glu Phe Trp Gln Phe Pro Thr 180 185 190gta tct atg ggt ctg ggt ccg att ggt gct att tac cag gct aaa ttc 624Val Ser Met Gly Leu Gly Pro Ile Gly Ala Ile Tyr Gln Ala Lys Phe 195 200 205ctg aaa tat ctg gaa cac cgt ggc ctg aaa gat acc tct aaa caa acc 672Leu Lys Tyr Leu Glu His Arg Gly Leu Lys Asp Thr Ser Lys Gln Thr 210 215 220gtt tac gcg ttc ctc ggt gac ggt gaa atg gac gaa ccg gaa tcc aaa 720Val Tyr Ala Phe Leu Gly Asp Gly Glu Met Asp Glu Pro Glu Ser Lys225 230 235 240ggt gcg atc acc atc gct acc cgt gaa aaa ctg gat aac ctg gtc ttc 768Gly Ala Ile Thr Ile Ala Thr Arg Glu Lys Leu Asp Asn Leu Val Phe 245 250 255gtt atc aac tgt aac ctg cag cgt ctt gac ggc ccg gtc acc ggt aac 816Val Ile Asn Cys Asn Leu Gln Arg Leu Asp Gly Pro Val Thr Gly Asn 260 265 270ggc aag atc atc aac gaa ctg gaa ggc atc ttc gaa ggt gct ggc tgg 864Gly Lys Ile Ile Asn Glu Leu Glu Gly Ile Phe Glu Gly Ala Gly Trp 275 280 285aac gtg atc aaa gtg atg tgg ggt agc cgt tgg gat gaa ctg ctg cgt 912Asn Val Ile Lys Val Met Trp Gly Ser Arg Trp Asp Glu Leu Leu Arg 290 295 300aag gat acc agc ggt aaa ctg atc cag ctg atg aac gaa acc gtt gac 960Lys Asp Thr Ser Gly Lys Leu Ile Gln Leu Met Asn Glu Thr Val Asp305 310 315 320ggc gac tac cag acc ttc aaa tcg aaa gat ggt gcg tac gtt cgt gaa 1008Gly Asp Tyr Gln Thr Phe Lys Ser Lys Asp Gly Ala Tyr Val Arg Glu 325 330 335cac ttc ttc ggt aaa tat cct gaa acc gca gca ctg gtt gca gac tgg 1056His Phe Phe Gly Lys Tyr Pro Glu Thr Ala Ala Leu Val Ala Asp Trp 340 345 350act gac gag cag atc tgg gca ctg aac cgt ggt ggt cac gat ccg aag 1104Thr Asp Glu Gln Ile Trp Ala Leu Asn Arg Gly Gly His Asp Pro Lys 355 360 365aaa atc tac gct gca ttc aag aaa gcg cag gaa acc aaa ggc aaa gcg 1152Lys Ile Tyr Ala Ala Phe Lys Lys Ala Gln Glu Thr Lys Gly Lys Ala 370 375 380aca gta atc ctt gct cat acc att aaa ggt tac ggc atg ggc gac gcg 1200Thr Val Ile Leu Ala His Thr Ile Lys Gly Tyr Gly Met Gly Asp Ala385 390 395 400gct gaa ggt aaa aac atc gcg cac cag gtt aag aaa atg aac atg gac 1248Ala Glu Gly Lys Asn Ile Ala His Gln Val Lys Lys Met Asn Met Asp 405 410 415ggt gtg cgt cat atc cgc gac cgt ttc aat gtg ccg gtg tct gat gca 1296Gly Val Arg His Ile Arg Asp Arg Phe Asn Val Pro Val Ser Asp Ala 420 425 430gat atc gaa aaa ctg ccg tac atc acc ttc ccg gaa ggt tct gaa gag 1344Asp Ile Glu Lys Leu Pro Tyr Ile Thr Phe Pro Glu Gly Ser Glu Glu 435 440 445cat acc tat ctg cac gct cag cgt cag aaa ctg cac ggt tat ctg cca 1392His Thr Tyr Leu His Ala Gln Arg Gln Lys Leu His Gly Tyr Leu Pro 450 455 460agc cgt cag ccg aac ttc acc gag aag ctt gag ctg ccg agc ctg caa 1440Ser Arg Gln Pro Asn Phe Thr Glu Lys Leu Glu Leu Pro Ser Leu Gln465 470 475 480gac ttc ggc gcg ctg ttg gaa gag cag agc aaa gag atc tct acc act 1488Asp Phe Gly Ala Leu Leu Glu Glu Gln Ser Lys Glu Ile Ser Thr Thr 485 490 495atc gct ttc gtt cgt gct ctg aac gtg atg ctg aag aac aag tcg atc 1536Ile Ala Phe Val Arg Ala Leu Asn Val Met Leu Lys Asn Lys Ser Ile 500 505 510aaa gat cgt ctg gta ccg atc atc gcc gac gaa gcg cgt act ttc ggt 1584Lys Asp Arg Leu Val Pro Ile Ile Ala Asp Glu Ala Arg Thr Phe Gly 515 520 525atg gaa ggt ctg ttc cgt cag att ggt att tac agc ccg aac ggt cag 1632Met Glu

Gly Leu Phe Arg Gln Ile Gly Ile Tyr Ser Pro Asn Gly Gln 530 535 540cag tac acc ccg cag gac cgc gag cag gtt gct tac tat aaa gaa gac 1680Gln Tyr Thr Pro Gln Asp Arg Glu Gln Val Ala Tyr Tyr Lys Glu Asp545 550 555 560gag aaa ggt cag att ctg cag gaa ggg atc aac gag ctg ggc gca ggt 1728Glu Lys Gly Gln Ile Leu Gln Glu Gly Ile Asn Glu Leu Gly Ala Gly 565 570 575tgt tcc tgg ctg gca gcg gcg acc tct tac agc acc aac aat ctg ccg 1776Cys Ser Trp Leu Ala Ala Ala Thr Ser Tyr Ser Thr Asn Asn Leu Pro 580 585 590atg atc ccg ttc tac atc tat tac tcg atg ttc ggc ttc cag cgt att 1824Met Ile Pro Phe Tyr Ile Tyr Tyr Ser Met Phe Gly Phe Gln Arg Ile 595 600 605ggc gat ctg tgc tgg gcg gct ggc gac cag caa gcg cgt ggc ttc ctg 1872Gly Asp Leu Cys Trp Ala Ala Gly Asp Gln Gln Ala Arg Gly Phe Leu 610 615 620atc ggc ggt act tcc ggt cgt acc acc ctg aac ggc gaa ggt ctg cag 1920Ile Gly Gly Thr Ser Gly Arg Thr Thr Leu Asn Gly Glu Gly Leu Gln625 630 635 640cac gaa gat ggt cac agc cac att cag tcg ctg act atc ccg aac tgt 1968His Glu Asp Gly His Ser His Ile Gln Ser Leu Thr Ile Pro Asn Cys 645 650 655atc tct tac gac ccg gct tac gct tac gaa gtt gct gtc atc atg cat 2016Ile Ser Tyr Asp Pro Ala Tyr Ala Tyr Glu Val Ala Val Ile Met His 660 665 670gac ggt ctg gag cgt atg tac ggt gaa aaa caa gag aac gtt tac tac 2064Asp Gly Leu Glu Arg Met Tyr Gly Glu Lys Gln Glu Asn Val Tyr Tyr 675 680 685tac atc act acg ctg aac gaa aac tac cac atg ccg gca atg ccg gaa 2112Tyr Ile Thr Thr Leu Asn Glu Asn Tyr His Met Pro Ala Met Pro Glu 690 695 700ggt gct gag gaa ggt atc cgt aaa ggt atc tac aaa ctc gaa act att 2160Gly Ala Glu Glu Gly Ile Arg Lys Gly Ile Tyr Lys Leu Glu Thr Ile705 710 715 720gaa ggt agc aaa ggt aaa gtt cag ctg ctc ggc tcc ggt tct atc ctg 2208Glu Gly Ser Lys Gly Lys Val Gln Leu Leu Gly Ser Gly Ser Ile Leu 725 730 735cgt cac gtc cgt gaa gca gct gag atc ctg gcg aaa gat tac ggc gta 2256Arg His Val Arg Glu Ala Ala Glu Ile Leu Ala Lys Asp Tyr Gly Val 740 745 750ggt tct gac gtt tat agc gtg acc tcc ttc acc gag ctg gcg cgt gat 2304Gly Ser Asp Val Tyr Ser Val Thr Ser Phe Thr Glu Leu Ala Arg Asp 755 760 765ggt cag gat tgt gaa cgc tgg aac atg ctg cac ccg ctg gaa act ccg 2352Gly Gln Asp Cys Glu Arg Trp Asn Met Leu His Pro Leu Glu Thr Pro 770 775 780cgc gtt ccg tat atc gct cag gtg atg aac gac gct ccg gca gtg gca 2400Arg Val Pro Tyr Ile Ala Gln Val Met Asn Asp Ala Pro Ala Val Ala785 790 795 800tct acc gac tat atg aaa ctg ttc gct gag cag gtc cgt act tac gta 2448Ser Thr Asp Tyr Met Lys Leu Phe Ala Glu Gln Val Arg Thr Tyr Val 805 810 815ccg gct gac gac tac cgc gta ctg ggt act gat ggc ttc ggt cgt tcc 2496Pro Ala Asp Asp Tyr Arg Val Leu Gly Thr Asp Gly Phe Gly Arg Ser 820 825 830gac agc cgt gag aac ctg cgt cac cac ttc gaa gtt gat gct tct tat 2544Asp Ser Arg Glu Asn Leu Arg His His Phe Glu Val Asp Ala Ser Tyr 835 840 845gtc gtg gtt gcg gcg ctg ggc gaa ctg gct aaa cgt ggc gaa atc gat 2592Val Val Val Ala Ala Leu Gly Glu Leu Ala Lys Arg Gly Glu Ile Asp 850 855 860aag aaa gtg gtt gct gac gca atc gcc aaa ttc aac atc gat gca gat 2640Lys Lys Val Val Ala Asp Ala Ile Ala Lys Phe Asn Ile Asp Ala Asp865 870 875 880aaa gtt aac ccg cgt ctg gcg taa 2664Lys Val Asn Pro Arg Leu Ala 88547887PRTEscherichia coli 47Met Ser Glu Arg Phe Pro Asn Asp Val Asp Pro Ile Glu Thr Arg Asp1 5 10 15Trp Leu Gln Ala Ile Glu Ser Val Ile Arg Glu Glu Gly Val Glu Arg 20 25 30Ala Gln Tyr Leu Ile Asp Gln Leu Leu Ala Glu Ala Arg Lys Gly Gly 35 40 45Val Asn Val Ala Ala Gly Thr Gly Ile Ser Asn Tyr Ile Asn Thr Ile 50 55 60Pro Val Glu Glu Gln Pro Glu Tyr Pro Gly Asn Leu Glu Leu Glu Arg65 70 75 80Arg Ile Arg Ser Ala Ile Arg Trp Asn Ala Ile Met Thr Val Leu Arg 85 90 95Ala Ser Lys Lys Asp Leu Glu Leu Gly Gly His Met Ala Ser Phe Gln 100 105 110Ser Ser Ala Thr Ile Tyr Asp Val Cys Phe Asn His Phe Phe Arg Ala 115 120 125Arg Asn Glu Gln Asp Gly Gly Asp Leu Val Tyr Phe Gln Gly His Ile 130 135 140Ser Pro Gly Val Tyr Ala Arg Ala Phe Leu Glu Gly Arg Leu Thr Gln145 150 155 160Glu Gln Leu Asp Asn Phe Arg Gln Glu Val His Gly Asn Gly Leu Ser 165 170 175Ser Tyr Pro His Pro Lys Leu Met Pro Glu Phe Trp Gln Phe Pro Thr 180 185 190Val Ser Met Gly Leu Gly Pro Ile Gly Ala Ile Tyr Gln Ala Lys Phe 195 200 205Leu Lys Tyr Leu Glu His Arg Gly Leu Lys Asp Thr Ser Lys Gln Thr 210 215 220Val Tyr Ala Phe Leu Gly Asp Gly Glu Met Asp Glu Pro Glu Ser Lys225 230 235 240Gly Ala Ile Thr Ile Ala Thr Arg Glu Lys Leu Asp Asn Leu Val Phe 245 250 255Val Ile Asn Cys Asn Leu Gln Arg Leu Asp Gly Pro Val Thr Gly Asn 260 265 270Gly Lys Ile Ile Asn Glu Leu Glu Gly Ile Phe Glu Gly Ala Gly Trp 275 280 285Asn Val Ile Lys Val Met Trp Gly Ser Arg Trp Asp Glu Leu Leu Arg 290 295 300Lys Asp Thr Ser Gly Lys Leu Ile Gln Leu Met Asn Glu Thr Val Asp305 310 315 320Gly Asp Tyr Gln Thr Phe Lys Ser Lys Asp Gly Ala Tyr Val Arg Glu 325 330 335His Phe Phe Gly Lys Tyr Pro Glu Thr Ala Ala Leu Val Ala Asp Trp 340 345 350Thr Asp Glu Gln Ile Trp Ala Leu Asn Arg Gly Gly His Asp Pro Lys 355 360 365Lys Ile Tyr Ala Ala Phe Lys Lys Ala Gln Glu Thr Lys Gly Lys Ala 370 375 380Thr Val Ile Leu Ala His Thr Ile Lys Gly Tyr Gly Met Gly Asp Ala385 390 395 400Ala Glu Gly Lys Asn Ile Ala His Gln Val Lys Lys Met Asn Met Asp 405 410 415Gly Val Arg His Ile Arg Asp Arg Phe Asn Val Pro Val Ser Asp Ala 420 425 430Asp Ile Glu Lys Leu Pro Tyr Ile Thr Phe Pro Glu Gly Ser Glu Glu 435 440 445His Thr Tyr Leu His Ala Gln Arg Gln Lys Leu His Gly Tyr Leu Pro 450 455 460Ser Arg Gln Pro Asn Phe Thr Glu Lys Leu Glu Leu Pro Ser Leu Gln465 470 475 480Asp Phe Gly Ala Leu Leu Glu Glu Gln Ser Lys Glu Ile Ser Thr Thr 485 490 495Ile Ala Phe Val Arg Ala Leu Asn Val Met Leu Lys Asn Lys Ser Ile 500 505 510Lys Asp Arg Leu Val Pro Ile Ile Ala Asp Glu Ala Arg Thr Phe Gly 515 520 525Met Glu Gly Leu Phe Arg Gln Ile Gly Ile Tyr Ser Pro Asn Gly Gln 530 535 540Gln Tyr Thr Pro Gln Asp Arg Glu Gln Val Ala Tyr Tyr Lys Glu Asp545 550 555 560Glu Lys Gly Gln Ile Leu Gln Glu Gly Ile Asn Glu Leu Gly Ala Gly 565 570 575Cys Ser Trp Leu Ala Ala Ala Thr Ser Tyr Ser Thr Asn Asn Leu Pro 580 585 590Met Ile Pro Phe Tyr Ile Tyr Tyr Ser Met Phe Gly Phe Gln Arg Ile 595 600 605Gly Asp Leu Cys Trp Ala Ala Gly Asp Gln Gln Ala Arg Gly Phe Leu 610 615 620Ile Gly Gly Thr Ser Gly Arg Thr Thr Leu Asn Gly Glu Gly Leu Gln625 630 635 640His Glu Asp Gly His Ser His Ile Gln Ser Leu Thr Ile Pro Asn Cys 645 650 655Ile Ser Tyr Asp Pro Ala Tyr Ala Tyr Glu Val Ala Val Ile Met His 660 665 670Asp Gly Leu Glu Arg Met Tyr Gly Glu Lys Gln Glu Asn Val Tyr Tyr 675 680 685Tyr Ile Thr Thr Leu Asn Glu Asn Tyr His Met Pro Ala Met Pro Glu 690 695 700Gly Ala Glu Glu Gly Ile Arg Lys Gly Ile Tyr Lys Leu Glu Thr Ile705 710 715 720Glu Gly Ser Lys Gly Lys Val Gln Leu Leu Gly Ser Gly Ser Ile Leu 725 730 735Arg His Val Arg Glu Ala Ala Glu Ile Leu Ala Lys Asp Tyr Gly Val 740 745 750Gly Ser Asp Val Tyr Ser Val Thr Ser Phe Thr Glu Leu Ala Arg Asp 755 760 765Gly Gln Asp Cys Glu Arg Trp Asn Met Leu His Pro Leu Glu Thr Pro 770 775 780Arg Val Pro Tyr Ile Ala Gln Val Met Asn Asp Ala Pro Ala Val Ala785 790 795 800Ser Thr Asp Tyr Met Lys Leu Phe Ala Glu Gln Val Arg Thr Tyr Val 805 810 815Pro Ala Asp Asp Tyr Arg Val Leu Gly Thr Asp Gly Phe Gly Arg Ser 820 825 830Asp Ser Arg Glu Asn Leu Arg His His Phe Glu Val Asp Ala Ser Tyr 835 840 845Val Val Val Ala Ala Leu Gly Glu Leu Ala Lys Arg Gly Glu Ile Asp 850 855 860Lys Lys Val Val Ala Asp Ala Ile Ala Lys Phe Asn Ile Asp Ala Asp865 870 875 880Lys Val Asn Pro Arg Leu Ala 885 481893DNAEscherichia coliCDS(1)..(1893) 48atg gct atc gaa atc aaa gta ccg gac atc ggg gct gat gaa gtt gaa 48Met Ala Ile Glu Ile Lys Val Pro Asp Ile Gly Ala Asp Glu Val Glu1 5 10 15atc acc gag atc ctg gtc aaa gtg ggc gac aaa gtt gaa gcc gaa cag 96Ile Thr Glu Ile Leu Val Lys Val Gly Asp Lys Val Glu Ala Glu Gln 20 25 30tcg ctg atc acc gta gaa ggc gac aaa gcc tct atg gaa gtt ccg tct 144Ser Leu Ile Thr Val Glu Gly Asp Lys Ala Ser Met Glu Val Pro Ser 35 40 45ccg cag gcg ggt atc gtt aaa gag atc aaa gtc tct gtt ggc gat aaa 192Pro Gln Ala Gly Ile Val Lys Glu Ile Lys Val Ser Val Gly Asp Lys 50 55 60acc cag acc ggc gca ctg att atg att ttc gat tcc gcc gac ggt gca 240Thr Gln Thr Gly Ala Leu Ile Met Ile Phe Asp Ser Ala Asp Gly Ala65 70 75 80gca gac gct gca cct gct cag gca gaa gag aag aaa gaa gca gct ccg 288Ala Asp Ala Ala Pro Ala Gln Ala Glu Glu Lys Lys Glu Ala Ala Pro 85 90 95gca gca gca cca gcg gct gcg gcg gca aaa gac gtt aac gtt ccg gat 336Ala Ala Ala Pro Ala Ala Ala Ala Ala Lys Asp Val Asn Val Pro Asp 100 105 110atc ggc agc gac gaa gtt gaa gtg acc gaa atc ctg gtg aaa gtt ggc 384Ile Gly Ser Asp Glu Val Glu Val Thr Glu Ile Leu Val Lys Val Gly 115 120 125gat aaa gtt gaa gct gaa cag tcg ctg atc acc gta gaa ggc gac aag 432Asp Lys Val Glu Ala Glu Gln Ser Leu Ile Thr Val Glu Gly Asp Lys 130 135 140gct tct atg gaa gtt ccg gct ccg ttt gct ggc acc gtg aaa gag atc 480Ala Ser Met Glu Val Pro Ala Pro Phe Ala Gly Thr Val Lys Glu Ile145 150 155 160aaa gtg aac gtg ggt gac aaa gtg tct acc ggc tcg ctg att atg gtc 528Lys Val Asn Val Gly Asp Lys Val Ser Thr Gly Ser Leu Ile Met Val 165 170 175ttc gaa gtc gcg ggt gaa gca ggc gcg gca gct ccg gcc gct aaa cag 576Phe Glu Val Ala Gly Glu Ala Gly Ala Ala Ala Pro Ala Ala Lys Gln 180 185 190gaa gca gct ccg gca gcg gcc cct gca cca gcg gct ggc gtg aaa gaa 624Glu Ala Ala Pro Ala Ala Ala Pro Ala Pro Ala Ala Gly Val Lys Glu 195 200 205gtt aac gtt ccg gat atc ggc ggt gac gaa gtt gaa gtg act gaa gtg 672Val Asn Val Pro Asp Ile Gly Gly Asp Glu Val Glu Val Thr Glu Val 210 215 220atg gtg aaa gtg ggc gac aaa gtt gcc gct gaa cag tca ctg atc acc 720Met Val Lys Val Gly Asp Lys Val Ala Ala Glu Gln Ser Leu Ile Thr225 230 235 240gta gaa ggc gac aaa gct tct atg gaa gtt ccg gcg ccg ttt gca ggc 768Val Glu Gly Asp Lys Ala Ser Met Glu Val Pro Ala Pro Phe Ala Gly 245 250 255gtc gtg aag gaa ctg aaa gtc aac gtt ggc gat aaa gtg aaa act ggc 816Val Val Lys Glu Leu Lys Val Asn Val Gly Asp Lys Val Lys Thr Gly 260 265 270tcg ctg att atg atc ttc gaa gtt gaa ggc gca gcg cct gcg gca gct 864Ser Leu Ile Met Ile Phe Glu Val Glu Gly Ala Ala Pro Ala Ala Ala 275 280 285cct gcg aaa cag gaa gcg gca gcg ccg gca ccg gca gca aaa gct gaa 912Pro Ala Lys Gln Glu Ala Ala Ala Pro Ala Pro Ala Ala Lys Ala Glu 290 295 300gcc ccg gca gca gca cca gct gcg aaa gcg gaa ggc aaa tct gaa ttt 960Ala Pro Ala Ala Ala Pro Ala Ala Lys Ala Glu Gly Lys Ser Glu Phe305 310 315 320gct gaa aac gac gct tat gtt cac gcg act ccg ctg atc cgc cgt ctg 1008Ala Glu Asn Asp Ala Tyr Val His Ala Thr Pro Leu Ile Arg Arg Leu 325 330 335gca cgc gag ttt ggt gtt aac ctt gcg aaa gtg aag ggc act ggc cgt 1056Ala Arg Glu Phe Gly Val Asn Leu Ala Lys Val Lys Gly Thr Gly Arg 340 345 350aaa ggt cgt atc ctg cgc gaa gac gtt cag gct tac gtg aaa gaa gct 1104Lys Gly Arg Ile Leu Arg Glu Asp Val Gln Ala Tyr Val Lys Glu Ala 355 360 365atc aaa cgt gca gaa gca gct ccg gca gcg act ggc ggt ggt atc cct 1152Ile Lys Arg Ala Glu Ala Ala Pro Ala Ala Thr Gly Gly Gly Ile Pro 370 375 380ggc atg ctg ccg tgg ccg aag gtg gac ttc agc aag ttt ggt gaa atc 1200Gly Met Leu Pro Trp Pro Lys Val Asp Phe Ser Lys Phe Gly Glu Ile385 390 395 400gaa gaa gtg gaa ctg ggc cgc atc cag aaa atc tct ggt gcg aac ctg 1248Glu Glu Val Glu Leu Gly Arg Ile Gln Lys Ile Ser Gly Ala Asn Leu 405 410 415agc cgt aac tgg gta atg atc ccg cat gtt act cac ttc gac aaa acc 1296Ser Arg Asn Trp Val Met Ile Pro His Val Thr His Phe Asp Lys Thr 420 425 430gat atc acc gag ttg gaa gcg ttc cgt aaa cag cag aac gaa gaa gcg 1344Asp Ile Thr Glu Leu Glu Ala Phe Arg Lys Gln Gln Asn Glu Glu Ala 435 440 445gcg aaa cgt aag ctg gat gtg aag atc acc ccg gtt gtc ttc atc atg 1392Ala Lys Arg Lys Leu Asp Val Lys Ile Thr Pro Val Val Phe Ile Met 450 455 460aaa gcc gtt gct gca gct ctt gag cag atg cct cgc ttc aat agt tcg 1440Lys Ala Val Ala Ala Ala Leu Glu Gln Met Pro Arg Phe Asn Ser Ser465 470 475 480ctg tcg gaa gac ggt cag cgt ctg acc ctg aag aaa tac atc aac atc 1488Leu Ser Glu Asp Gly Gln Arg Leu Thr Leu Lys Lys Tyr Ile Asn Ile 485 490 495ggt gtg gcg gtg gat acc ccg aac ggt ctg gtt gtt ccg gta ttc aaa 1536Gly Val Ala Val Asp Thr Pro Asn Gly Leu Val Val Pro Val Phe Lys 500 505 510gac gtc aac aag aaa ggc atc atc gag ctg tct cgc gag ctg atg act 1584Asp Val Asn Lys Lys Gly Ile Ile Glu Leu Ser Arg Glu Leu Met Thr 515 520 525att tct aag aaa gcg cgt gac ggt aag ctg act gcg ggc gaa atg cag 1632Ile Ser Lys Lys Ala Arg Asp Gly Lys Leu Thr Ala Gly Glu Met Gln 530 535 540ggc ggt tgc ttc acc atc tcc agc atc ggc ggc ctg ggt act acc cac 1680Gly Gly Cys Phe Thr Ile Ser Ser Ile Gly Gly Leu Gly Thr Thr His545 550 555 560ttc gcg ccg att gtg aac gcg ccg gaa gtg gct atc ctc ggc gtt tcc 1728Phe Ala Pro Ile Val Asn Ala Pro Glu Val Ala Ile Leu Gly Val Ser 565 570 575aag tcc gcg atg gag ccg gtg tgg aat ggt aaa gag ttc gtg ccg cgt 1776Lys Ser Ala Met Glu Pro Val Trp Asn Gly Lys Glu Phe Val Pro Arg 580 585 590ctg atg ctg ccg att tct ctc tcc ttc gac cac cgc gtg atc gac ggt 1824Leu Met Leu Pro Ile Ser Leu Ser Phe Asp His Arg Val Ile Asp Gly 595 600 605gct gat ggt gcc cgt ttc att acc atc att aac aac acg ctg tct gac 1872Ala Asp Gly Ala Arg Phe Ile Thr Ile Ile Asn Asn Thr Leu Ser Asp 610 615 620att cgc cgt ctg gtg atg taa

1893Ile Arg Arg Leu Val Met625 63049630PRTEscherichia coli 49Met Ala Ile Glu Ile Lys Val Pro Asp Ile Gly Ala Asp Glu Val Glu1 5 10 15Ile Thr Glu Ile Leu Val Lys Val Gly Asp Lys Val Glu Ala Glu Gln 20 25 30Ser Leu Ile Thr Val Glu Gly Asp Lys Ala Ser Met Glu Val Pro Ser 35 40 45Pro Gln Ala Gly Ile Val Lys Glu Ile Lys Val Ser Val Gly Asp Lys 50 55 60Thr Gln Thr Gly Ala Leu Ile Met Ile Phe Asp Ser Ala Asp Gly Ala65 70 75 80Ala Asp Ala Ala Pro Ala Gln Ala Glu Glu Lys Lys Glu Ala Ala Pro 85 90 95Ala Ala Ala Pro Ala Ala Ala Ala Ala Lys Asp Val Asn Val Pro Asp 100 105 110Ile Gly Ser Asp Glu Val Glu Val Thr Glu Ile Leu Val Lys Val Gly 115 120 125Asp Lys Val Glu Ala Glu Gln Ser Leu Ile Thr Val Glu Gly Asp Lys 130 135 140Ala Ser Met Glu Val Pro Ala Pro Phe Ala Gly Thr Val Lys Glu Ile145 150 155 160Lys Val Asn Val Gly Asp Lys Val Ser Thr Gly Ser Leu Ile Met Val 165 170 175Phe Glu Val Ala Gly Glu Ala Gly Ala Ala Ala Pro Ala Ala Lys Gln 180 185 190Glu Ala Ala Pro Ala Ala Ala Pro Ala Pro Ala Ala Gly Val Lys Glu 195 200 205Val Asn Val Pro Asp Ile Gly Gly Asp Glu Val Glu Val Thr Glu Val 210 215 220Met Val Lys Val Gly Asp Lys Val Ala Ala Glu Gln Ser Leu Ile Thr225 230 235 240Val Glu Gly Asp Lys Ala Ser Met Glu Val Pro Ala Pro Phe Ala Gly 245 250 255Val Val Lys Glu Leu Lys Val Asn Val Gly Asp Lys Val Lys Thr Gly 260 265 270Ser Leu Ile Met Ile Phe Glu Val Glu Gly Ala Ala Pro Ala Ala Ala 275 280 285Pro Ala Lys Gln Glu Ala Ala Ala Pro Ala Pro Ala Ala Lys Ala Glu 290 295 300Ala Pro Ala Ala Ala Pro Ala Ala Lys Ala Glu Gly Lys Ser Glu Phe305 310 315 320Ala Glu Asn Asp Ala Tyr Val His Ala Thr Pro Leu Ile Arg Arg Leu 325 330 335Ala Arg Glu Phe Gly Val Asn Leu Ala Lys Val Lys Gly Thr Gly Arg 340 345 350Lys Gly Arg Ile Leu Arg Glu Asp Val Gln Ala Tyr Val Lys Glu Ala 355 360 365Ile Lys Arg Ala Glu Ala Ala Pro Ala Ala Thr Gly Gly Gly Ile Pro 370 375 380Gly Met Leu Pro Trp Pro Lys Val Asp Phe Ser Lys Phe Gly Glu Ile385 390 395 400Glu Glu Val Glu Leu Gly Arg Ile Gln Lys Ile Ser Gly Ala Asn Leu 405 410 415Ser Arg Asn Trp Val Met Ile Pro His Val Thr His Phe Asp Lys Thr 420 425 430Asp Ile Thr Glu Leu Glu Ala Phe Arg Lys Gln Gln Asn Glu Glu Ala 435 440 445Ala Lys Arg Lys Leu Asp Val Lys Ile Thr Pro Val Val Phe Ile Met 450 455 460Lys Ala Val Ala Ala Ala Leu Glu Gln Met Pro Arg Phe Asn Ser Ser465 470 475 480Leu Ser Glu Asp Gly Gln Arg Leu Thr Leu Lys Lys Tyr Ile Asn Ile 485 490 495Gly Val Ala Val Asp Thr Pro Asn Gly Leu Val Val Pro Val Phe Lys 500 505 510Asp Val Asn Lys Lys Gly Ile Ile Glu Leu Ser Arg Glu Leu Met Thr 515 520 525Ile Ser Lys Lys Ala Arg Asp Gly Lys Leu Thr Ala Gly Glu Met Gln 530 535 540Gly Gly Cys Phe Thr Ile Ser Ser Ile Gly Gly Leu Gly Thr Thr His545 550 555 560Phe Ala Pro Ile Val Asn Ala Pro Glu Val Ala Ile Leu Gly Val Ser 565 570 575Lys Ser Ala Met Glu Pro Val Trp Asn Gly Lys Glu Phe Val Pro Arg 580 585 590Leu Met Leu Pro Ile Ser Leu Ser Phe Asp His Arg Val Ile Asp Gly 595 600 605Ala Asp Gly Ala Arg Phe Ile Thr Ile Ile Asn Asn Thr Leu Ser Asp 610 615 620Ile Arg Arg Leu Val Met625 630501425DNAEscherichia coliCDS(1)..(1425) 50atg agt act gaa atc aaa act cag gtc gtg gta ctt ggg gca ggc ccc 48Met Ser Thr Glu Ile Lys Thr Gln Val Val Val Leu Gly Ala Gly Pro1 5 10 15gca ggt tac tcc gct gcc ttc cgt tgc gct gat tta ggt ctg gaa acc 96Ala Gly Tyr Ser Ala Ala Phe Arg Cys Ala Asp Leu Gly Leu Glu Thr 20 25 30gta atc gta gaa cgt tac aac acc ctt ggc ggt gtt tgc ctg aac gtc 144Val Ile Val Glu Arg Tyr Asn Thr Leu Gly Gly Val Cys Leu Asn Val 35 40 45ggc tgt atc cct tct aaa gca ctg ctg cac gta gca aaa gtt atc gaa 192Gly Cys Ile Pro Ser Lys Ala Leu Leu His Val Ala Lys Val Ile Glu 50 55 60gaa gcc aaa gcg ctg gct gaa cac ggt atc gtc ttc ggc gaa ccg aaa 240Glu Ala Lys Ala Leu Ala Glu His Gly Ile Val Phe Gly Glu Pro Lys65 70 75 80acc gat atc gac aag att cgt acc tgg aaa gag aaa gtg atc aat cag 288Thr Asp Ile Asp Lys Ile Arg Thr Trp Lys Glu Lys Val Ile Asn Gln 85 90 95ctg acc ggt ggt ctg gct ggt atg gcg aaa ggc cgc aaa gtc aaa gtg 336Leu Thr Gly Gly Leu Ala Gly Met Ala Lys Gly Arg Lys Val Lys Val 100 105 110gtc aac ggt ctg ggt aaa ttc acc ggg gct aac acc ctg gaa gtt gaa 384Val Asn Gly Leu Gly Lys Phe Thr Gly Ala Asn Thr Leu Glu Val Glu 115 120 125ggt gag aac ggc aaa acc gtg atc aac ttc gac aac gcg atc att gca 432Gly Glu Asn Gly Lys Thr Val Ile Asn Phe Asp Asn Ala Ile Ile Ala 130 135 140gcg ggt tct cgc ccg atc caa ctg ccg ttt att ccg cat gaa gat ccg 480Ala Gly Ser Arg Pro Ile Gln Leu Pro Phe Ile Pro His Glu Asp Pro145 150 155 160cgt atc tgg gac tcc act gac gcg ctg gaa ctg aaa gaa gta cca gaa 528Arg Ile Trp Asp Ser Thr Asp Ala Leu Glu Leu Lys Glu Val Pro Glu 165 170 175cgc ctg ctg gta atg ggt ggc ggt atc atc ggt ctg gaa atg ggc acc 576Arg Leu Leu Val Met Gly Gly Gly Ile Ile Gly Leu Glu Met Gly Thr 180 185 190gtt tac cac gcg ctg ggt tca cag att gac gtg gtt gaa atg ttc gac 624Val Tyr His Ala Leu Gly Ser Gln Ile Asp Val Val Glu Met Phe Asp 195 200 205cag gtt atc ccg gca gct gac aaa gac atc gtt aaa gtc ttc acc aag 672Gln Val Ile Pro Ala Ala Asp Lys Asp Ile Val Lys Val Phe Thr Lys 210 215 220cgt atc agc aag aaa ttc aac ctg atg ctg gaa acc aaa gtt acc gcc 720Arg Ile Ser Lys Lys Phe Asn Leu Met Leu Glu Thr Lys Val Thr Ala225 230 235 240gtt gaa gcg aaa gaa gac ggc att tat gtg acg atg gaa ggc aaa aaa 768Val Glu Ala Lys Glu Asp Gly Ile Tyr Val Thr Met Glu Gly Lys Lys 245 250 255gca ccc gct gaa ccg cag cgt tac gac gcc gtg ctg gta gcg att ggt 816Ala Pro Ala Glu Pro Gln Arg Tyr Asp Ala Val Leu Val Ala Ile Gly 260 265 270cgt gtg ccg aac ggt aaa aac ctc gac gca ggc aaa gca ggc gtg gaa 864Arg Val Pro Asn Gly Lys Asn Leu Asp Ala Gly Lys Ala Gly Val Glu 275 280 285gtt gac gac cgt ggt ttc atc cgc gtt gac aaa cag ctg cgt acc aac 912Val Asp Asp Arg Gly Phe Ile Arg Val Asp Lys Gln Leu Arg Thr Asn 290 295 300gta ccg cac atc ttt gct atc ggc gat atc gtc ggt caa ccg atg ctg 960Val Pro His Ile Phe Ala Ile Gly Asp Ile Val Gly Gln Pro Met Leu305 310 315 320gca cac aaa ggt gtt cac gaa ggt cac gtt gcc gct gaa gtt atc gcc 1008Ala His Lys Gly Val His Glu Gly His Val Ala Ala Glu Val Ile Ala 325 330 335ggt aag aaa cac tac ttc gat ccg aaa gtt atc ccg tcc atc gcc tat 1056Gly Lys Lys His Tyr Phe Asp Pro Lys Val Ile Pro Ser Ile Ala Tyr 340 345 350acc gaa cca gaa gtt gca tgg gtg ggt ctg act gag aaa gaa gcg aaa 1104Thr Glu Pro Glu Val Ala Trp Val Gly Leu Thr Glu Lys Glu Ala Lys 355 360 365gag aaa ggc atc agc tat gaa acc gcc acc ttc ccg tgg gct gct tct 1152Glu Lys Gly Ile Ser Tyr Glu Thr Ala Thr Phe Pro Trp Ala Ala Ser 370 375 380ggt cgt gct atc gct tcc gac tgc gca gac ggt atg acc aag ctg att 1200Gly Arg Ala Ile Ala Ser Asp Cys Ala Asp Gly Met Thr Lys Leu Ile385 390 395 400ttc gac aaa gaa tct cac cgt gtg atc ggt ggt gcg att gtc ggt act 1248Phe Asp Lys Glu Ser His Arg Val Ile Gly Gly Ala Ile Val Gly Thr 405 410 415aac ggc ggc gag ctg ctg ggt gaa atc ggc ctg gca atc gaa atg ggt 1296Asn Gly Gly Glu Leu Leu Gly Glu Ile Gly Leu Ala Ile Glu Met Gly 420 425 430tgt gat gct gaa gac atc gca ctg acc atc cac gcg cac ccg act ctg 1344Cys Asp Ala Glu Asp Ile Ala Leu Thr Ile His Ala His Pro Thr Leu 435 440 445cac gag tct gtg ggc ctg gcg gca gaa gtg ttc gaa ggt agc att acc 1392His Glu Ser Val Gly Leu Ala Ala Glu Val Phe Glu Gly Ser Ile Thr 450 455 460gac ctg ccg aac ccg aaa gcg aag aag aag taa 1425Asp Leu Pro Asn Pro Lys Ala Lys Lys Lys465 47051474PRTEscherichia coli 51Met Ser Thr Glu Ile Lys Thr Gln Val Val Val Leu Gly Ala Gly Pro1 5 10 15Ala Gly Tyr Ser Ala Ala Phe Arg Cys Ala Asp Leu Gly Leu Glu Thr 20 25 30Val Ile Val Glu Arg Tyr Asn Thr Leu Gly Gly Val Cys Leu Asn Val 35 40 45Gly Cys Ile Pro Ser Lys Ala Leu Leu His Val Ala Lys Val Ile Glu 50 55 60Glu Ala Lys Ala Leu Ala Glu His Gly Ile Val Phe Gly Glu Pro Lys65 70 75 80Thr Asp Ile Asp Lys Ile Arg Thr Trp Lys Glu Lys Val Ile Asn Gln 85 90 95Leu Thr Gly Gly Leu Ala Gly Met Ala Lys Gly Arg Lys Val Lys Val 100 105 110Val Asn Gly Leu Gly Lys Phe Thr Gly Ala Asn Thr Leu Glu Val Glu 115 120 125Gly Glu Asn Gly Lys Thr Val Ile Asn Phe Asp Asn Ala Ile Ile Ala 130 135 140Ala Gly Ser Arg Pro Ile Gln Leu Pro Phe Ile Pro His Glu Asp Pro145 150 155 160Arg Ile Trp Asp Ser Thr Asp Ala Leu Glu Leu Lys Glu Val Pro Glu 165 170 175Arg Leu Leu Val Met Gly Gly Gly Ile Ile Gly Leu Glu Met Gly Thr 180 185 190Val Tyr His Ala Leu Gly Ser Gln Ile Asp Val Val Glu Met Phe Asp 195 200 205Gln Val Ile Pro Ala Ala Asp Lys Asp Ile Val Lys Val Phe Thr Lys 210 215 220Arg Ile Ser Lys Lys Phe Asn Leu Met Leu Glu Thr Lys Val Thr Ala225 230 235 240Val Glu Ala Lys Glu Asp Gly Ile Tyr Val Thr Met Glu Gly Lys Lys 245 250 255Ala Pro Ala Glu Pro Gln Arg Tyr Asp Ala Val Leu Val Ala Ile Gly 260 265 270Arg Val Pro Asn Gly Lys Asn Leu Asp Ala Gly Lys Ala Gly Val Glu 275 280 285Val Asp Asp Arg Gly Phe Ile Arg Val Asp Lys Gln Leu Arg Thr Asn 290 295 300Val Pro His Ile Phe Ala Ile Gly Asp Ile Val Gly Gln Pro Met Leu305 310 315 320Ala His Lys Gly Val His Glu Gly His Val Ala Ala Glu Val Ile Ala 325 330 335Gly Lys Lys His Tyr Phe Asp Pro Lys Val Ile Pro Ser Ile Ala Tyr 340 345 350Thr Glu Pro Glu Val Ala Trp Val Gly Leu Thr Glu Lys Glu Ala Lys 355 360 365Glu Lys Gly Ile Ser Tyr Glu Thr Ala Thr Phe Pro Trp Ala Ala Ser 370 375 380Gly Arg Ala Ile Ala Ser Asp Cys Ala Asp Gly Met Thr Lys Leu Ile385 390 395 400Phe Asp Lys Glu Ser His Arg Val Ile Gly Gly Ala Ile Val Gly Thr 405 410 415Asn Gly Gly Glu Leu Leu Gly Glu Ile Gly Leu Ala Ile Glu Met Gly 420 425 430Cys Asp Ala Glu Asp Ile Ala Leu Thr Ile His Ala His Pro Thr Leu 435 440 445His Glu Ser Val Gly Leu Ala Ala Glu Val Phe Glu Gly Ser Ile Thr 450 455 460Asp Leu Pro Asn Pro Lys Ala Lys Lys Lys465 470521698DNAEscherichia coliCDS(1)..(1698) 52atg gaa cca aaa aca aaa aaa cag cgt tcg ctt tat atc cct tac gct 48Met Glu Pro Lys Thr Lys Lys Gln Arg Ser Leu Tyr Ile Pro Tyr Ala1 5 10 15ggc cct gta ctg ctg gaa ttt ccg ttg ttg aat aaa ggc agt gcc ttc 96Gly Pro Val Leu Leu Glu Phe Pro Leu Leu Asn Lys Gly Ser Ala Phe 20 25 30agc atg gaa gaa cgc cgt aac ttc aac ctg ctg ggg tta ctg ccg gaa 144Ser Met Glu Glu Arg Arg Asn Phe Asn Leu Leu Gly Leu Leu Pro Glu 35 40 45gtg gtc gaa acc atc gaa gaa caa gcg gaa cga gca tgg atc cag tat 192Val Val Glu Thr Ile Glu Glu Gln Ala Glu Arg Ala Trp Ile Gln Tyr 50 55 60cag gga ttc aaa acc gaa atc gac aaa cac atc tac ctg cgt aac atc 240Gln Gly Phe Lys Thr Glu Ile Asp Lys His Ile Tyr Leu Arg Asn Ile65 70 75 80cag gac act aac gaa acc ctc ttc tac cgt ctg gta aac aat cat ctt 288Gln Asp Thr Asn Glu Thr Leu Phe Tyr Arg Leu Val Asn Asn His Leu 85 90 95gat gag atg atg cct gtt att tat acc cca acc gtc ggc gca gcc tgt 336Asp Glu Met Met Pro Val Ile Tyr Thr Pro Thr Val Gly Ala Ala Cys 100 105 110gag cgt ttt tct gag atc tac cgc cgt tca cgc ggc gtg ttt atc tct 384Glu Arg Phe Ser Glu Ile Tyr Arg Arg Ser Arg Gly Val Phe Ile Ser 115 120 125tac cag aac cgg cac aat atg gac gat att ctg caa aac gtg ccg aac 432Tyr Gln Asn Arg His Asn Met Asp Asp Ile Leu Gln Asn Val Pro Asn 130 135 140cat aat att aaa gtg att gtg gtg act gac ggt gaa cgc att ctg ggg 480His Asn Ile Lys Val Ile Val Val Thr Asp Gly Glu Arg Ile Leu Gly145 150 155 160ctt ggt gac cag ggc atc ggc ggg atg ggc att ccg atc ggt aaa ctg 528Leu Gly Asp Gln Gly Ile Gly Gly Met Gly Ile Pro Ile Gly Lys Leu 165 170 175tcg ctc tat acc gcc tgt ggc ggc atc agc ccg gcg tat acc ctt ccg 576Ser Leu Tyr Thr Ala Cys Gly Gly Ile Ser Pro Ala Tyr Thr Leu Pro 180 185 190gtg gtg ctg gat gtc gga acg aac aac caa cag ctg ctt aac gat ccg 624Val Val Leu Asp Val Gly Thr Asn Asn Gln Gln Leu Leu Asn Asp Pro 195 200 205ctg tat atg ggc tgg cgt aat ccg cgt atc act gac gac gaa tac tat 672Leu Tyr Met Gly Trp Arg Asn Pro Arg Ile Thr Asp Asp Glu Tyr Tyr 210 215 220gaa ttc gtt gat gaa ttt atc cag gct gtg aaa caa cgc tgg cca gac 720Glu Phe Val Asp Glu Phe Ile Gln Ala Val Lys Gln Arg Trp Pro Asp225 230 235 240gtg ctg ttg cag ttt gaa gac ttt gct caa aaa aat gcg atg ccg tta 768Val Leu Leu Gln Phe Glu Asp Phe Ala Gln Lys Asn Ala Met Pro Leu 245 250 255ctt aac cgc tat cgc aat gaa att tgt tct ttt aac gat gac att cag 816Leu Asn Arg Tyr Arg Asn Glu Ile Cys Ser Phe Asn Asp Asp Ile Gln 260 265 270ggc act gcg gcg gta aca gtc ggc aca ctg atc gca gca agc cgc gcg 864Gly Thr Ala Ala Val Thr Val Gly Thr Leu Ile Ala Ala Ser Arg Ala 275 280 285gca ggt ggt cag tta agc gag aaa aaa atc gtc ttc ctt ggc gca ggt 912Ala Gly Gly Gln Leu Ser Glu Lys Lys Ile Val Phe Leu Gly Ala Gly 290 295 300tca gcg gga tgc ggc att gcc gaa atg atc atc tcc cag acc cag cgc 960Ser Ala Gly Cys Gly Ile Ala Glu Met Ile Ile Ser Gln Thr Gln Arg305 310 315 320gaa gga tta agc gag gaa gcg gcg cgg cag aaa gtc ttt atg gtc gat 1008Glu Gly Leu Ser Glu Glu Ala Ala Arg Gln Lys Val Phe Met Val Asp 325 330 335cgc ttt ggc ttg ctg act gac aag atg ccg aac ctg ctg cct ttc cag 1056Arg Phe Gly Leu Leu Thr Asp Lys Met Pro Asn Leu Leu Pro Phe Gln 340 345 350acc aaa ctg gtg cag aag cgc gaa aac ctc agt gac tgg gat acc gac 1104Thr Lys Leu Val Gln Lys Arg Glu Asn Leu Ser Asp Trp Asp Thr Asp

355 360 365agc gat gtg ctg tca ctg ctg gat gtg gtg cgc aat gta aaa cca gat 1152Ser Asp Val Leu Ser Leu Leu Asp Val Val Arg Asn Val Lys Pro Asp 370 375 380att ctg att ggc gtc tca gga cag acc ggg ctg ttt acg gaa gag atc 1200Ile Leu Ile Gly Val Ser Gly Gln Thr Gly Leu Phe Thr Glu Glu Ile385 390 395 400atc cgt gag atg cat aaa cac tgt ccg cgt ccg atc gtg atg ccg ctg 1248Ile Arg Glu Met His Lys His Cys Pro Arg Pro Ile Val Met Pro Leu 405 410 415tct aac ccg acg tca cgc gtg gaa gcc aca ccg cag gac att atc gcc 1296Ser Asn Pro Thr Ser Arg Val Glu Ala Thr Pro Gln Asp Ile Ile Ala 420 425 430tgg acc gaa ggt aac gcg ctg gtc gcc acg ggc agc ccg ttt aat cca 1344Trp Thr Glu Gly Asn Ala Leu Val Ala Thr Gly Ser Pro Phe Asn Pro 435 440 445gtg gta tgg aaa gat aaa atc tac cct atc gcc cag tgt aac aac gcc 1392Val Val Trp Lys Asp Lys Ile Tyr Pro Ile Ala Gln Cys Asn Asn Ala 450 455 460ttt att ttc ccg ggc atc ggc ctg ggt gtt att gct tcc ggc gcg tca 1440Phe Ile Phe Pro Gly Ile Gly Leu Gly Val Ile Ala Ser Gly Ala Ser465 470 475 480cgt atc acc gat gag atg ctg atg tcg gca agt gaa acg ctg gcg cag 1488Arg Ile Thr Asp Glu Met Leu Met Ser Ala Ser Glu Thr Leu Ala Gln 485 490 495tat tca cca ttg gtg ctg aac ggc gaa ggt atg gta ctg ccg gaa ctg 1536Tyr Ser Pro Leu Val Leu Asn Gly Glu Gly Met Val Leu Pro Glu Leu 500 505 510aaa gat att cag aaa gtc tcc cgc gca att gcg ttt gcg gtt ggc aaa 1584Lys Asp Ile Gln Lys Val Ser Arg Ala Ile Ala Phe Ala Val Gly Lys 515 520 525atg gcg cag cag caa ggc gtg gcg gtg aaa acc tct gcc gaa gcc ctg 1632Met Ala Gln Gln Gln Gly Val Ala Val Lys Thr Ser Ala Glu Ala Leu 530 535 540caa cag gcc att gac gat aat ttc tgg caa gcc gaa tac cgc gac tac 1680Gln Gln Ala Ile Asp Asp Asn Phe Trp Gln Ala Glu Tyr Arg Asp Tyr545 550 555 560cgc cgt acc tcc atc taa 1698Arg Arg Thr Ser Ile 56553565PRTEscherichia coli 53Met Glu Pro Lys Thr Lys Lys Gln Arg Ser Leu Tyr Ile Pro Tyr Ala1 5 10 15Gly Pro Val Leu Leu Glu Phe Pro Leu Leu Asn Lys Gly Ser Ala Phe 20 25 30Ser Met Glu Glu Arg Arg Asn Phe Asn Leu Leu Gly Leu Leu Pro Glu 35 40 45Val Val Glu Thr Ile Glu Glu Gln Ala Glu Arg Ala Trp Ile Gln Tyr 50 55 60Gln Gly Phe Lys Thr Glu Ile Asp Lys His Ile Tyr Leu Arg Asn Ile65 70 75 80Gln Asp Thr Asn Glu Thr Leu Phe Tyr Arg Leu Val Asn Asn His Leu 85 90 95Asp Glu Met Met Pro Val Ile Tyr Thr Pro Thr Val Gly Ala Ala Cys 100 105 110Glu Arg Phe Ser Glu Ile Tyr Arg Arg Ser Arg Gly Val Phe Ile Ser 115 120 125Tyr Gln Asn Arg His Asn Met Asp Asp Ile Leu Gln Asn Val Pro Asn 130 135 140His Asn Ile Lys Val Ile Val Val Thr Asp Gly Glu Arg Ile Leu Gly145 150 155 160Leu Gly Asp Gln Gly Ile Gly Gly Met Gly Ile Pro Ile Gly Lys Leu 165 170 175Ser Leu Tyr Thr Ala Cys Gly Gly Ile Ser Pro Ala Tyr Thr Leu Pro 180 185 190Val Val Leu Asp Val Gly Thr Asn Asn Gln Gln Leu Leu Asn Asp Pro 195 200 205Leu Tyr Met Gly Trp Arg Asn Pro Arg Ile Thr Asp Asp Glu Tyr Tyr 210 215 220Glu Phe Val Asp Glu Phe Ile Gln Ala Val Lys Gln Arg Trp Pro Asp225 230 235 240Val Leu Leu Gln Phe Glu Asp Phe Ala Gln Lys Asn Ala Met Pro Leu 245 250 255Leu Asn Arg Tyr Arg Asn Glu Ile Cys Ser Phe Asn Asp Asp Ile Gln 260 265 270Gly Thr Ala Ala Val Thr Val Gly Thr Leu Ile Ala Ala Ser Arg Ala 275 280 285Ala Gly Gly Gln Leu Ser Glu Lys Lys Ile Val Phe Leu Gly Ala Gly 290 295 300Ser Ala Gly Cys Gly Ile Ala Glu Met Ile Ile Ser Gln Thr Gln Arg305 310 315 320Glu Gly Leu Ser Glu Glu Ala Ala Arg Gln Lys Val Phe Met Val Asp 325 330 335Arg Phe Gly Leu Leu Thr Asp Lys Met Pro Asn Leu Leu Pro Phe Gln 340 345 350Thr Lys Leu Val Gln Lys Arg Glu Asn Leu Ser Asp Trp Asp Thr Asp 355 360 365Ser Asp Val Leu Ser Leu Leu Asp Val Val Arg Asn Val Lys Pro Asp 370 375 380Ile Leu Ile Gly Val Ser Gly Gln Thr Gly Leu Phe Thr Glu Glu Ile385 390 395 400Ile Arg Glu Met His Lys His Cys Pro Arg Pro Ile Val Met Pro Leu 405 410 415Ser Asn Pro Thr Ser Arg Val Glu Ala Thr Pro Gln Asp Ile Ile Ala 420 425 430Trp Thr Glu Gly Asn Ala Leu Val Ala Thr Gly Ser Pro Phe Asn Pro 435 440 445Val Val Trp Lys Asp Lys Ile Tyr Pro Ile Ala Gln Cys Asn Asn Ala 450 455 460Phe Ile Phe Pro Gly Ile Gly Leu Gly Val Ile Ala Ser Gly Ala Ser465 470 475 480Arg Ile Thr Asp Glu Met Leu Met Ser Ala Ser Glu Thr Leu Ala Gln 485 490 495Tyr Ser Pro Leu Val Leu Asn Gly Glu Gly Met Val Leu Pro Glu Leu 500 505 510Lys Asp Ile Gln Lys Val Ser Arg Ala Ile Ala Phe Ala Val Gly Lys 515 520 525Met Ala Gln Gln Gln Gly Val Ala Val Lys Thr Ser Ala Glu Ala Leu 530 535 540Gln Gln Ala Ile Asp Asp Asn Phe Trp Gln Ala Glu Tyr Arg Asp Tyr545 550 555 560Arg Arg Thr Ser Ile 565542280DNAEscherichia coliCDS(1)..(2280) 54atg gat gac cag tta aaa caa agt gca ctt gat ttc cat gaa ttt cca 48Met Asp Asp Gln Leu Lys Gln Ser Ala Leu Asp Phe His Glu Phe Pro1 5 10 15gtt cca ggg aaa atc cag gtt tct cca acc aag cct ctg gca aca cag 96Val Pro Gly Lys Ile Gln Val Ser Pro Thr Lys Pro Leu Ala Thr Gln 20 25 30cgc gat ctg gcg ctg gcc tac tca cca ggc gtt gcc gca cct tgt ctt 144Arg Asp Leu Ala Leu Ala Tyr Ser Pro Gly Val Ala Ala Pro Cys Leu 35 40 45gaa atc gaa aaa gac ccg tta aaa gcc tac aaa tat acc gcc cga ggt 192Glu Ile Glu Lys Asp Pro Leu Lys Ala Tyr Lys Tyr Thr Ala Arg Gly 50 55 60aac ctg gtg gcg gtg atc tct aac ggt acg gcg gtg ctg ggg tta ggc 240Asn Leu Val Ala Val Ile Ser Asn Gly Thr Ala Val Leu Gly Leu Gly65 70 75 80aac att ggc gcg ctg gca ggc aaa ccg gtg atg gaa ggc aag ggc gtt 288Asn Ile Gly Ala Leu Ala Gly Lys Pro Val Met Glu Gly Lys Gly Val 85 90 95ctg ttt aag aaa ttc gcc ggg att gat gta ttt gac att gaa gtt gac 336Leu Phe Lys Lys Phe Ala Gly Ile Asp Val Phe Asp Ile Glu Val Asp 100 105 110gaa ctc gac ccg gac aaa ttt att gaa gtt gtc gcc gcg ctc gaa cca 384Glu Leu Asp Pro Asp Lys Phe Ile Glu Val Val Ala Ala Leu Glu Pro 115 120 125acc ttc ggc ggc atc aac ctc gaa gac att aaa gcg cca gaa tgt ttc 432Thr Phe Gly Gly Ile Asn Leu Glu Asp Ile Lys Ala Pro Glu Cys Phe 130 135 140tat att gaa cag aaa ctg cgc gag cgg atg aat att ccg gta ttc cac 480Tyr Ile Glu Gln Lys Leu Arg Glu Arg Met Asn Ile Pro Val Phe His145 150 155 160gac gat cag cac ggc acg gca att atc agc act gcc gcc atc ctc aac 528Asp Asp Gln His Gly Thr Ala Ile Ile Ser Thr Ala Ala Ile Leu Asn 165 170 175ggc ttg cgc gtg gtg gag aaa aac atc tcc gac gtg cgg atg gtg gtt 576Gly Leu Arg Val Val Glu Lys Asn Ile Ser Asp Val Arg Met Val Val 180 185 190tcc ggc gcg ggt gcc gca gca atc gcc tgt atg aac ctg ctg gta gcg 624Ser Gly Ala Gly Ala Ala Ala Ile Ala Cys Met Asn Leu Leu Val Ala 195 200 205ctg ggt ctg caa aaa cat aac atc gtg gtt tgc gat tca aaa ggc gtt 672Leu Gly Leu Gln Lys His Asn Ile Val Val Cys Asp Ser Lys Gly Val 210 215 220 atc tat cag ggc cgt gag cca aac atg gcg gaa acc aaa gcc gca tat 720Ile Tyr Gln Gly Arg Glu Pro Asn Met Ala Glu Thr Lys Ala Ala Tyr225 230 235 240gcg gtg gtg gat gac ggc aaa cgt acc ctc gat gat gtg att gaa ggc 768Ala Val Val Asp Asp Gly Lys Arg Thr Leu Asp Asp Val Ile Glu Gly 245 250 255gcg gat att ttc ctg ggc tgt tcc ggc ccg aaa gtg ctg acc cag gaa 816Ala Asp Ile Phe Leu Gly Cys Ser Gly Pro Lys Val Leu Thr Gln Glu 260 265 270atg gtg aag aaa atg gct cgt gcg cca atg atc ctg gcg ctg gcg aac 864Met Val Lys Lys Met Ala Arg Ala Pro Met Ile Leu Ala Leu Ala Asn 275 280 285ccg gaa ccg gaa att ctg ccg ccg ctg gcg aaa gaa gtg cgt ccg gat 912Pro Glu Pro Glu Ile Leu Pro Pro Leu Ala Lys Glu Val Arg Pro Asp 290 295 300gcc atc att tgc acc ggt cgt tct gac tat ccg aac cag gtg aac aac 960Ala Ile Ile Cys Thr Gly Arg Ser Asp Tyr Pro Asn Gln Val Asn Asn305 310 315 320gtc ctg tgc ttc ccg ttc atc ttc cgt ggc gcg ctg gac gtt ggc gca 1008Val Leu Cys Phe Pro Phe Ile Phe Arg Gly Ala Leu Asp Val Gly Ala 325 330 335acc gcc atc aac gaa gag atg aaa ctg gcg gcg gta cgt gcg att gca 1056Thr Ala Ile Asn Glu Glu Met Lys Leu Ala Ala Val Arg Ala Ile Ala 340 345 350gaa ctc gcc cat gcg gaa cag agc gaa gtg gtg gct tca gcg tat ggc 1104Glu Leu Ala His Ala Glu Gln Ser Glu Val Val Ala Ser Ala Tyr Gly 355 360 365gat cag gat ctg agc ttt ggt ccg gaa tac atc att cca aaa ccg ttt 1152Asp Gln Asp Leu Ser Phe Gly Pro Glu Tyr Ile Ile Pro Lys Pro Phe 370 375 380gat ccg cgc ttg atc gtt aag atc gct cct gcg gtc gct aaa gcc gcg 1200Asp Pro Arg Leu Ile Val Lys Ile Ala Pro Ala Val Ala Lys Ala Ala385 390 395 400atg gag tcg ggc gtg gcg act cgt ccg att gct gat ttc gac gtc tac 1248Met Glu Ser Gly Val Ala Thr Arg Pro Ile Ala Asp Phe Asp Val Tyr 405 410 415atc gac aag ctg act gag ttc gtt tac aaa acc aac ctg ttt atg aag 1296Ile Asp Lys Leu Thr Glu Phe Val Tyr Lys Thr Asn Leu Phe Met Lys 420 425 430ccg att ttc tcc cag gct cgc aaa gcg ccg aag cgc gtt gtt ctg ccg 1344Pro Ile Phe Ser Gln Ala Arg Lys Ala Pro Lys Arg Val Val Leu Pro 435 440 445gaa ggg gaa gag gcg cgc gtt ctg cat gcc act cag gaa ctg gta acg 1392Glu Gly Glu Glu Ala Arg Val Leu His Ala Thr Gln Glu Leu Val Thr 450 455 460ctg gga ctg gcg aaa ccg atc ctt atc ggt cgt ccg aac gtg atc gaa 1440Leu Gly Leu Ala Lys Pro Ile Leu Ile Gly Arg Pro Asn Val Ile Glu465 470 475 480atg cgc att cag aaa ctg ggc ttg cag atc aaa gcg ggc gtt gat ttt 1488Met Arg Ile Gln Lys Leu Gly Leu Gln Ile Lys Ala Gly Val Asp Phe 485 490 495gag atc gtc aat aac gaa tcc gat ccg cgc ttt aaa gag tac tgg acc 1536Glu Ile Val Asn Asn Glu Ser Asp Pro Arg Phe Lys Glu Tyr Trp Thr 500 505 510gaa tac ttc cag atc atg aag cgt cgc ggc gtc act cag gaa cag gcg 1584Glu Tyr Phe Gln Ile Met Lys Arg Arg Gly Val Thr Gln Glu Gln Ala 515 520 525cag cgg gcg ctg atc agt aac ccg aca gtg atc ggc gcg atc atg gtt 1632Gln Arg Ala Leu Ile Ser Asn Pro Thr Val Ile Gly Ala Ile Met Val 530 535 540cag cgt ggg gaa gcc gat gca atg att tgc ggt acg gtg ggt gat tat 1680Gln Arg Gly Glu Ala Asp Ala Met Ile Cys Gly Thr Val Gly Asp Tyr545 550 555 560cat gaa cat ttt agc gtg gtg aaa aat gtc ttt ggt tat cgc gat ggc 1728His Glu His Phe Ser Val Val Lys Asn Val Phe Gly Tyr Arg Asp Gly 565 570 575gtt cac acc gca ggt gcc atg aac gcg ctg ctg ctg ccg agt ggt aac 1776Val His Thr Ala Gly Ala Met Asn Ala Leu Leu Leu Pro Ser Gly Asn 580 585 590acc ttt att gcc gat aca tat gtt aat gat gaa ccg gat gca gaa gag 1824Thr Phe Ile Ala Asp Thr Tyr Val Asn Asp Glu Pro Asp Ala Glu Glu 595 600 605ctg gcg gag atc acc ttg atg gcg gca gaa act gtc cgt cgt ttt ggt 1872Leu Ala Glu Ile Thr Leu Met Ala Ala Glu Thr Val Arg Arg Phe Gly 610 615 620att gag ccg cgc gtt gct ttg ttg tcg cac tcc aac ttt ggt tct tct 1920Ile Glu Pro Arg Val Ala Leu Leu Ser His Ser Asn Phe Gly Ser Ser625 630 635 640gac tgc ccg tcg tcg agc aaa atg cgt cag gcg ctg gaa ctg gtc agg 1968Asp Cys Pro Ser Ser Ser Lys Met Arg Gln Ala Leu Glu Leu Val Arg 645 650 655gaa cgt gca cca gaa ctg atg att gat ggt gaa atg cac ggc gat gca 2016Glu Arg Ala Pro Glu Leu Met Ile Asp Gly Glu Met His Gly Asp Ala 660 665 670gcg ctg gtg gaa gcg att cgc aac gac cgt atg ccg gac agc tct ttg 2064Ala Leu Val Glu Ala Ile Arg Asn Asp Arg Met Pro Asp Ser Ser Leu 675 680 685aaa ggt tcc gcc aat att ctg gtg atg ccg aac atg gaa gct gcc cgc 2112Lys Gly Ser Ala Asn Ile Leu Val Met Pro Asn Met Glu Ala Ala Arg 690 695 700att agt tac aac tta ctg cgt gtt tcc agc tcg gaa ggt gtg act gtc 2160Ile Ser Tyr Asn Leu Leu Arg Val Ser Ser Ser Glu Gly Val Thr Val705 710 715 720ggc ccg gtg ctg atg ggt gtg gcg aaa ccg gtt cac gtg tta acg ccg 2208Gly Pro Val Leu Met Gly Val Ala Lys Pro Val His Val Leu Thr Pro 725 730 735atc gca tcg gtg cgt cgt atc gtc aac atg gtg gcg ctg gcc gtg gta 2256Ile Ala Ser Val Arg Arg Ile Val Asn Met Val Ala Leu Ala Val Val 740 745 750gaa gcg caa acc caa ccg ctg taa 2280Glu Ala Gln Thr Gln Pro Leu 75555759PRTEscherichia coli 55Met Asp Asp Gln Leu Lys Gln Ser Ala Leu Asp Phe His Glu Phe Pro1 5 10 15Val Pro Gly Lys Ile Gln Val Ser Pro Thr Lys Pro Leu Ala Thr Gln 20 25 30Arg Asp Leu Ala Leu Ala Tyr Ser Pro Gly Val Ala Ala Pro Cys Leu 35 40 45Glu Ile Glu Lys Asp Pro Leu Lys Ala Tyr Lys Tyr Thr Ala Arg Gly 50 55 60Asn Leu Val Ala Val Ile Ser Asn Gly Thr Ala Val Leu Gly Leu Gly65 70 75 80Asn Ile Gly Ala Leu Ala Gly Lys Pro Val Met Glu Gly Lys Gly Val 85 90 95Leu Phe Lys Lys Phe Ala Gly Ile Asp Val Phe Asp Ile Glu Val Asp 100 105 110Glu Leu Asp Pro Asp Lys Phe Ile Glu Val Val Ala Ala Leu Glu Pro 115 120 125Thr Phe Gly Gly Ile Asn Leu Glu Asp Ile Lys Ala Pro Glu Cys Phe 130 135 140Tyr Ile Glu Gln Lys Leu Arg Glu Arg Met Asn Ile Pro Val Phe His145 150 155 160Asp Asp Gln His Gly Thr Ala Ile Ile Ser Thr Ala Ala Ile Leu Asn 165 170 175Gly Leu Arg Val Val Glu Lys Asn Ile Ser Asp Val Arg Met Val Val 180 185 190Ser Gly Ala Gly Ala Ala Ala Ile Ala Cys Met Asn Leu Leu Val Ala 195 200 205Leu Gly Leu Gln Lys His Asn Ile Val Val Cys Asp Ser Lys Gly Val 210 215 220Ile Tyr Gln Gly Arg Glu Pro Asn Met Ala Glu Thr Lys Ala Ala Tyr225 230 235 240Ala Val Val Asp Asp Gly Lys Arg Thr Leu Asp Asp Val Ile Glu Gly 245 250 255Ala Asp Ile Phe Leu Gly Cys Ser Gly Pro Lys Val Leu Thr Gln Glu 260 265 270Met Val Lys Lys Met Ala Arg Ala Pro Met Ile Leu Ala Leu Ala Asn 275 280 285Pro Glu Pro Glu Ile Leu Pro Pro Leu Ala Lys Glu Val Arg Pro Asp 290 295 300Ala Ile Ile Cys Thr Gly Arg Ser Asp Tyr Pro Asn Gln Val Asn Asn305 310 315 320Val Leu Cys Phe Pro Phe Ile Phe Arg Gly Ala Leu Asp Val Gly Ala 325 330 335Thr Ala Ile Asn Glu Glu Met Lys Leu Ala Ala Val Arg Ala Ile Ala

340 345 350Glu Leu Ala His Ala Glu Gln Ser Glu Val Val Ala Ser Ala Tyr Gly 355 360 365Asp Gln Asp Leu Ser Phe Gly Pro Glu Tyr Ile Ile Pro Lys Pro Phe 370 375 380Asp Pro Arg Leu Ile Val Lys Ile Ala Pro Ala Val Ala Lys Ala Ala385 390 395 400Met Glu Ser Gly Val Ala Thr Arg Pro Ile Ala Asp Phe Asp Val Tyr 405 410 415Ile Asp Lys Leu Thr Glu Phe Val Tyr Lys Thr Asn Leu Phe Met Lys 420 425 430Pro Ile Phe Ser Gln Ala Arg Lys Ala Pro Lys Arg Val Val Leu Pro 435 440 445Glu Gly Glu Glu Ala Arg Val Leu His Ala Thr Gln Glu Leu Val Thr 450 455 460Leu Gly Leu Ala Lys Pro Ile Leu Ile Gly Arg Pro Asn Val Ile Glu465 470 475 480Met Arg Ile Gln Lys Leu Gly Leu Gln Ile Lys Ala Gly Val Asp Phe 485 490 495Glu Ile Val Asn Asn Glu Ser Asp Pro Arg Phe Lys Glu Tyr Trp Thr 500 505 510Glu Tyr Phe Gln Ile Met Lys Arg Arg Gly Val Thr Gln Glu Gln Ala 515 520 525Gln Arg Ala Leu Ile Ser Asn Pro Thr Val Ile Gly Ala Ile Met Val 530 535 540Gln Arg Gly Glu Ala Asp Ala Met Ile Cys Gly Thr Val Gly Asp Tyr545 550 555 560His Glu His Phe Ser Val Val Lys Asn Val Phe Gly Tyr Arg Asp Gly 565 570 575Val His Thr Ala Gly Ala Met Asn Ala Leu Leu Leu Pro Ser Gly Asn 580 585 590Thr Phe Ile Ala Asp Thr Tyr Val Asn Asp Glu Pro Asp Ala Glu Glu 595 600 605Leu Ala Glu Ile Thr Leu Met Ala Ala Glu Thr Val Arg Arg Phe Gly 610 615 620Ile Glu Pro Arg Val Ala Leu Leu Ser His Ser Asn Phe Gly Ser Ser625 630 635 640Asp Cys Pro Ser Ser Ser Lys Met Arg Gln Ala Leu Glu Leu Val Arg 645 650 655Glu Arg Ala Pro Glu Leu Met Ile Asp Gly Glu Met His Gly Asp Ala 660 665 670Ala Leu Val Glu Ala Ile Arg Asn Asp Arg Met Pro Asp Ser Ser Leu 675 680 685Lys Gly Ser Ala Asn Ile Leu Val Met Pro Asn Met Glu Ala Ala Arg 690 695 700Ile Ser Tyr Asn Leu Leu Arg Val Ser Ser Ser Glu Gly Val Thr Val705 710 715 720Gly Pro Val Leu Met Gly Val Ala Lys Pro Val His Val Leu Thr Pro 725 730 735Ile Ala Ser Val Arg Arg Ile Val Asn Met Val Ala Leu Ala Val Val 740 745 750Glu Ala Gln Thr Gln Pro Leu 755

Claims

1. A method for producing an L-amino acid selected from the group consisting of L-lysine, L-tryptophan, L-phenylalanine, L-valine, L-leucine, L-isoleucine, and L-serine comprising: A) culturing in a medium a microorganism which has an ability to produce the L-amino acid, and B) collecting the L-amino acid from the medium or the microorganism, wherein said microorganism has been modified to increase an activity of NADH+ oxidoreductase by a method selected from the group consisting of: i) increasing the copy number of a gene encoding NADH+ oxidoreductase, ii) modifying an expression control sequence of the gene, and iii) combinations thereof; and wherein NADH+ oxidoreductase is selected from the group consisting of: (a) a polypeptide comprising the amino acid sequence shown in SEQ ID NO: 6, and (b) a polypeptide comprising the amino acid sequence shown in SEQ ID NO: 6, but which includes between 1 and 20 substitutions, deletions, insertions, or additions, and has NADH+ oxidoreductase activity.

2. The method according to claim 1, wherein the medium contains ethanol or an aliphatic acid as the carbon source.

3. The method according to claim 1, wherein the gene encoding NADH+ oxidoreductase comprises a DNA selected from the group consisting of: (a) a DNA comprising the nucleotide sequence shown in SEQ ID NO: 5, and (b) a DNA which is able to hybridize with a sequence complementary to the nucleotide sequence shown in SEQ ID NO: 5 under stringent conditions comprising washing at 68.degree. C., 0.1.times.SSC, 0.1% SDS and encoding a polypeptide having NADH+ oxidoreductase activity.

4. The method according to claim 1, wherein the microorganism has been further modified to increase the activity of ferredoxin-NADP.sup.+ reductase by a method selected from the group consisting of: a) increasing the copy number of a gene encoding ferrodoxin-NADP.sup.+ reductase, b) modifying an expression control sequence of the gene, and c) combinations thereof.

5. The method according to claim 1, wherein the microorganism has been further modified to increase production of ferredoxin or flavodoxin by a method selected from the group consisting of: a) increasing the copy number of a gene encoding ferredoxin or flavodoxin, b) modifying an expression control sequence of the gene, and c) combinations thereof.

6. The method according to claim 1, wherein the microorganism has been further modified to decrease pyruvate dehydrogenase activity by a method selected from the group consisting of: a) introducing a deletion or mutation into a gene encoding pyruvate dehydrogenase, b) introducing a deletion or mutation into an expression control sequence of the gene, and c) combinations thereof.

7. The method according to claim 1, wherein the microorganism has been further modified so that it can aerobically assimilate ethanol.

8. The method according to claim 1, wherein the microorganism is a bacterium belonging to a genus selected from the group consisting of Escherichia, Enterobacter, Pantoea, Klebsiella, and Serratia.

9. The method according to claim 1, wherein the microorganism is a coryneform bacterium.

10. The method according to claim 1, wherein the microorganism is Escherichia coli.

11. A method for producing an L-amino acid selected from the group consisting of L-lysine, L-tryptophan, L-phenylalanine, L-valine, L-leucine, L-isoleucine and L-serine comprising: A) culturing in a medium a microorganism which has an ability to produce the L-amino acid, and B) collecting the L-amino acid from the medium or the microorganism, wherein said microorganism has been modified to increase an activity of NADH+ oxidoreductase by a method selected from the group consisting of: i) increasing the copy number of a gene encoding NADH+ oxidoreductase, ii) modifying an expression control sequence of the gene, and iii) combinations thereof; and wherein NADH+ oxidoreductase comprises the amino acid sequence shown in SEQ ID NO: 6.

12. A method for producing an L-amino acid selected from the group consisting of L-lysine, L-tryptophan, L-phenylalanine, L-valine, L-leucine, L-isoleucine and L-serine comprising: A) culturing in a medium a microorganism which has an ability to produce the L-amino acid, and B) collecting the L-amino acid from the medium or the microorganism, wherein said microorganism has been modified to increase an activity of NADH+ oxidoreductase by method selected from the group consisting of: i) increasing the copy number of a gene encoding NADH+ oxidoreductase, ii) modifying an expression control sequence of the gene, and iii) combinations thereof; and wherein the gene encoding NADH+ oxidoreductase is a DNA comprising the nucleotide sequence shown in SEQ ID NO: 5.